Q2--12-310001114995false0001114995us-gaap:TradeNamesMember2024-06-300001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember2021-11-300001114995pi:VoyanticOyMember2024-04-012024-06-300001114995us-gaap:GeneralAndAdministrativeExpenseMember2024-01-012024-06-300001114995us-gaap:ConvertibleDebtMember2024-01-012024-06-300001114995pi:ConvertiblePromissoryNotesDueTwoThousandTwentySevenMember2021-11-012021-11-300001114995us-gaap:CommonStockMember2023-12-310001114995us-gaap:AdditionalPaidInCapitalMember2023-03-310001114995us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CashEquivalentsMember2023-12-310001114995us-gaap:AdditionalPaidInCapitalMember2022-12-310001114995us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995us-gaap:CommonStockMember2023-04-012023-06-300001114995us-gaap:AdditionalPaidInCapitalMember2023-12-310001114995us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CashEquivalentsMember2024-06-300001114995pi:TwoThousandTwentyOneNotesMember2023-01-012023-06-300001114995pi:VoyanticOyMember2024-06-300001114995us-gaap:RetainedEarningsMember2024-06-300001114995us-gaap:CommonStockMember2022-12-310001114995us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995us-gaap:AdditionalPaidInCapitalMember2023-06-300001114995us-gaap:RetainedEarningsMember2023-06-300001114995us-gaap:ResearchAndDevelopmentExpenseMember2023-04-012023-06-300001114995us-gaap:RetainedEarningsMember2024-03-310001114995us-gaap:CostOfSalesMember2023-01-012023-06-300001114995us-gaap:RetainedEarningsMember2023-04-012023-06-300001114995pi:MarketAndServiceConditionUnitsMember2023-12-310001114995us-gaap:SellingAndMarketingExpenseMember2024-04-012024-06-300001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember2023-01-012023-06-300001114995us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-06-300001114995pi:EmployeeStockPurchasePlanSharesMember2024-01-012024-06-3000011149952024-03-132024-03-130001114995us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995us-gaap:AgencySecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995pi:EndpointICsMember2024-01-012024-06-300001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember2024-01-012024-06-300001114995us-gaap:CommonStockMember2023-01-012023-03-310001114995us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001114995pi:RestrictedStockUnitsMarketAndServiceConditionUnitsAndPerformanceStockUnitsMember2024-04-012024-06-3000011149952024-02-072024-02-070001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember2024-04-012024-06-300001114995us-gaap:SellingAndMarketingExpenseMember2024-01-012024-06-300001114995us-gaap:AdditionalPaidInCapitalMember2024-03-310001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySixMember2019-12-112019-12-110001114995us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995pi:VoyanticOyMember2023-04-030001114995us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001114995us-gaap:RetainedEarningsMember2022-12-310001114995us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995pi:VoyanticOyMember2023-04-032023-04-030001114995us-gaap:CostOfSalesMember2024-04-012024-06-3000011149952024-06-3000011149952024-01-012024-03-310001114995pi:EmployeeStockPurchasePlanSharesMember2023-04-012023-06-300001114995us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001114995pi:TwoThousandTwentyOneNotesMember2023-04-012023-06-300001114995us-gaap:FairValueInputsLevel2Memberpi:ConvertiblePromissoryNotesDueTwoThousandTwentySevenMember2023-12-310001114995us-gaap:RetainedEarningsMember2023-01-012023-03-310001114995pi:SystemsMember2024-04-012024-06-3000011149952023-01-012023-03-310001114995us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CashEquivalentsMember2024-06-300001114995us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-06-300001114995us-gaap:EmployeeStockOptionMember2024-01-012024-06-3000011149952024-03-310001114995us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-06-300001114995pi:ContingentConsiderationLiabilityMember2023-12-3100011149952024-01-012024-06-300001114995us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CashEquivalentsMember2024-06-300001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySixMemberpi:TwoThousandNineteenNoteRepurchaseMember2021-11-012021-11-300001114995us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001114995us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberpi:YankeeBondsMember2024-06-300001114995us-gaap:EmployeeStockOptionMember2023-01-012023-06-300001114995us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001114995us-gaap:FairValueInputsLevel2Memberpi:ConvertiblePromissoryNotesDueTwoThousandTwentySevenMember2024-06-300001114995us-gaap:GeneralAndAdministrativeExpenseMember2023-04-012023-06-300001114995pi:SystemsMember2023-04-012023-06-300001114995us-gaap:AccruedLiabilitiesMember2023-12-310001114995us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001114995us-gaap:RelatedPartyMemberus-gaap:PatentsMemberpi:EndpointICsMember2023-06-232023-06-230001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember2023-12-310001114995us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001114995us-gaap:RestrictedStockUnitsRSUMember2024-06-300001114995us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001114995pi:ConvertiblePromissoryNotesDueTwoThousandTwentySevenMember2021-11-300001114995pi:RestrictedStockUnitsMarketAndServiceConditionUnitsAndPerformanceStockUnitsMember2023-01-012023-06-300001114995us-gaap:RestrictedStockUnitsRSUMember2023-12-310001114995us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001114995us-gaap:FairValueMeasurementsRecurringMemberpi:YankeeBondsMember2024-06-300001114995pi:BacklogMember2024-06-300001114995us-gaap:ShortTermInvestmentsMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-3100011149952022-12-310001114995us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberpi:YankeeBondsMember2023-12-310001114995us-gaap:FairValueMeasurementsRecurringMemberpi:YankeeBondsMember2023-12-310001114995us-gaap:CostOfSalesMember2024-01-012024-06-300001114995us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001114995us-gaap:SellingAndMarketingExpenseMember2023-04-012023-06-3000011149952023-04-012023-06-300001114995pi:EndpointICsMember2024-04-012024-06-300001114995us-gaap:CommonStockMember2023-06-300001114995us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995us-gaap:ResearchAndDevelopmentExpenseMember2024-04-012024-06-300001114995pi:ContingentConsiderationLiabilityMember2024-06-300001114995pi:EndpointICsMember2023-01-012023-06-300001114995us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001114995pi:EmployeeStockPurchasePlanSharesMember2023-01-012023-06-300001114995us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-3000011149952023-12-310001114995pi:SystemsMember2024-01-012024-06-300001114995us-gaap:AccruedLiabilitiesMember2024-06-300001114995us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001114995pi:RestrictedStockUnitsMarketAndServiceConditionUnitsAndPerformanceStockUnitsMember2023-04-012023-06-300001114995pi:TwoThousandTwentyOneNotesMember2024-01-012024-06-3000011149952023-03-310001114995us-gaap:ShortTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001114995us-gaap:GeneralAndAdministrativeExpenseMember2024-04-012024-06-300001114995srt:MinimumMemberus-gaap:ConvertibleDebtMember2024-01-012024-06-300001114995us-gaap:CommonStockMember2024-04-012024-06-300001114995us-gaap:RetainedEarningsMember2024-04-012024-06-300001114995us-gaap:AdditionalPaidInCapitalMember2024-06-300001114995us-gaap:CostOfSalesMember2023-04-012023-06-300001114995us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001114995us-gaap:CommonStockMember2023-03-310001114995us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001114995us-gaap:RetainedEarningsMember2023-03-310001114995us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CashEquivalentsMember2023-12-310001114995us-gaap:AgencySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995us-gaap:CommonStockMember2024-01-012024-03-310001114995pi:RestrictedStockUnitsMarketAndServiceConditionUnitsAndPerformanceStockUnitsMember2024-01-012024-06-300001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember2024-06-300001114995pi:MarketAndServiceConditionUnitsMember2024-01-012024-06-300001114995pi:SystemsMember2023-01-012023-06-300001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySixMemberpi:TwoThousandNineteenNoteRepurchaseMember2022-06-012022-06-300001114995us-gaap:RetainedEarningsMember2024-01-012024-03-310001114995us-gaap:RetainedEarningsMember2023-12-310001114995us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001114995pi:EmployeeStockPurchasePlanSharesMember2024-04-012024-06-300001114995us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CashEquivalentsMember2023-12-310001114995us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995pi:VoyanticOyMemberus-gaap:GeneralAndAdministrativeExpenseMember2024-04-012024-06-300001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember2021-11-012021-11-300001114995pi:ContingentConsiderationLiabilityMember2024-01-012024-06-300001114995us-gaap:ShortTermInvestmentsMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-3000011149952023-01-012023-06-300001114995us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-3100011149952023-06-300001114995us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberpi:YankeeBondsMember2024-06-300001114995us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-3000011149952024-07-1200011149952024-04-012024-06-300001114995us-gaap:PatentsMember2024-06-300001114995us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-06-300001114995us-gaap:ConvertibleDebtMembersrt:MaximumMember2024-01-012024-06-300001114995us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001114995us-gaap:AgencySecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995us-gaap:DevelopedTechnologyRightsMember2024-06-300001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySixMember2019-12-012019-12-310001114995us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001114995us-gaap:ShortTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995us-gaap:CommonStockMember2024-06-300001114995us-gaap:SellingAndMarketingExpenseMember2023-01-012023-06-300001114995us-gaap:CustomerRelationshipsMember2024-06-300001114995pi:MarketAndServiceConditionUnitsMember2024-06-300001114995us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001114995us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CashEquivalentsMember2023-12-310001114995us-gaap:FairValueMeasurementsRecurringMember2024-06-300001114995us-gaap:EmployeeStockOptionMember2023-04-012023-06-300001114995pi:EndpointICsMember2023-04-012023-06-300001114995pi:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember2023-04-012023-06-300001114995us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CashEquivalentsMember2024-06-300001114995pi:VoyanticOyMemberus-gaap:GeneralAndAdministrativeExpenseMember2024-01-012024-06-300001114995us-gaap:CommonStockMember2024-03-310001114995us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001114995us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberpi:YankeeBondsMember2023-12-310001114995pi:TwoThousandTwentyOneNotesMember2024-04-012024-06-300001114995us-gaap:FairValueMeasurementsRecurringMember2023-12-310001114995us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001114995us-gaap:EmployeeStockOptionMember2024-04-012024-06-30xbrli:purexbrli:sharespi:Unitpi:Segmentiso4217:USDiso4217:USDxbrli:sharespi:Days

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2024

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission File Number: 001-37824

 

IMPINJ, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

91-2041398

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

400 Fairview Avenue North, Suite 1200, Seattle, Washington

 

98109

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (206) 517-5300

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

PI

The Nasdaq Global Select Market

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

 

 

 

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

As of July 12, 2024, 28,116,027 shares of common stock were outstanding.

 


IMPINJ, INC.

QUARTERLY REPORT ON FORM 10-Q

 

Table of Contents

 

 

 

Page

 

 

Risk Factor Summary

 

3

 

 

 

 

 

 

 

PART I. — FINANCIAL INFORMATION

 

Item 1.

 

Financial Statements (Unaudited)

 

4

 

Condensed Consolidated Balance Sheets

 

4

 

 

Condensed Consolidated Statements of Operations

 

5

 

 

Condensed Consolidated Statements of Comprehensive Income (Loss)

 

6

 

Condensed Consolidated Statements of Cash Flows

 

7

 

 

Condensed Consolidated Statements of Changes in Stockholders' Equity

 

8

 

Notes to Condensed Consolidated Financial Statements

 

9

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

19

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

29

Item 4.

 

Controls and Procedures

 

30

 

 

PART II. — OTHER INFORMATION

 

 

Item 1.

 

Legal Proceedings

 

31

Item 1A.

 

Risk Factors

 

31

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

48

Item 3.

 

Defaults Upon Senior Securities

 

48

Item 4.

 

Mine Safety Disclosures

 

48

Item 5.

 

Other Information

 

49

Item 6.

 

Exhibits

 

50

 

 

Signatures

 

51

 

 

2


 

Risk Factor Summary

 

Our business is subject to numerous risks and uncertainties, including those highlighted in the section of this report captioned “Risk

Factors.” These risks include, but are not limited to, the following:

 

we operate in a very competitive market;
RAIN adoption is concentrated in key markets and the extent and pace of RAIN market adoption beyond these markets is uncertain;
our abilities to deliver enterprise solutions at scale are nascent;
poor product quality could result in significant costs to us and impair our ability to sell our products;
end users and partners must design our products into their products and business processes;
an inability or limited ability of end user systems to exploit RAIN information may adversely affect the market for our products;
alternative technologies may enable products and services that compete with ours;
we obtain the products we sell through a limited number of third parties with whom we do not have long-term supply contracts;
shortages of silicon wafers, integrated-circuit (IC) post processing capacity or components used in our readers and gateways may adversely affect our ability to meet demand for our products and adversely affect our revenue and/or gross margins;
we rely on a small number of customers for a large share of our revenue;
our ability to affect or determine end-user demand is limited in part because we sell and fulfill primarily through partners and rarely to end users;
our growth strategy depends in part on the success of strategic relationships with third parties and their continued performance and alignment;
inherent difficulties protecting and enforcing our intellectual property;
we have been, and may in the future be, party to intellectual property disputes which could be time consuming and costly to prosecute, defend or settle, result in the loss of significant rights and adversely affect RAIN adoption or adoption of our products or platform;
we have a history of losses and have only achieved profitability intermittently and we cannot be certain that we will attain or sustain profitability in the future;
we have a history of significant fluctuations in our quarterly and annual operating results;
our executive officers, directors and principal stockholders, together with their affiliates, beneficially owned approximately 46.6% of our outstanding common stock as of June 30, 2024, and as a result are able to exercise significant influence over matters subject to stockholder approval; and
we may not have sufficient cash flow or access to cash necessary to satisfy our obligations under the $287.5 million aggregate principal amount 1.125% convertible senior notes due 2027, also referred to as the 2021 Notes, and our current and future indebtedness may restrict our business.

 

3


PART I — FINANCIAL INFORMATION

 

Item 1. Financial Statements (unaudited).

IMPINJ, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except par value, unaudited)

 

 

June 30, 2024

 

 

December 31, 2023

 

Assets:

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

214,653

 

 

$

94,793

 

Short-term investments

 

5,563

 

 

 

18,440

 

Accounts receivable, net

 

54,181

 

 

 

54,919

 

Inventory

 

80,773

 

 

 

97,172

 

Prepaid expenses and other current assets

 

3,148

 

 

 

4,372

 

Total current assets

 

358,318

 

 

 

269,696

 

Property and equipment, net

 

47,209

 

 

 

44,891

 

Intangible assets, net

 

11,645

 

 

 

13,913

 

Operating lease right-of-use assets

 

8,424

 

 

 

9,735

 

Other non-current assets

 

1,235

 

 

 

1,478

 

Goodwill

 

19,256

 

 

 

19,696

 

Total assets

$

446,087

 

 

$

359,409

 

Liabilities and stockholders' equity:

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

$

15,305

 

 

$

8,661

 

Accrued compensation and employee related benefits

 

12,549

 

 

 

8,519

 

Accrued and other current liabilities

 

2,848

 

 

 

8,614

 

Current portion of operating lease liabilities

 

3,462

 

 

 

3,373

 

Current portion of long-term debt

 

282,671

 

 

 

 

Current portion of deferred revenue

 

2,087

 

 

 

1,713

 

Total current liabilities

 

318,922

 

 

 

30,880

 

Long-term debt

 

 

 

 

281,855

 

Operating lease liabilities, net of current portion

 

7,546

 

 

 

9,360

 

Deferred tax liabilities, net

 

2,466

 

 

 

2,911

 

Deferred revenue, net of current portion

 

181

 

 

 

272

 

Total liabilities

 

329,115

 

 

 

325,278

 

Commitments and contingencies (Note 6)

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

Preferred stock, $0.001 par value — 5,000 shares authorized, no shares issued and outstanding at June 30, 2024 and December 31, 2023

 

 

 

 

 

Common stock, $0.001 par value — 495,000 shares authorized, 28,073 and 27,166 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively

 

28

 

 

 

27

 

Additional paid-in capital

 

504,206

 

 

 

463,900

 

Accumulated other comprehensive income (loss)

 

(418

)

 

 

355

 

Accumulated deficit

 

(386,844

)

 

 

(430,151

)

Total stockholders' equity

 

116,972

 

 

 

34,131

 

Total liabilities and stockholders' equity

$

446,087

 

 

$

359,409

 

See accompanying notes to condensed consolidated financial statements.

 

4


IMPINJ, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data, unaudited)

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenue

$

102,495

 

 

$

85,986

 

 

$

179,320

 

 

$

171,883

 

Cost of revenue

 

44,979

 

 

 

42,172

 

 

 

84,256

 

 

 

84,539

 

Gross profit

 

57,516

 

 

 

43,814

 

 

 

95,064

 

 

 

87,344

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

24,924

 

 

 

23,403

 

 

 

47,443

 

 

 

45,838

 

Sales and marketing

 

9,827

 

 

 

10,632

 

 

 

20,003

 

 

 

20,605

 

General and administrative

 

13,223

 

 

 

16,002

 

 

 

26,588

 

 

 

31,566

 

Amortization of intangibles

 

496

 

 

 

2,146

 

 

 

1,905

 

 

 

2,146

 

Restructuring costs

 

 

 

 

 

 

 

1,812

 

 

 

 

Total operating expenses

 

48,470

 

 

 

52,183

 

 

 

97,751

 

 

 

100,155

 

Income (loss) from operations

 

9,046

 

 

 

(8,369

)

 

 

(2,687

)

 

 

(12,811

)

Other income, net

 

2,122

 

 

 

1,165

 

 

 

3,414

 

 

 

2,530

 

Income from settlement of litigation

 

 

 

 

 

 

 

45,000

 

 

 

 

Interest expense

 

(1,217

)

 

 

(1,211

)

 

 

(2,433

)

 

 

(2,420

)

Income (loss) before income taxes

 

9,951

 

 

 

(8,415

)

 

 

43,294

 

 

 

(12,701

)

Income tax benefit

 

12

 

 

 

349

 

 

 

13

 

 

 

277

 

Net income (loss)

$

9,963

 

 

$

(8,066

)

 

$

43,307

 

 

$

(12,424

)

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share — basic

$

0.36

 

 

$

(0.30

)

 

$

1.57

 

 

$

(0.47

)

Net income (loss) per share — diluted

$

0.34

 

 

$

(0.30

)

 

$

1.44

 

 

$

(0.47

)

Weighted-average shares outstanding — basic

 

27,889

 

 

 

26,713

 

 

 

27,623

 

 

 

26,499

 

Weighted-average shares outstanding — diluted

 

29,422

 

 

 

26,713

 

 

 

31,718

 

 

 

26,499

 

See accompanying notes to condensed consolidated financial statements.

 

5


IMPINJ, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in thousands, unaudited)

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Net income (loss)

$

9,963

 

 

$

(8,066

)

 

$

43,307

 

 

$

(12,424

)

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

 

 

 

Unrealized loss on investments

 

13

 

 

 

193

 

 

 

47

 

 

 

837

 

Foreign currency translation adjustment

 

(161

)

 

 

87

 

 

 

(820

)

 

 

87

 

Total other comprehensive income (loss)

 

(148

)

 

 

280

 

 

 

(773

)

 

 

924

 

Comprehensive income (loss)

$

9,815

 

 

$

(7,786

)

 

$

42,534

 

 

$

(11,500

)

See accompanying notes to condensed consolidated financial statements.

 

6


IMPINJ, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, unaudited)

 

 

 

Six Months Ended June 30,

 

 

 

 

2024

 

 

2023

 

Operating activities:

 

 

 

 

 

 

 

Net income (loss)

 

 

$

43,307

 

 

 

(12,424

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

6,908

 

 

 

6,066

 

Stock-based compensation

 

 

 

26,495

 

 

 

23,372

 

Restructuring equity modification expense

 

 

 

366

 

 

 

 

Accretion of discount or amortization of premium on investments

 

 

 

(109

)

 

 

(1,285

)

Amortization of debt issuance costs

 

 

 

815

 

 

 

802

 

Deferred tax expense

 

 

 

(372

)

 

 

(399

)

Revaluation of acquisition-related contingent consideration liability

 

 

 

986

 

 

 

 

Changes in operating assets and liabilities, net of amounts acquired:

 

 

 

 

 

 

 

Accounts receivable

 

 

 

699

 

 

 

(7,755

)

Inventory

 

 

 

16,378

 

 

 

(64,733

)

Prepaid expenses and other assets

 

 

 

1,461

 

 

 

2,277

 

Accounts payable

 

 

 

6,996

 

 

 

6,113

 

Accrued compensation and employee related benefits

 

 

 

4,056

 

 

 

(1,879

)

Accrued and other liabilities

 

 

 

290

 

 

 

2,043

 

Acquisition-related contingent consideration liability

 

 

 

(2,556

)

 

 

 

Operating lease right-of-use assets

 

 

 

1,293

 

 

 

1,331

 

Operating lease liabilities

 

 

 

(1,706

)

 

 

(1,661

)

Deferred revenue

 

 

 

312

 

 

 

(972

)

Net cash provided by (used in) operating activities

 

 

 

105,619

 

 

 

(49,104

)

Investing activities:

 

 

 

 

 

 

 

Proceeds from sales of investments

 

 

 

 

 

 

13,372

 

Proceeds from maturities of investments

 

 

 

13,033

 

 

 

92,424

 

Purchases of intangible assets

 

 

 

 

 

 

(250

)

Purchases of property and equipment

 

 

 

(7,568

)

 

 

(13,198

)

Business acquisitions, net of cash acquired

 

 

 

 

 

 

(23,357

)

Net cash provided by investing activities

 

 

 

5,465

 

 

 

68,991

 

Financing activities:

 

 

 

 

 

 

 

Proceeds from exercise of stock options and employee stock purchase plan

 

 

 

13,446

 

 

 

5,753

 

Payment of acquisition-related contingent consideration

 

 

 

(4,602

)

 

 

 

Net cash provided by financing activities

 

 

 

8,844

 

 

 

5,753

 

Effect of exchange rate changes on cash and cash equivalents

 

 

 

(68

)

 

 

7

 

Net increase in cash and cash equivalents

 

 

 

119,860

 

 

 

25,647

 

Cash and cash equivalents

 

 

 

 

 

 

 

Beginning of period

 

 

 

94,793

 

 

 

19,597

 

End of period

 

 

$

214,653

 

 

$

45,244

 

 

 

 

 

 

 

 

Supplemental disclosure of cashflow information:

 

 

 

 

 

 

 

Cash paid for interest

 

 

 

1,617

 

 

 

1,617

 

Purchases of property and equipment not yet paid

 

 

 

1,198

 

 

 

1,973

 

Operating lease liabilities arising from obtaining ROU assets

 

 

 

 

 

 

979

 

Lease liabilities arising from remeasurement of ROU assets

 

 

 

 

 

 

159

 

26,396 shares of common stock issued for Voyantic Oy acquisition

 

 

 

 

 

 

3,579

 

Acquisition-related contingent consideration liability

 

 

 

 

 

 

4,602

 

See accompanying notes to condensed consolidated financial statements.

 

7


IMPINJ, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(in thousands, unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

Other

 

 

Total

 

 

 

Common Stock

 

 

Paid-in

 

 

Accumulated

 

 

Comprehensive

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income (Loss)

 

 

Equity

 

Balance at December 31, 2023

 

 

27,166

 

 

$

27

 

 

$

463,900

 

 

$

(430,151

)

 

$

355

 

 

$

34,131

 

Issuance of common stock

 

 

494

 

 

 

1

 

 

 

6,916

 

 

 

 

 

 

 

 

 

6,917

 

Stock-based compensation

 

 

 

 

 

 

 

 

11,790

 

 

 

 

 

 

 

 

 

11,790

 

Restructuring equity modification expense

 

 

 

 

 

 

 

 

366

 

 

 

 

 

 

 

 

 

366

 

Net income

 

 

 

 

 

 

 

 

 

 

 

33,344

 

 

 

 

 

 

33,344

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(625

)

 

 

(625

)

Balance at March 31, 2024

 

 

27,660

 

 

$

28

 

 

$

482,972

 

 

$

(396,807

)

 

$

(270

)

 

$

85,923

 

Issuance of common stock

 

 

413

 

 

 

 

 

 

6,529

 

 

 

 

 

 

 

 

 

6,529

 

Stock-based compensation

 

 

 

 

 

 

 

 

14,705

 

 

 

 

 

 

 

 

 

14,705

 

Net income

 

 

 

 

 

 

 

 

 

 

 

9,963

 

 

 

 

 

 

9,963

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(148

)

 

 

(148

)

Balance at June 30, 2024

 

 

28,073

 

 

$

28

 

 

$

504,206

 

 

$

(386,844

)

 

$

(418

)

 

$

116,972

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

Other

 

 

Total

 

 

 

Common Stock

 

 

Paid-in

 

 

Accumulated

 

 

Comprehensive

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income (Loss)

 

 

Equity

 

Balance at December 31, 2022

 

 

26,098

 

 

$

26

 

 

$

403,599

 

 

$

(386,785

)

 

$

(1,249

)

 

$

15,591

 

Issuance of common stock

 

 

483

 

 

 

1

 

 

 

4,519

 

 

 

 

 

 

 

 

 

4,520

 

Stock-based compensation

 

 

 

 

 

 

 

 

10,224

 

 

 

 

 

 

 

 

 

10,224

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(4,358

)

 

 

 

 

 

(4,358

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

644

 

 

 

644

 

Balance at March 31, 2023

 

 

26,581

 

 

$

27

 

 

$

418,342

 

 

$

(391,143

)

 

$

(605

)

 

$

26,621

 

Issuance of common stock

 

 

211

 

 

 

 

 

 

1,233

 

 

 

 

 

 

 

 

 

1,233

 

Stock-based compensation

 

 

 

 

 

 

 

 

13,148

 

 

 

 

 

 

 

 

 

13,148

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(8,066

)

 

 

 

 

 

(8,066

)

Common stock issued for Voyantic Acquisition (Note 4)

 

 

27

 

 

 

 

 

 

3,579

 

 

 

 

 

 

 

 

 

3,579

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

280

 

 

 

280

 

Balance at June 30, 2023

 

 

26,819

 

 

$

27

 

 

$

436,302

 

 

$

(399,209

)

 

$

(325

)

 

$

36,795

 

See accompanying notes to condensed consolidated financial statements.

8


IMPINJ, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Note 1. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements include Impinj, Inc. and its wholly owned subsidiaries. We have eliminated intercompany balances and transactions in consolidation. We have prepared these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ("GAAP"), and applicable rules and regulations of the Securities and Exchange Commission ("SEC"), regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2023 included in Impinj, Inc.’s Annual Report on Form 10-K, which was filed with the SEC on February 12, 2024.

The unaudited condensed consolidated interim financial statements, in the opinion of management, reflect all adjustments, comprising normal recurring adjustments, necessary to state fairly our financial position, results of operations and our cash flows for the periods presented. Interim results are not necessarily indicative of the results for a full year or for any other future period.

Use of Estimates

Preparing financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and related disclosures as of the date of the financial statements, as well as the reported revenue and expenses during the periods presented. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, sales incentives, percentage completion of development contracts, inventory excess and obsolescence, income taxes and fair value of stock awards. To the extent there are material differences between our estimates, judgments, or assumptions and actual results, our financial statements will be affected.

Licensing of Intellectual Property

On March 13, 2024, we and NXP Semiconductors N.V. ("NXP") entered into a Settlement and Patent Cross-License Agreement (the “Settlement Agreement”). Under the Settlement Agreement, NXP made a one-time payment of $45 million and agreed to make annual license fee payments on April 1 of each year, starting on April 1, 2024, until the termination of the Settlement Agreement. The annual license fee payment for 2024 was $15 million and will increase each subsequent year by a fixed percentage. We allocated the consideration from the Settlement Agreement to the related components of the agreement. During the first quarter of 2024, we recorded the $45 million payment in income from settlement of litigation in the condensed consolidated statements of operations upon receipt. We will recognize the license fee, which relates to annual usage of the license from April 1 to March 31 of each applicable year, as revenue in the second quarter of each until the Settlement Agreement terminates. The license fee for the first annual usage period was recognized in the second quarter of 2024.

We recognize revenue from licensing the right to use functional intellectual property, such as the Settlement Agreement discussed above, at the point in time the control of the license transfers to the customer, which is generally upon delivery, or as usage occurs. See Note 6 Commitments and Contingencies for additional details of the Settlement Agreement with NXP.

Recently Issued Accounting Standards Not Yet Adopted

In November 2023, the FASB released ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which amends reportable segment requirements, primarily through enhanced disclosures about significant segment expenses, including for public entities that have a single reportable segment. The standard is effective for fiscal years beginning after December 31, 2023 and interim periods within fiscal years beginning after December 31, 2024. We are currently evaluating the impact of this standard, if any, on our financial statement disclosures.

In December 2023, the FASB released ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which amends income tax disclosure requirements to enhance the transparency and decision usefulness for users of the financial statements. The standard is effective for fiscal years beginning after December 31, 2024. We are currently evaluating impact of this standard, if any, on our financial statement disclosures.

9


Note 2. Fair Value Measurements

Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. The standards also establish a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:

Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Assets and liabilities valued based on observable market data for similar instruments, such as quoted prices for similar assets or liabilities.
Level 3 — Unobservable inputs that are supported by little or no market activity; instruments valued based on the best available data, some of which is internally developed, and considers risk premiums that a market participant would require.

We do not have any financial assets or liabilities in Level 3 as of June 30, 2024, and only had the liability for the earnout consideration related to the Voyantic Oy acquisition in Level 3 as of December 31, 2023. We classified this liability as Level 3 because we determined the fair value using significant unobservable inputs.

We applied the following methods and assumptions in estimating our fair value measurements:

Cash Equivalents — Cash equivalents comprise highly liquid investments, including money market funds with original maturities of less than three months at the acquisition date. We record the fair value measurement of these assets based on quoted market prices in active markets.

Investments — Our investments comprise fixed income securities, which include U.S. government agency securities, corporate notes and bonds, commercial paper, treasury bills and asset-backed securities. The fair value measurement of these assets is based on observable market-based inputs or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Long-term Debt — See Note 7 for the carrying amount and estimated fair value of the Notes.

Contingent Consideration — The contingent consideration liability is related to our acquisition of Voyantic Oy (see Note 4: Goodwill and Intangible Assets). We paid the contingent consideration amount of $7.2 million in second-quarter 2024.

The following table presents the balances of assets and liabilities measured at fair value on a recurring basis, by level within the fair value hierarchy, as of the dates presented (in thousands):

 

 

June 30, 2024

 

 

December 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

181,391

 

 

$

 

 

$

 

 

$

181,391

 

 

$

78,661

 

 

$

 

 

$

 

 

$

78,661

 

Total cash equivalents

 

 

181,391

 

 

 

 

 

 

 

 

 

181,391

 

 

 

78,661

 

 

 

 

 

 

 

 

 

78,661

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government agency securities

 

 

 

 

 

3,493

 

 

 

 

 

 

3,493

 

 

 

 

 

 

11,893

 

 

 

 

 

 

11,893

 

Yankee bonds

 

 

 

 

 

1,998

 

 

 

 

 

 

1,998

 

 

 

 

 

 

1,951

 

 

 

 

 

 

1,951

 

Agency bonds

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,994

 

 

 

 

 

 

2,994

 

Asset-backed securities

 

 

 

 

 

72

 

 

 

 

 

 

72

 

 

 

 

 

 

1,602

 

 

 

 

 

 

1,602

 

Total short-term investments

 

 

 

 

 

5,563

 

 

 

 

 

 

5,563

 

 

 

 

 

 

18,440

 

 

 

 

 

 

18,440

 

Total

 

$

181,391

 

 

$

5,563

 

 

$

 

 

$

186,954

 

 

$

78,661

 

 

$

18,440

 

 

$

 

 

$

97,101

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition related contingent consideration liability

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,180

 

 

 

6,180

 

Total liabilities at fair value

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

6,180

 

 

$

6,180

 

 

The following table presents additional information about liabilities measured at fair value for which the Company uses Level 3 inputs to determine fair value as of June 30, 2024 (in thousands):

 

 

 

Six Months Ended June 30,

 

 

 

2024

 

Balance as of January 1

 

$

6,180

 

Change in fair value of contingent consideration liability due to remeasurement

 

 

986

 

Contingent consideration payment made

 

 

(7,166

)

Balance as of June 30

 

$

 

 

10


 

At the acquisition date, we recorded the contingent consideration related to the Voyantic Oy acquisition at its fair value using unobservable inputs and used the Monte Carlo simulation option pricing framework, incorporating contractual terms and assumptions regarding financial forecasts, discount rates and volatility of forecasted revenue and gross margins. Developing and determining the unobservable inputs for Level 3 fair-value measurements and fair-value calculations is management's responsibility with assistance from a third-party valuation specialist. During the quarter ended June 30, 2024, we made the payment for contingent consideration and as of June 30, 2024, the contingent consideration liability is $0.

 

As of December 31, 2023, the contingent consideration liability was $6.2 million.

 

We expect short-term investments to mature within 1 year of the reporting date. See Note 7 for the carrying amount and estimated fair value of our convertible senior notes due 2027.

Investments

The following tables present the cost or amortized cost, gross unrealized gains, gross unrealized losses and total estimated fair value of our financial assets as of the dates presented (in thousands):

 

June 30, 2024

 

 

Cost or

 

 

Gross

 

 

Gross

 

 

Total Estimated

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

Description:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

181,391

 

 

$

 

 

$

 

 

$

181,391

 

U.S. government agency securities

 

3,496

 

 

 

 

 

 

(3

)

 

 

3,493

 

Yankee bonds

 

1,998

 

 

 

 

 

 

 

 

 

1,998

 

Asset-backed securities

 

72

 

 

 

 

 

 

 

 

 

72

 

Total

$

186,957

 

 

$

 

 

$

(3

)

 

$

186,954

 

 

 

December 31, 2023

 

 

Cost or

 

 

Gross

 

 

Gross

 

 

Total Estimated

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

Description:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

78,661

 

 

$

 

 

$

 

 

$

78,661

 

U.S. government agency securities

 

11,932

 

 

 

 

 

 

(39

)

 

 

11,893

 

Yankee bonds

 

1,956

 

 

 

 

 

 

(5

)

 

 

1,951

 

Agency bond

 

2,998

 

 

 

 

 

 

(4

)

 

 

2,994

 

Asset-backed securities

 

1,604

 

 

 

 

 

 

(2

)

 

 

1,602

 

Total

$

97,151

 

 

$

 

 

$

(50

)

 

$

97,101

 

Marketable securities in a continuous loss position for less than 12 months had an estimated fair value of $2.0 million and immaterial unrealized losses as of June 30, 2024, and an estimated fair value of $10.2 million and $25,000 in unrealized losses as of December 31, 2023. Marketable securities in a continuous loss position for greater than 12 months had an estimated fair value of $3.6 million and immaterial unrealized losses as of June 30, 2024, and an estimated fair value of $8.2 million $26,000 in unrealized losses as of December 31, 2023.

11


Note 3. Inventory

The following table presents the detail of inventories as of the dates presented (in thousands):

 

 

 

 

 

 

 

 

 

June 30, 2024

 

 

December 31, 2023

 

Raw materials

 

$

18,972

 

 

$

21,773

 

Work-in-process

 

 

37,633

 

 

 

42,217

 

Finished goods

 

 

24,168

 

 

 

33,182

 

Total inventory

 

$

80,773

 

 

$

97,172

 

 

Note 4. Goodwill and Intangible Assets

On April 3, 2023, we acquired all outstanding equity of Voyantic Oy for an aggregate purchase price of $32.7 million. Our acquisition of Voyantic Oy adds label design, manufacturing and testing to our systems offerings, to advance the quality, reliability and readability of partner inlays. The consideration comprised (i) $3.6 million in shares of our common stock valued using the market price on the date of the acquisition, (ii) $4.6 million in deferred payments contingent upon revenue and gross margin performance over a one-year period from the acquisition date and (iii) the remainder in cash paid at closing.

We recorded the assets acquired and liabilities assumed at their estimated fair values as of the acquisition date. We recorded the excess of the purchase price over the assets acquired and liabilities assumed as goodwill. The fair value of net assets acquired, goodwill, intangible assets and deferred tax liability were $2.4 million, $15.6 million, $18.4 million and $3.7 million, respectively. The goodwill amount represents synergies we expect to realize from the business combination and assembled workforce. We allocated the goodwill to our one reporting unit and reportable segment. The acquired goodwill and intangible assets were not deductible for tax purposes.

The transaction-related costs for the acquisition were $0.1 million and $1.0 million for the three and six months ended June 30, 2024. These costs are related to the revaluation of the contingent consideration subsequent to the acquisition date and are included in general and administrative expenses in the condensed consolidated statements of operations. See Note 2. Fair Value Measures for additional information on the contingent consideration.

This acquisition did not have a material impact on our reported revenue or net loss amounts for any period presented; therefore, we have not presented historical and pro forma disclosures.

Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in business combinations accounted for under the purchase method of accounting. The following table presents goodwill as of June 30, 2024 (in thousands):

 

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

Balance at beginning of period

 

$

19,696

 

 

$

3,881

 

Additions from acquisition

 

 

 

 

 

15,590

 

Foreign currency translation adjustment

 

 

(440

)

 

 

45

 

   Total

 

$

19,256

 

 

$

19,516

 

As of June 30, 2024, intangible assets comprised the following (in thousands):

 

 

 

Estimated Useful Life in Years

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net

 

Definite-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

   Backlog

 

0.25

 

$

751

 

 

$

(751

)

 

$

 

   Customer Relationships

 

1

 

 

3,595

 

 

 

(3,595

)

 

 

 

   Developed Technology

 

7.25

 

 

12,662

 

 

 

(2,183

)

 

 

10,479

 

   Patent

 

3

 

 

250

 

 

 

(80

)

 

 

170

 

   Tradename

 

8

 

 

1,180

 

 

 

(184

)

 

 

996

 

   Total definite-lived intangible assets (1)

 

 

 

 

18,438

 

 

 

(6,793

)

 

 

11,645

 

(1) Foreign intangible asset carrying amounts are affected by foreign currency translation

 

We amortize identifiable intangible assets with finite lives over their useful lives on a straight-line basis. The weighted average life of our intangible assets is approximately six years. Amortization of intangible assets was $0.5 million and $1.9 million for the three and six months ended June 30, 2024, respectively and $2.1 million for the three and six months ended June 30, 2023.

12


As of June 30, 2024, the estimated intangible asset amortization expense for the next five years and thereafter is as follows:

 

 

Estimated Amortization

 

 

 

(in thousands)

 

2024

 

 

989

 

2025

 

 

1,977

 

2026

 

 

1,939

 

2027

 

 

1,894

 

2028

 

 

1,894

 

Thereafter

 

 

2,952

 

Total

 

$

11,645

 

 

Note 5. Stock-Based Awards

Restricted Stock Units

We grant restricted stock units ("RSUs") with a service condition, and RSUs with market and service conditions ("MSUs").

The following table summarizes activity for RSUs and MSUs for the six months ended June 30, 2024 (in thousands):

 

 

Number of Underlying Shares

 

 

 

RSUs

 

 

MSUs

 

Outstanding at December 31, 2023

 

 

 

1,078

 

 

 

174

 

Granted

 

 

 

397

 

 

 

161

 

Vested

 

 

 

(313

)

 

 

(98

)

Forfeited

 

 

 

(97

)

 

 

(2

)

Outstanding at June 30, 2024

 

 

 

1,065

 

 

 

235

 

Stock-Based Compensation Expense

The following table presents the detail of stock-based compensation expense amounts included in our condensed consolidated statements of operations for the periods presented (in thousands):

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of revenue

$

534

 

 

$

472

 

 

$

987

 

 

$

889

 

Research and development expense

 

6,543

 

 

 

5,879

 

 

 

11,805

 

 

 

10,448

 

Sales and marketing expense

 

2,802

 

 

 

2,790

 

 

 

5,211

 

 

 

4,929

 

General and administrative expense

 

4,826

 

 

 

4,007

 

 

 

8,492

 

 

 

7,106

 

Total stock-based compensation expense

$

14,705

 

 

$

13,148

 

 

$

26,495

 

 

$

23,372

 

 

 

13


Note 6. Commitments and Contingencies

For information on our commitments and contingencies, see Part II, Item 8 (Financial Statements and Supplementary Data, Note 12, Commitments and Contingencies) of our Annual Report on Form 10-K for the year ended December 31, 2023. There have been no material changes to our commitments and contingencies as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023, except for “Obligations with Third Parties” and “Litigation” as discussed below.

Obligations with Third Parties

We manufacture products with third-party manufacturers. We are committed to purchase $27.8 million of inventory as of June 30, 2024.

Litigation

From time to time, we are subject to various legal proceedings or claims that arise in the ordinary course of business. We accrue a liability when management believes that it is both probable that we have incurred a liability and we can reasonably estimate the amount of loss. As of June 30, 2024 and December 31, 2023, we did not have accrued contingency liabilities. The following is a description of our significant legal proceedings.

Patent Infringement Claims and Counterclaims

Impinj Patent Infringement Claims Against NXP

From 2019 to 2023, we engaged in active patent litigation against our primary endpoint IC competitor, NXP Semiconductors N.V., or NXP. During this time, we filed three patent infringement lawsuits against subsidiaries of NXP in federal courts in California and Texas. Our complaints alleged that certain NXP endpoint ICs infringed a number of our U.S. patents. In response, NXP filed a suit against us in federal court in Delaware, later transferred to Washington, countersued us in Texas, and filed three lawsuits against our subsidiary in China. NXP’s complaints alleged that certain of our endpoint ICs infringed a number of their own U.S. or Chinese patents or U.S. patents that they exclusively licensed from a third-party to assert against us.

Through 2023, we prevailed in these lawsuits. In three U.S. trials held in 2023, juries in California and Texas returned verdicts that NXP endpoint ICs infringed five of our patents that made it to trial, and juries in Washington and Texas ruled that we did not infringe any of the three patents NXP accused us in court of infringing. Also in 2023, NXP withdrew all three cases it filed against us in China.

On March 13, 2024, while additional trials were pending in China and Texas, and post-trial motions and appeals were pending in China and the U.S., we and NXP entered into the Settlement Agreement. Under the agreement we and NXP agreed to terminate and withdraw all pending proceedings and release one another for all patent infringement claims preceding March 31, 2024 and grant to each other non-exclusive, worldwide patent licenses to make, have made, import, use, offer for sale, and sell their respective products and services, subject to the terms of the agreement. The Settlement Agreement will remain in force until all the valid claims of a specified set of Impinj patents (the “Indicator Patents”) expire in about ten years. Either party can terminate the Settlement Agreement if the other party materially breaches the terms of the Agreement and NXP can terminate the Settlement Agreement if it successfully designs out all valid claims of the Indicator Patents.

Under the Settlement Agreement, NXP paid us a one-time amount of $45 million and agreed to make annual license fee payments, if the specified set of Indicator Patents are still in use, on April 1 of each year, effective April 1, 2024. The annual license fee will increase by a fixed percentage each year after 2024 for the remaining term of the Settlement Agreement. We have no obligation to pay NXP under the Settlement Agreement.

We allocated the consideration from the Settlement Agreement to the components of the Settlement Agreement. We recorded the $45 million payment in income from settlement of litigation in the condensed consolidated statements of operations in the first quarter of 2024, upon receipt. Licensing of our intellectual property is part of our ongoing operations and therefore, we will recognize the license fee, which relates to annual usage of the license from April 1 to March 31 of each applicable year, as revenue in the second quarter of each year until the Settlement Agreement terminates. We recognized the first annual license fee of $15 million in revenue in the second quarter of 2024.

 

 

14


Note 7. Long-term debt

Convertible Senior Notes

In November 2021, we issued $287.5 million aggregate principal amount of convertible promissory notes due May 15, 2027 (the “2021 Notes”).

The following table presents the outstanding principal amount and carrying value of the 2021 Notes as of the dates indicated (in thousands):

 

 

June 30, 2024

 

 

December 31, 2023

 

 

 

Principal Amount

 

 

Unamortized debt issuance costs

 

 

Net Carrying Amount

 

 

Principal Amount

 

 

Unamortized debt issuance costs

 

 

Net Carrying Amount

 

2021 Notes

 

 

287,500

 

 

 

(4,830

)

 

 

282,670

 

 

 

287,500

 

 

 

(5,645

)

 

 

281,855

 

Further details of the 2021 Notes are as follows:

Issuance

 

Maturity Date

 

Interest Rate

 

First Interest Payment Date

 

Effective Interest Rate

 

Semi-Annual Interest Payment Dates

 

Initial Conversion Rate per $1,000 Principal

 

Initial Conversion Price

 

 

Number of Shares (in millions)

2021 Notes

 

May 15, 2027

 

1.125%

 

May 15, 2022

 

1.72%

 

May 15; November 15

 

9.0061

 

$

111.04

 

 

2.6

 

The 2021 Notes are senior unsecured obligations, do not contain any financial covenants and are governed by indentures (the Indentures). The total net proceeds from the 2021 Notes, after deducting initial debt issuance costs, fees and expenses, was $278.4 million. We used approximately $183.6 million of the 2021 Notes net proceeds, excluding accrued interest, to repurchase approximately $76.4 million aggregate principal amount of convertible notes due 2026 (the “2019 Notes” and, together with the 2021 Notes, the “Notes”) through individual privately negotiated transactions concurrent with us offering the 2021 Notes. We used approximately $17.6 million, excluding accrued interest, to repurchase the remaining $9.9 million aggregate principal amount of the 2019 Notes in June 2022. We will use the remainder of the net proceeds from the 2021 Notes for general corporate purposes.

Terms of the 2021 Notes

The holders of the 2021 Notes may convert their respective 2021 Notes at their option at any time prior to the close of business on the business day immediately preceding the respective conversion dates under the following circumstances:

during any fiscal quarter commencing after the fiscal quarter ending on March 31, 2022 (and only during such fiscal quarter), if the last reported sale price of our common stock, for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2021 Notes for each trading day was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day;
prior to the close of business on the second scheduled trading day immediately preceding the redemption date if we call the 2021 Notes for redemption; or
upon the occurrence of specified corporate events, as described in the indenture.

Regardless of the foregoing circumstances, holders may convert all or any portion of the 2021 Notes, in increments of $1,000 principal amount, on or after February 15, 2027, until the close of business on the second scheduled trading day immediately preceding the maturity date.

We may redeem all or a portion of the 2021 Notes for cash, at our option, on or after November 20, 2024, if the last reported sale price of our common stock has been at least 130% of the conversion price at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period at a redemption price equal to 100% of the principal amount of the 2021 Notes being redeemed, plus any accrued and unpaid interest to, but excluding, the redemption date.

Holders who convert their 2021 Notes in connection with certain corporate events that constitute a make-whole fundamental change (as defined in the indenture) are, under certain circumstances, entitled to an increase in the conversion rate. Additionally in the event of a corporate event constituting a fundamental change (as defined in the indenture), holders of the 2021 Notes may require us to repurchase all or a portion of their 2021 Notes at a repurchase price equal to 100% of the principal amount of the 2021 Notes being repurchased, plus any accrued and unpaid interest to, but excluding, the repurchase date.

15


Our common stock exceeded 130% of the conversion price of the 2021 Notes for more than 20 trading days during the 30 consecutive trading days ended June 30, 2024. Accordingly, the 2021 Notes are convertible at the option of the holders as of June 30, 2024 and have been reclassified to current portion of long-term debt on the condensed consolidated balance sheet as of June 30, 2024. The “if-converted value” exceeded the principal amounts by $118.4 million based on the closing price of our common stock of $156.77 as of June 30, 2024.

Interest expense related to the Notes was as follows (in thousands):

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

2021 Notes

 

 

2021 Notes

 

 

2021 Notes

 

 

2021 Notes

 

Amortization of debt issuance costs

 

 

409

 

 

 

402

 

 

 

816

 

 

 

802

 

Cash interest expense

 

 

808

 

 

 

809

 

 

 

1,617

 

 

 

1,618

 

Total interest expense

 

$

1,217

 

 

$

1,211

 

 

$

2,433

 

 

$

2,420

 

Accrued interest related to the 2021 Notes as of June 30, 2024 and December 31, 2023 was $0.4 million, for both periods. We record accrued interest in accrued liabilities in our consolidated balance sheet.

We estimate the fair value of the 2021 Notes to be $446.2 million and $314.0 million as of June 30, 2024 and December 31, 2023, respectively, which we determined through consideration of quoted market prices. The fair value for the 2021 Notes is classified as Level 2, as defined in Note 2.

Capped Calls

In connection with the issuance of the 2019 Notes, we entered into privately negotiated capped-call transactions with certain financial counterparties. The capped call transactions are generally designed to reduce the potential dilution to our common stock upon any conversion or settlement of the 2019 Notes, or to offset any cash payments we are required to make in excess of the principal amount upon conversion of the 2019 Notes, as the case may be, with the reduction or offset subject to a cap based on the cap price. If, however, the market price per share of our common stock exceeds the cap price of the capped-call transactions, then our stock would experience some dilution and/or the capped call would not fully offset the potential cash payments, in each case, to the extent then-market price per share of our common stock exceeds the cap price. The capped call remains outstanding even though we have repurchased the 2019 Notes. The initial cap price of the capped call transactions is $54.20 per share, subject to certain adjustments under the terms of the capped call transactions. The capped call transactions expire over 40 consecutive scheduled trading days ending on December 11, 2026. The capped call transactions meet the criteria for classification in equity, are not accounted for as derivatives and are not remeasured each reporting period.

 

 

16


Note 8. Net Earnings (Loss) Per Share

For the periods presented, the following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net earnings (loss) per share (in thousands, except per share amounts):

 

 

Three months ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

9,963

 

 

$

(8,066

)

 

$

43,307

 

 

$

(12,424

)

Interest add back

 

 

 

 

 

 

 

 

2,433

 

 

 

 

Net income (loss) attributable to common stock holders

 

$

9,963

 

 

$

(8,066

)

 

$

45,740

 

 

$

(12,424

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding, basic

 

 

27,889

 

 

 

26,713

 

 

 

27,623

 

 

 

26,499

 

Dilutive effect of:

 

 

 

 

 

 

 

 

 

 

 

 

Stock plans

 

 

1,533

 

 

 

 

 

 

1,506

 

 

 

 

2021 Notes

 

 

 

 

 

 

 

 

2,589

 

 

 

 

Weighted average common shares outstanding, diluted

 

 

29,422

 

 

 

26,713

 

 

 

31,718

 

 

 

26,499

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings (loss) per share — basic

 

$

0.36

 

 

$

(0.30

)

 

$

1.57

 

 

$

(0.47

)

Net earnings (loss) per share — diluted

 

$

0.34

 

 

$

(0.30

)

 

$

1.44

 

 

$

(0.47

)

 

Basic net earnings (loss) per share is calculated using our net income (loss) and our weighted average outstanding common shares.

Diluted net earnings (loss) per share is calculated using our net income (loss) attributable to common stockholders with interest charges applicable to our convertible debt added back under the if converted method, if dilutive, and our weighted average outstanding common shares including the dilutive effect of stock awards and employee stock purchase plan shares as determined under the treasury stock method and of our convertible notes using the if converted method, if dilutive. In periods when we recognize a net loss, we exclude the impact of outstanding stock awards and the potential share settlement impact related to our convertible notes from the diluted loss per share calculation as their inclusion would have an antidilutive effect.

The following table presents the outstanding shares of our common stock equivalents excluded from the computation of diluted net earnings (loss) per share as of the dates presented because their effect would have been antidilutive (in thousands):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Stock options

 

 

 

 

 

1,543

 

 

 

 

 

 

1,543

 

RSUs, MSUs and PSUs

 

 

114

 

 

 

1,475

 

 

 

737

 

 

 

1,475

 

Employee stock purchase plan shares

 

 

 

 

 

23

 

 

 

 

 

 

23

 

2021 Notes

 

 

2,589

 

 

 

2,589

 

 

 

 

 

 

2,589

 

 

Note 9. Segment Information

We have one reportable and operating segment: developing and selling of our RAIN products and services. We identified our operating segment based on how our chief operating decision-maker manages our business, makes operating decisions and evaluates our operating performance. Our chief executive officer acts as the chief operating decision-maker and reviews financial and operational information on an entity-wide basis. Accordingly, we have determined we have a single reportable and operating segment.

Our chief executive officer reviews information about our revenue categories, endpoint ICs, including licensing revenue, and systems, defined as reader ICs, readers, gateways, test and measurement solutions and software and cloud services. The following table presents our revenue categories for the indicated periods (in thousands):

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Endpoint ICs

$

89,392

 

 

$

64,905

 

 

$

150,898

 

 

$

131,954

 

Systems

 

13,103

 

 

 

21,081

 

 

 

28,422

 

 

 

39,929

 

Total revenue

$

102,495

 

 

$

85,986

 

 

$

179,320

 

 

$

171,883

 

 

 

17


Note 10. Deferred Revenue

Deferred revenue, comprising individually immaterial amounts for extended warranty, enhanced product maintenance and advance payments on nonrecurring engineering ("NRE") services contracts, represents contracted revenue that has not yet been recognized. We recognized $1.1 million of revenue related to amounts included in deferred revenue as of December 31, 2023 for the six months ended June 30, 2024. We recognized $2.0 million of revenue related to amounts included in deferred revenue as of December 31, 2022 for the six months ended June 30, 2023.

The following table presents the changes in deferred revenue for the indicated periods (in thousands):

 

Six Months Ended June 30,

 

 

2024

 

 

2023

 

Balance at beginning of period

$

1,985

 

 

$

2,599

 

Opening balance from Voyantic acquisition

 

 

 

 

1,233

 

Deferral of revenue

 

1,630

 

 

 

1,672

 

Recognition of deferred revenue

 

(1,347

)

 

 

(2,640

)

Balance at end of period

$

2,268

 

 

$

2,864

 

 

Note 11. Related-Party Transactions

On June 23, 2023, we acquired a patent from a related party in which a member of our board of directors holds an executive leadership position. The patent pertains to our endpoint IC products and the acquisition price was $250,000. The patent is included in the Indicator Patents, expires on July 17, 2026 and does not have renewal rights. This patent is included in our intangible assets on our condensed consolidated balance sheet as of June 30, 2024.

 

Note 12. Restructuring

On February 7, 2024, we initiated a strategic restructuring to align financial, business and research and development objectives for long-term growth, including a reduction-in-force affecting approximately 10% of our employees. We incurred restructuring charges of $1.8 million for employee terminations benefits, including equity modification expense for the three and six months ended June 30, 2024. Restructuring payments were complete as of June 30, 2024.

A summary of accrued restructuring costs as of June 30, 2024 is shown in the table below (in thousands):

 

 

 

Six months ended June 30, 2024

 

Restructuring costs

 

 

1,812

 

Non cash payments

 

 

(366

)

Cash payments

 

 

(1,446

)

Accrued restructuring costs as of June 30, 2024

 

$

 

 

18


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements containing words such as “may,” “believe,” “anticipate,” “expect,” “intend,” “plan,” “project,” “projections,” “business outlook,” “estimate,” or similar expressions constitute forward-looking statements. You should read these statements carefully because they discuss future expectations, contain projections of future results of operations or financial condition or state other “forward-looking” information. These statements relate to our future plans, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements. They include, but are not limited to, statements about:

our market opportunity;
the adoption of RAIN technology and solutions;
our ability to compete effectively against competitors and competing technologies;
our market share and product leadership;
our business model, strategic plans and product-development plans;
the impact of any future health outbreak or pandemic, including a potential resurgence of Covid-19 on our business, operations and financial condition as well as on macroeconomic conditions;
our future financial performance, including our average selling prices, or ASPs, gross margins and the dependency of our future financial performance on macroeconomic conditions;
the performance of third parties on which we rely for product development, manufacturing, assembly and testing; and our relationship with other third parties on which we rely for product distribution, sales, integration and deployment;
our ability to adequately protect our intellectual property;
the regulatory environment for our products and services; and
our leadership in industry and standards-setting bodies.

Our actual results may differ materially from those contained in or implied by any forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this report, including those factors discussed in Part II, Item 1A (Risk Factors).

Considering the significant uncertainties and risks inherent in these forward-looking statements, you should not regard these statements as a representation or warranty by us or anyone else that we will achieve our objectives and plans in any specified time frame, or at all, or as predictions of future events. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Our Business

Our vision is a world in which every item that enterprises manufacture, transport and sell, and that people own, use and recycle, is wirelessly and ubiquitously connected to the cloud. And a world in which the ownership, history and linked information for every one of those items is seamlessly available to enterprises and people. We call our expansive vision a Boundless Internet of Things, or IoT. We design and sell a platform that enables that wireless item-to-cloud connectivity and with which we and our partners innovate Internet of Things, or IoT, solutions.

We have enabled connectivity for more than 100 billion items to date, delivering item visibility and improving operational efficiencies for retailers, supply chain and logistics, or SC&L providers, restaurants and food-service providers, airlines, automobile manufacturers, healthcare companies and many more. We are today focused on extending item connectivity from tens of billions to trillions of items, and delivering item data not just to enterprises but to people, so they too can derive value from their connected items. We believe the Boundless IoT we are enabling will, in the not-too-distant future, give people ubiquitous access to cloud-based digital twins of every item, each storing the item’s history and linked information and helping people explore and learn about the item. We believe that that connectivity will transform the world.

We and our partner ecosystem build item-visibility solutions using products that we design and either sell or license, including silicon RAIN radios; manufacturing, test, encoding and reading systems, software and cloud services that encapsulate our solutions know-how and intellectual property. We sell two types of silicon integrated circuit, or IC, radios. The first are endpoint ICs that store a serialized number to wirelessly identify an item. Our partners embed endpoint ICs into an item or its packaging. The ICs may also contain a cryptographic key to authenticate the item. The second are reader ICs that our partners use in finished readers to wirelessly discover, inventory and engage the endpoint ICs. Those readers may also protect an item or consumer, for example by authenticating the item as genuine or privatizing the item by rendering the endpoint IC unresponsive without the consumer first providing a password. Our manufacturing, test and encoding systems enable partner products and facilitate enterprise deployments. Our reading

19


systems comprise high-performance finished readers and gateways for autonomous reading solutions. Our software and cloud services focus on solutions enablement.

We sell our products, individually or as a whole platform offering primarily with or through our partner ecosystem. That ecosystem comprises original equipment manufacturers, or OEMs, tag service bureaus, original device manufacturers, or ODMs, systems integrators, or SIs, value-added resellers, or VARs, independent software vendors, or ISVs, and other solution partners.

Our silicon radios follow the RAIN industry’s air-interface standard for their core functionality. We create partner and enterprise preference for our radios and solutions by adding differentiated features into our products, and supporting or licensing those features across our platform, to deliver solutions capabilities and performance that surpasses mix-and-match solutions built from competitor products.

Factors Affecting Our Performance

Inventory Supply

Most of our revenue derives from endpoint ICs that our partners embed into or onto enterprise items and is therefore affected by macroeconomic trends. Further, we sell most of our products, both endpoint ICs and systems, through partners and distributors, limiting our visibility to enterprise demand. We work closely with those partners and distributors to gain as accurate a view as possible, however, correctly forecasting demand for our products and identifying market shifts in a timely manner remains a challenge. As a result, we sometimes experience inventory overages or shortages. Inventory overages can increase expenses, expose us to product obsolescence and/or increased reserves and negatively affect our business. Inventory shortages can cause long lead times, missed opportunities, market-share losses and/or damaged customer relationships, also negatively affecting our business.

In 2021 and 2022, demand for our endpoint ICs increased while worldwide wafer demand also increased, leading to wafer shortfalls for many semiconductor companies, including us. These wafer shortfalls prevented us from fully meeting customer demand and, in some cases, caused customers to cancel orders, qualify alternative suppliers or purchase from our competitors. In 2023, macroeconomic conditions led to softness in demand and inventory overages.

Product Adoption and Unit Growth Rates

Enterprises have significantly adopted RAIN in retail apparel, our largest market, and SC&L, but the rate of adoption and unit growth rates have been uneven and unpredictable. From 2010 to 2023, our overall endpoint IC sales volumes increased at a 26% compounded annual growth rate; however, we have experienced uneven growth rates in various periods.

Regardless of the uneven pace of retail, SC&L and other industry adoption and growth rates, we believe the long-term trend is continued RAIN adoption and growth and we intend to continue investing in developing new products and expanding our product offerings for the foreseeable future. However, we cannot predict whether historical annual growth rates are indicative of the pace of future growth.

Our systems business, at least for readers and gateways, depends significantly on large-scale deployments at discrete end users, and deployment timing causes large yearly variability in our systems revenue. For example, we generated 14% of total 2019 revenue from a gateway deployment at a large North American SC&L provider. We did not have comparable project-based revenue in 2020. Similarly, in 2021, we generated 13% of our quarterly revenue from a project-based gateway deployment for RAIN-based self-checkout and loss prevention at a large Europe-based global retailer. We did not have comparable project-based revenue in 2022, 2023 or first-half 2024.

Seasonality and Pricing

We typically negotiate pricing with most of our endpoint IC OEMs with an effective date of the first quarter of the calendar year. In the past, this negotiation typically resulted in reduced revenue and gross margins in the first quarter compared to prior periods, which then normalized in subsequent quarters as we reduced costs and adjust product mix by migrating those OEMs and end users to newer, lower-cost products.

Endpoint IC volumes tend to be lower in the fourth quarter than in the third quarter. System sales tend to be higher in the fourth quarter and lower in the first quarter, we believe due to the availability of residual funding for capital expenditures prior to the end of many end users’ fiscal years.

We did not see these seasonal trends in 2023 and may not see them in 2024. Whether and when these trends will return is not clear. We do expect continued quarter-to-quarter revenue variability due to changing macroeconomic conditions.

20


Results of Operations

The following table presents our results of operations for the periods indicated:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands, except percentages)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Revenue

 

$

102,495

 

 

$

85,986

 

 

$

16,509

 

 

$

179,320

 

 

$

171,883

 

 

$

7,437

 

Gross profit

 

$

57,516

 

 

$

43,814

 

 

$

13,702

 

 

$

95,064

 

 

$

87,344

 

 

$

7,720

 

Gross margin

 

 

56.1

%

 

 

51.0

%

 

 

5.1

%

 

 

53.0

%

 

 

50.8

%

 

 

2.2

%

Income (loss) from operations

 

$

9,046

 

 

$

(8,369

)

 

$

17,415

 

 

$

(2,687

)

 

$

(12,811

)

 

$

10,124

 

Three months ended June 30, 2024 compared with three months ended June 30, 2023

Revenue and gross profit increased, due primarily to higher endpoint IC revenue partially offset by lower systems revenue. The endpoint IC revenue increase was driven primarily by licensing revenue as well as higher endpoint IC shipment volumes when compared to the prior-year period. Systems revenue decreased, due primarily to lower shipment volumes. Gross margin increased, due primarily to the high-margin licensing revenue contribution, slightly offset by a decrease in product margins due to revenue mix between endpoint ICs and systems. Income from operations increased, due primarily to increased gross profit and decreased operating expenses. The operating expense decrease was due to lower general and administrative costs, sales and marketing costs and amortization of intangibles, partially offset by higher research and development costs.

Six months ended June 30, 2024 compared with six months ended June 30, 2023

Revenue and gross profit increased, due primarily to higher endpoint IC revenue partially offset by lower systems revenue. The endpoint IC revenue increase was driven primarily by licensing revenue as well as higher endpoint IC shipment volumes when compared to the prior-year period. Systems revenue decreased, due primarily to lower shipment volumes. Gross margin increased, due primarily to the high-margin licensing revenue contribution. Loss from operations decreased, due primarily to increased gross profit and decreased operating expenses. The operating expense decrease was due primarily to lower general and administrative costs and sales and marketing costs, partially offset by higher research and development and restructuring costs.

Revenue

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Endpoint ICs

 

$

89,392

 

 

$

64,905

 

 

$

24,487

 

 

$

150,898

 

 

$

131,954

 

 

$

18,944

 

Systems

 

 

13,103

 

 

 

21,081

 

 

 

(7,978

)

 

 

28,422

 

 

 

39,929

 

 

 

(11,507

)

Total revenue

 

$

102,495

 

 

$

85,986

 

 

$

16,509

 

 

$

179,320

 

 

$

171,883

 

 

$

7,437

 

We currently derive substantially all our revenue from sales of endpoint ICs, reader ICs, readers, gateways, test and measurement solutions and licensing. We sell our endpoint ICs and test and measurement solutions primarily to inlay manufacturers; our reader ICs primarily to OEMs and ODMs through distributors; and our readers and gateways to solutions providers, VARs and SIs, also primarily through distributors. We expect endpoint IC sales to represent the majority of our revenue for the foreseeable future.

Three months ended June 30, 2024 compared with three months ended June 30, 2023

Endpoint IC revenue increased $24.5 million, due to a $15.0 million increase in licensing revenue and a $17.7 million increase in shipment volumes, partially offset by a $8.2 million decrease from lower ASP due primarily to a product mix shift within the 300mm products, and to a lesser extent, short term special pricing incentives on legacy products. The product mix shift within the 300mm products was due primarily to higher contribution from authentication ICs in prior year.

Systems revenue decreased $8.0 million, due primarily to a decrease in shipment volumes. Reader and gateway revenues decreased $3.4 million and $3.9 million, respectively, and non-recurring engineering revenue decreased $0.5 million. These decreases were partially offset by an increase in reader IC revenue due to increased shipment volumes.

21


Six months ended June 30, 2024 compared with six months ended June 30, 2023

Endpoint IC revenue increased $18.9, million due to a $15.0 million increase in licensing revenue that did not occur in the prior-year period and a $15.2 million increase in shipment volumes, partially offset by a $11.3 million decrease from lower ASP due primarily to a product mix shift within the 300mm products, and to a lesser extent, short term special pricing incentives on legacy products. The product mix shift within the 300mm products was due primarily to higher contribution from authentication ICs in prior year.

Systems revenue decreased by $11.5 million due primarily to a decrease in shipment volumes. Reader revenue decreased $6.9 million, gateway revenue decreased $5.4 million, reader IC revenue decreased $1.6 million and nonrecurring engineering revenue decreased $0.5 million. The decrease was partially offset by an increase of $2.9 million from test and measurement solutions revenue.

Gross Profit and Gross Margin

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands, except percentages)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Cost of revenue

 

$

44,979

 

 

$

42,172

 

 

$

2,807

 

 

$

84,256

 

 

$

84,539

 

 

$

(283

)

Gross profit

 

 

57,516

 

 

 

43,814

 

 

 

13,702

 

 

 

95,064

 

 

 

87,344

 

 

 

7,720

 

Gross margin

 

 

56.1

%

 

 

51.0

%

 

 

5.1

%

 

 

53.0

%

 

 

50.8

%

 

 

2.2

%

Cost of revenue includes costs associated with manufacturing our endpoint ICs, reader ICs, readers, gateways and test and measurement solutions, including direct materials and outsourced manufacturing costs as well as associated overhead costs such as logistics, quality control, planning and procurement. Cost of revenue also includes charges for excess and obsolescence and warranty costs. Our gross margin varies from period to period based on the mix of endpoint IC and systems; underlying product margins driven by changes in mix, ASPs or costs; as well as from inventory excess and obsolescence charges.

Three months ended June 30, 2024 compared with three months ended June 30, 2023

Gross profit increased, due primarily to increased endpoint IC revenue, partially offset by decreased systems revenue. Gross margin increased, due primarily to high-margin licensing revenue recognized in the second quarter of 2024 that did not occur in the prior-year period, slightly offset by a decrease in product margins due to revenue mix between endpoint ICs and systems.

Six months ended June 30, 2024 compared with six months ended June 30, 2023

Gross profit increased, due primarily to increased endpoint IC revenue partially offset by decreased systems revenue. Gross margin increased, due primarily to high-margin licensing revenue recognized in the year that did not occur in the prior year.

Operating Expenses

Research and Development

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Research and development

 

$

24,924

 

 

$

23,403

 

 

$

1,521

 

 

$

47,443

 

 

$

45,838

 

 

$

1,605

 

Research and development expense comprises primarily personnel expenses (salaries, benefits and other employee related costs) and stock-based compensation expense for our product-development personnel; product development costs which include external consulting and service costs, prototype materials and other new-product development costs; and an allocated portion of infrastructure costs which include occupancy, depreciation and software costs. We expect research and development expense to increase in absolute dollars in future periods as we continue to focus on new product development and introductions.

Three months ended June 30, 2024 compared with three months ended June 30, 2023

Research and development expense increased $1.5 million, due primarily to increases of $2.6 million in personnel expenses related to higher bonus achievement and higher taxes associated with equity vesting; $0.7 million in stock-based compensation expense primarily related to increased outstanding equity grants; and $0.4 million in infrastructure costs; partially offset by a $2.0 million decrease in product development costs due to timing.

22


Six months ended June 30, 2024 compared with six months ended June 30, 2023

Research and development expense increased $1.6 million, due primarily to increases of $3.2 million in personnel expenses from higher bonus achievement, higher headcount primarily related to our acquisition of Voyantic and higher taxes associated with equity vesting; $1.4 million in stock-based compensation expense primarily related to increased outstanding equity grants; and $0.7 million in infrastructure costs; partially offset by a $3.5 million decrease in product development costs due to timing.

Sales and Marketing

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Sales and marketing

 

$

9,827

 

 

$

10,632

 

 

$

(805

)

 

$

20,003

 

 

$

20,605

 

 

$

(602

)

Sales and marketing expense comprises primarily personnel expenses (salaries, incentive sales compensation, or commission, benefits and other employee-related costs) and stock-based compensation expense for our sales and marketing personnel; travel, advertising and promotional expenses; and an allocated portion of infrastructure costs which include occupancy, depreciation and software costs.

Three months ended June 30, 2024 compared with three months ended June 30, 2023

Sales and marketing expense decreased $0.8 million, due primarily to decreases in personnel expenses resulting from a decrease in headcount, partially offset by higher bonus achievement.

Six months ended June 30, 2024 compared with six months ended June 30, 2023

Sales and marketing expense decreased $0.6 million, due primarily to decreases of $0.5 million in personnel expenses resulting from a decrease in headcount, partially offset by higher bonus achievement.

General and Administrative

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

General and administrative

 

$

13,223

 

 

$

16,002

 

 

$

(2,779

)

 

$

26,588

 

 

$

31,566

 

 

$

(4,978

)

General and administrative expense comprises primarily personnel expenses (salaries, benefits and other employee related costs) and stock-based compensation expense for our executive, finance, human resources and information technology personnel; legal, accounting and other professional service fees; travel and insurance expense; and an allocated portion of infrastructure costs which include occupancy, depreciation and software costs.

Three months ended June 30, 2024 compared with three months ended June 30, 2023

General and administrative expense decreased $2.8 million, due primarily to a decrease of $5.5 million in professional services related to decreased legal fees and transaction expenses in current year. This decrease was partially offset by increases of $1.7 million in personnel expenses primarily from higher bonus achievement and higher taxes associated with equity vesting and $0.8 million in stock compensation expense due primarily to increased outstanding equity grants.

Six months ended June 30, 2024 compared with six months ended June 30, 2023

General and administrative expense decreased $5.0 million, due primarily to a decrease of $8.5 million in professional services due primarily to decreased legal fees and transaction expenses in the current year. This decrease was offset by an increase of $2.0 million in personnel expenses from higher bonus achievement, higher headcount and higher taxes associated with equity vesting, as well as an increase of $1.4 million in stock-based compensation expense, due primarily to increased outstanding equity grants.

Amortization of Intangibles

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Amortization of intangibles

 

$

496

 

 

$

2,146

 

 

$

(1,650

)

 

$

1,905

 

 

$

2,146

 

 

$

(241

)

 

23


Three months ended June 30, 2024 compared with three months ended June 30, 2023

Amortization of intangibles decreased $1.7 million. The decrease relates to the intangibles acquired as part of our April 3, 2023 acquisition of Voyantic Oy. Certain intangible assets acquired had a useful life of less than 1 year, resulting in a higher amortization expense in the prior-year period.

Six months ended June 30, 2024 compared with six months ended June 30, 2023

Amortization of intangibles decreased $241,000. The decrease relates to the intangibles acquired as part of our April 3, 2023 acquisition of Voyantic Oy. Certain intangible assets acquired had a useful life of less than 1 year, resulting in a higher amortization expense in the prior-year period.

Restructuring Costs

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Restructuring costs

 

$

 

 

$

 

 

$

 

 

$

1,812

 

 

$

 

 

$

1,812

 

Three months ended June 30, 2024 compared with three months ended June 30, 2023

There were no restructuring costs for the three months ended June 30, 2024 and 2023.

Six months ended June 30, 2024 compared with six months ended June 30, 2023

The increase in restructuring costs relates to the restructuring we initiated on February 7, 2024. See Note 12, Restructuring for further details.

Other Income, net

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Other income, net

 

$

2,122

 

 

$

1,165

 

 

$

957

 

 

$

3,414

 

 

$

2,530

 

 

$

884

 

Other income, net comprises primarily interest income on our short-term investments.

Three months ended June 30, 2024 compared with three months ended June 30, 2023

Other income, net increased from the prior period due to increased interest income given higher invested balances and higher interest rates.

Six months ended June 30, 2024 compared with six months ended June 30, 2023

Other income, net increased from the prior period due to increased interest income given higher invested balances and higher interest rates.

Income From Settlement of Litigation

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Income from settlement of litigation

 

$

 

 

$

 

 

$

 

 

$

45,000

 

 

$

 

 

$

45,000

 

Three months ended June 30, 2024 compared with three months ended June 30, 2023

There was no income from litigation for the three months ended June 30, 2024 and 2023.

24


Six months ended June 30, 2024 compared with six months ended June 30, 2023

The increase in income from settlement of litigation relates to the Settlement Agreement with NXP on March 13, 2024. See Note 6, Commitments and Contingencies for further details.

Interest Expense

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Interest expense

 

$

1,217

 

 

$

1,211

 

 

$

6

 

 

$

2,433

 

 

$

2,420

 

 

$

13

 

Interest expense comprises primarily cash interest and amortization of debt issuance costs on our debt.

Three months ended June 30, 2024 compared with three months ended June 30, 2023

Interest expense was comparable for the periods.

Six months ended June 30, 2024 compared with six months ended June 30, 2023

Interest expense was comparable for the periods.

Income Tax Expense

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Income tax benefit

 

$

12

 

 

$

349

 

 

$

(337

)

 

$

13

 

 

$

277

 

 

$

(264

)

We are subject to federal and state income taxes in the United States and foreign jurisdictions. Income tax expense decreased $0.3 million for the three and six months ended June 30, 2024 compared to the prior-year periods due to changes in our estimated effective tax rate after we acquired Voyantic Oy.

Non-GAAP Financial Measures

Our key non-GAAP performance measures include adjusted EBITDA and non-GAAP net income (loss), as defined below. We use adjusted EBITDA and non-GAAP net income (loss) as key measures to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget and to develop short- and long-term operating plans. We believe these measures provide useful information for period-to-period comparisons of our business to allow investors and others to understand and evaluate our operating results in the same manner as our management and board of directors. Our presentation of these non-GAAP financial measures is not meant to be considered in isolation or as a substitute for our financial results prepared in accordance with GAAP, and our non-GAAP measures may be different from similarly termed non-GAAP measures used by other companies.

25


Adjusted EBITDA

We define adjusted EBITDA as net income (loss) determined in accordance with GAAP, excluding, if applicable for the periods presented, the effects of stock-based compensation; depreciation and amortization; restructuring costs; settlement income and related costs; induced conversion expense; other income, net; interest expense; acquisition related expense and related purchase accounting adjustments; and income tax benefit (expense). During the year ended December 31, 2023, we revised our definition of adjusted EBITDA to exclude acquisition related expenses, related purchase accounting adjustments and amortization of intangibles in connection with our Voyantic Oy acquisition. During the three months ended March 31, 2024, we further revised our definition of adjusted EBITDA to exclude settlement income. We have excluded these items because we do not believe they reflect our core operations and us excluding them enables more consistent evaluation of our operating performance. The revision to our definition of adjusted EBITDA did not impact adjusted EBITDA for any previously reported periods because there was no impact of a similar nature in such prior periods affecting comparability.

The following table presents a reconciliation of net loss to adjusted EBITDA:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Net income (loss)

 

$

9,963

 

 

$

(8,066

)

 

$

18,029

 

 

$

43,307

 

 

$

(12,424

)

 

$

55,731

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income, net

 

 

(2,122

)

 

 

(1,165

)

 

 

(957

)

 

 

(3,414

)

 

 

(2,530

)

 

 

(884

)

Interest expense

 

 

1,217

 

 

 

1,211

 

 

 

6

 

 

 

2,433

 

 

 

2,420

 

 

 

13

 

Income tax expense (benefit)

 

 

(12

)

 

 

(349

)

 

 

337

 

 

 

(13

)

 

 

(277

)

 

 

264

 

Depreciation and amortization

 

 

2,999

 

 

 

4,273

 

 

 

(1,274

)

 

 

6,908

 

 

 

6,066

 

 

 

842

 

Stock-based compensation

 

 

14,705

 

 

 

13,148

 

 

 

1,557

 

 

 

26,495

 

 

 

23,372

 

 

 

3,123

 

Restructuring costs

 

 

 

 

 

 

 

 

 

 

 

1,812

 

 

 

 

 

 

1,812

 

Acquisition related expense

 

 

79

 

 

 

630

 

 

 

(551

)

 

 

986

 

 

 

1,672

 

 

 

(686

)

Purchase accounting adjustments

 

 

 

 

 

276

 

 

 

(276

)

 

 

 

 

 

276

 

 

 

(276

)

Income on settlement of litigation

 

 

 

 

 

 

 

 

 

 

 

(45,000

)

 

 

 

 

 

(45,000

)

Adjusted EBITDA

 

$

26,829

 

 

$

9,958

 

 

$

16,871

 

 

$

33,514

 

 

$

18,575

 

 

$

14,939

 

Non-GAAP Net Income (Loss)

We define non-GAAP net income as net income (loss), excluding, if applicable for the periods presented, the effects of stock-based compensation; depreciation and amortization; restructuring costs; settlement income and related costs; induced conversion expense; acquisition related expense and related purchase accounting adjustments; and the corresponding income tax impacts of adjustments to net income (loss).

During the year ended December 31, 2023, we revised our definition of non-GAAP net income to adjust for acquisition related expenses, related purchase accounting adjustments and amortization of intangibles in connection with our Voyantic Oy acquisition. During the three months ended March 31, 2024, we further revised our definition of non-GAAP net income to exclude settlement income. The revisions to our definition of non-GAAP net income did not impact non-GAAP net income for any previously reported periods because there was no impact of a similar nature in such prior periods affecting comparability.

Additionally, during the year ended December 31, 2023, we revised our definition of non-GAAP net income (loss) to adjust for income tax effects of adjustments to net income (loss), calculated at the statutory rate for current and historical periods. We have revised the prior period amounts to conform to our current period presentation.

26


The following table presents a reconciliation of net loss to non-GAAP net income (loss):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

 

Change

 

 

2024

 

 

2023

 

 

Change

 

Net income (loss)

 

$

9,963

 

 

$

(8,066

)

 

$

18,029

 

 

$

43,307

 

 

$

(12,424

)

 

$

55,731

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

2,999

 

 

 

4,273

 

 

 

(1,274

)

 

 

6,908

 

 

 

6,066

 

 

 

842

 

Stock-based compensation

 

 

14,705

 

 

 

13,148

 

 

 

1,557

 

 

 

26,495

 

 

 

23,372

 

 

 

3,123

 

Restructuring costs

 

 

 

 

 

 

 

 

 

 

 

1,812

 

 

 

 

 

 

1,812

 

Acquisition related expense

 

 

79

 

 

 

630

 

 

 

(551

)

 

 

986

 

 

 

1,672

 

 

 

(686

)

Purchase accounting adjustments

 

 

 

 

 

276

 

 

 

(276

)

 

 

 

 

 

276

 

 

 

(276

)

Income on settlement of litigation

 

 

 

 

 

 

 

 

 

 

 

(45,000

)

 

 

 

 

 

(45,000

)

Income tax effects of adjustments (1)

 

 

(2,433

)

 

 

(965

)

 

 

(1,468

)

 

 

(3,024

)

 

 

(1,783

)

 

 

(1,241

)

Non-GAAP net income

 

$

25,313

 

 

$

9,296

 

 

$

16,017

 

 

$

31,484

 

 

$

17,179

 

 

$

14,305

 

(1) The tax effects of the adjustments are calculated using the statutory rate, taking into consideration the nature of the item and relevant taxing jurisdiction.

 

 

 

 

 

 

 

 

 

 

Liquidity and Capital Resources

As of June 30, 2024, we had cash, cash equivalents and short-term investments of $220.2 million, comprising cash deposits held at major financial institutions and short-term investments in a variety of securities, including U.S. government securities, treasury bills, corporate notes and bonds, commercial paper, asset-backed securities and money market funds. As of June 30, 2024, we had working capital of $39.4 million.

Historically, we have funded our operations primarily through cash generated from operations and by issuing equity securities, convertible-debt offerings and/or borrowing under our prior senior credit facility. In 2023, our principal uses of cash were increases in our inventory balance, our acquisition of Voyantic Oy and capital expenditures.

We believe, based on our current operating plan, that our existing cash, cash equivalents and short-term investments will be sufficient to meet our anticipated cash needs for at least the next 12 months. Over the longer term, we plan to continue investing to enhance and extend our platform. If our available funds are insufficient to fund our future activities or execute our strategy, then we may raise additional capital through equity, equity-linked or debt financing, to the extent such funding sources are available. Alternatively, we may need to reduce expenses to manage liquidity; however, any such reductions could adversely impact our business and competitive position.

Sources of Funds

From time to time, we may explore additional financing sources and ways to reduce our cost of capital, including equity, equity-linked and debt financing. In addition, in connection with any future acquisitions, we may pursue additional financing which may be debt, equity or equity-linked financing or a combination thereof. We can provide no assurance that any additional financing will be available to us on acceptable terms.

2021 Notes

In November 2021, we issued convertible notes due 2027 in an aggregate principal amount of $287.5 million which we refer to as the 2021 Notes. The 2021 Notes are our senior unsecured obligation, bearing interest at a fixed rate of 1.125% per year, payable semi-annually in arrears on May 15 and November 15 of each year, beginning on May 15, 2022. The 2021 Notes are convertible into cash, shares of our common stock or a combination thereof, at our election, and will mature on May 15, 2027 unless earlier repurchased, redeemed or converted in accordance with the indenture terms.

The net proceeds from the 2021 Notes were approximately $278.4 million after initial debt issuance costs, fees and expenses. We used approximately $183.6 million of the net proceeds to repurchase approximately $76.4 million aggregate principal amount of convertible notes due 2026, or the 2019 Notes through individual privately negotiated transactions concurrent with the 2021 Notes offering. We used $17.6 million to repurchase the remaining $9.85 million aggregate principal of the 2019 Notes through individual privately negotiated transactions in June 2022. We will use the rest of the net proceeds for general corporate purposes.

For further information on the terms of this debt, please refer to Note 7 to our condensed consolidated financial statements included elsewhere in this report.

27


Cash Flows

The following table shows a summary of our cash flows for the periods indicated:

 

 

Six Months Ended June 30,

 

(in thousands)

 

2024

 

 

2023

 

Net cash provided by (used in) operating activities

 

$

105,619

 

 

$

(49,104

)

Net cash provided by (used in) investing activities

 

 

5,465

 

 

 

68,991

 

Net cash provided by financing activities

 

 

8,844

 

 

 

5,753

 

Operating Cash Flows

For the six months ended June 30, 2024, we generated $105.6 million of net cash from operating activities. These net cash proceeds were due primarily to $78.4 million of net income adjusted for non-cash items and $27.2 million in working capital due primarily to lower inventory.

For the six months ended June 30, 2023, we used $49.1 million of net cash from operating activities. This net cash usage was due primarily to $65.2 million in working capital due primarily to higher inventory and accounts receivable offset by higher accounts payable and $16.1 million of net loss adjusted for non-cash items.

Investing Cash Flows

For the six months ended June 30, 2024, we generated $5.5 million of net cash from investing activities. These net cash proceeds were due primarily to investment maturities of $13.0 million, partially offset by cash paid for equipment purchases of $7.6 million.

For the six months ended June 30, 2023, we generated $69.0 million of net cash from investing activities. These net cash proceeds were due primarily to investment maturities of $92.4 million and investment sales of $13.4 million, respectively, partially offset by cash paid for the Voyantic Oy acquisition of $23.4 million and net property and equipment purchases of $13.2 million.

Financing Cash Flows

For the six months ended June 30, 2024, we generated $8.8 million of net cash from financing activities. These net cash proceeds were due to stock-option exercises and our employee stock purchase plan, offset by $4.6 million of cash paid for the earnout payment related to the Voyantic Oy acquisition.

For the six months ended June 30, 2023, we generated $5.8 million of net cash from financing activities. These net cash proceeds were due primarily to $5.8 million from stock-option exercises and our employee stock purchase plan.

Cash Requirements and Contractual Obligations

Our primary cash requirements are for operating expenses and capital expenditures. Our operating expenses have generally increased as we invest in sales and marketing and in developing products and technologies that we believe have the potential to drive long-term business growth.

Convertible Notes – As of June 30, 2024 the principal balance outstanding on the 2021 Notes is $287.5 million. Refer to Note 7 of our Notes to Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for maturity date, stated interest rate and additional information on our 2021 Notes.

Operating Lease Obligations – Our lease portfolio comprises primarily operating leases for our office space. For additional information regarding our operating leases, see Note 11 of our Notes to Consolidated Financial Statements of our Annual Report on Form 10-K for the year ended December 31, 2023.

Purchase Commitments – Purchase commitments as of June 30, 2024 total $27.8 million and comprise noncancelable commitments to purchase inventory.

Off-Balance-Sheet Arrangements

Since inception, we have not had any relationships with unconsolidated entities, such as entities often referred to as structured finance or special-purpose entities, or financial partnerships that would have been established for the purpose of facilitating off-balance-sheet arrangements or for another contractually narrow or limited purpose.

28


Critical Accounting Policies and Significant Estimates

We have prepared our condensed consolidated financial statements in accordance with GAAP. Our preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates and assumptions. For information on our critical accounting policies and estimates, see Part II, Item 7 (Management’s Discussion and Analysis of Financial Condition and Results of Operations) of our Annual Report on Form 10-K for the year ended December 31, 2023.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are exposed to market risks in the ordinary course of our business.

Interest Rate Risk

Under our current investment policy, we invest our excess cash in money market funds, U.S. government securities, corporate bonds and notes and commercial paper. Our current investment policy seeks first to preserve principal, second to provide liquidity for our operating and capital needs and third to maximize yield without putting our principal at risk. We do not enter into investments for trading or speculative purposes.

We had cash, cash equivalents and short-term investments of $220.2 million as of June 30, 2024. Our investments are exposed to market risk due to fluctuations in prevailing interest rates, which may reduce the yield on our investments or their fair value. Because most of our investment portfolio is short-term in nature, we do not believe an immediate 10% increase in interest rates would have a material effect on the fair market value of our portfolio, and therefore we do not expect our results of operations or cash flows to be materially affected by a sudden change in market interest rates.

Our convertible notes have fixed interest rates, thus a hypothetical 100 basis point increase in interest rates would not impact interest expense.

Inflation Risk

We do not believe that inflation has had a material effect on our business, financial condition or results of operations. To date, we have been able to substantially offset higher product costs by increasing our product selling prices. If our product costs became subject to significant future inflationary pressures, then we may not be able to fully offset these higher costs through price increases. Our inability or failure to do so could adversely affect our business, financial condition and results of operations.

 

29


Foreign Currency Exchange Risk

We are subject to risks associated with transactions that are denominated in currencies other than our functional currency and the effects of translating amounts denominated in a foreign currency to the U.S. dollar as a normal part of our reporting process. The functional currency of the majority of our foreign subsidiaries is the U.S. dollar. Accordingly, gains and losses resulting from remeasuring transactions denominated in currencies other than U.S. dollars are included in other income, net on the consolidated statements of operations. One of our European subsidiaries utilize Euros as their functional currency, which results in a translation adjustment that we include as a component of accumulated other comprehensive income. For any of the periods presented, we did not have material impact from exposure to foreign currency fluctuation. As we grow operations, our exposure to foreign currency risk will likely become more significant.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our management, including our chief executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2024. Disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (2) accumulated and communicated to management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based on the evaluation of our disclosure controls and procedures, our chief executive officer and principal financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of June 30, 2024.

Changes in Internal Control over Financial Reporting

There were no changes that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the three months ended June 30, 2024.

Limitations on Controls

Our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving the desired control objectives. Our management recognizes that any control system, no matter how well designed and operated, is based upon certain judgments and assumptions and cannot provide absolute assurance that its objectives will be met. Similarly, an evaluation of controls cannot provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.

30


PART II — OTHER INFORMATION

In the normal course of business, we may be named as a party to various legal claims, actions and complaints. We cannot predict whether any resulting liability will have a material adverse effect on our financial position, results of operations, cash flows, market position or stock price.

Item 1A. Risk Factors.

You should carefully consider the following risk factors, in addition to the other information contained in this report, including the section of this report captioned “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and related notes. If any of the events described in the following risk factors and the risks described elsewhere in this report occur, then our business, operating results and financial condition could be materially impacted. This report also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements due to factors that are described below and elsewhere in this report.

Risks Relating to Our Platform, Products and Technologies

We operate in a very competitive market.

Our primary competitors are:

Endpoint ICs: NXP, EM Microelectronic, Kiloway, Quanray, Shanghai Fudan Microelectronics Group, Alibaba and Alien.
Reader ICs: Phychips Inc, Shanghai Fudan Microelectronics Group and MagicRF.
Readers and gateways: Zebra.
Test and measurement systems: CISC.

These competitors include companies that have much greater financial, operating, research and development, marketing and other resources than us. To gain market share, they could discount their products and accept lower margins, or they could maintain margins by achieving cost savings through better, more efficient designs or production methods. They could devote more resources than we can to product development, promotion, sales and support. They could also bundle other technologies, including those we do not have in our product portfolio, with their RAIN products.

Our partners, including our OEMs, ODMs, distributors, SIs, VARs and solution partners, may choose to compete with us rather than purchase our products, which would not only reduce our customer base but also increase competition in the market. Companies in adjacent markets or newly formed companies may decide to enter our market, particularly as RAIN adoption grows. Further, the Chinese government has made development of the Chinese semiconductor industry a priority, potentially increasing competition for us globally while possibly restricting our ability to participate in the Chinese market.

RAIN adoption is concentrated in key markets and the extent and pace of RAIN market adoption beyond those markets is uncertain.

Our financial performance depends on the pace of end-user RAIN adoption in key markets, such as retail apparel (our largest market), retail general merchandise and SC&L. Although RAIN has been adopted to some degree by end users in those markets, those end users as well as the markets themselves are subject to business cycles and macroeconomic trends. Continued RAIN adoption by those end users and in those markets may be at risk if and when negative business or economic conditions arise.

The RAIN opportunity is still developing. RAIN adoption, as well as adoption of our platform and products, depends on many factors, including the extent to which end users understand and embrace the benefits that RAIN offers; whether the benefits of RAIN adoption outweigh the cost and time to replace or modify end users’ existing systems and processes; and whether RAIN products and applications meet end users’ current or anticipated needs.

We have, at times, anticipated and forecasted a pace of end-user adoption that exceeded the actual pace of adoption. We expect continued difficulty forecasting the pace of adoption. As a result, we may be unable to accurately forecast our future operating results including revenue, gross margins, cash flows and—profitability, any or all of which could negatively impact our financial performance.

We must introduce new products, product enhancements and services to compete effectively.

31


We introduce new products and services to advance our business, satisfy increasingly demanding end-user requirements and grow RAIN market adoption. We commit significant resources developing and introducing these new products and services, and to improving the performance and reliability of, and reducing the costs of, our existing products and services.

Whether our new or enhanced products and services will succeed is uncertain. Our success developing the technologies, processes or capabilities necessary or desired for new or enhanced products and services, or licensing or otherwise acquiring them from third parties, and our ability to introduce new or enhanced products and services before our competition, depends on many factors, including:

 

our ability to identify new product capabilities or services that end users will widely adopt;
our timely and efficient completion of the design process;
our timely and efficient implementation of manufacturing, assembly and testing procedures;
our attainment of appropriate product or service performance levels and product certifications;
partnering successfully with others to deliver complementary products or services;
the quality, reliability and selling price of our product or service; and
the effectiveness of our marketing, sales and support.

When we introduce new products and services, our success in ramping adoption depends, in part, on us making those products and services easy for our partners and end users to deploy and use. For example, for our new M800-family endpoint ICs, we are currently significantly supporting our inlay partners to produce high-performing, high-quality inlays. Until our partners are able to deploy our products widely, adoption and our operating results could suffer.

Our abilities to deliver enterprise solutions at scale are nascent.

We believe we are still at a very early stage in our ability to deliver enterprise solutions. We are developing solutions for retail self-checkout and loss prevention and SC&L package routing that have been, or that we expect to be, deployed by the industry-leading enterprise end users. However, to fully capitalize on our platform's potential, we must make our current offerings repeatable across multiple enterprises as well as deliver additional solutions to enterprise needs. We must also develop relationships with top-tier solution partners to gain access to and address challenging new use cases. If we do not succeed in identifying, developing, selling and deploying enterprise solutions, particularly solutions that rely on autonomous reading, with top-tier partners and end users and across a range of markets and use cases, then our business prospects will suffer.

Delivering enterprise solutions requires a network of partner products and services that complement our own product offerings and that together address enterprise needs. Convincing enterprises to partner with us to solve their business problems—including evaluation, design, deployment, operations and services, as well as integrating RAIN data into the enterprise's information systems—requires tight coordination among our and our partners' sales, marketing, operations and engineering teams. We, or our partners, may be unable to successfully acquire customers for our enterprise solutions, or successfully address our market opportunity. Although we have partners who can successfully introduce our platform, or aspects of it, to their customers, even today their knowledge of our platform and RAIN in general is often still nascent. If we do not build our network of solutions, and partners to deliver those solutions, and broaden our efforts to deliver solutions that leverage our platform in large, complex enterprise opportunities, then our business prospects will suffer.

We rely on endpoint IC sales to generate most of our revenue.

We derive, and expect to continue to derive, most of our revenue from our endpoint ICs. If demand declines, or if we are unable to procure enough wafers to meet the demand we have, or if we are unable to raise prices to offset cost increases, then our business and operating results will suffer. In addition, the continued adoption of, and demand for, our endpoint ICs, derives in part from us demonstrating the benefits of using our systems. If we fail to establish those benefits then we may be unsuccessful in countering competitive endpoint IC price pressures and our business and operating results could be adversely affected.

The average selling prices of our products could fluctuate substantially.

The average selling price, or ASP, of our products has historically decreased with time or to meet end-user demands, encourage adoption, address macroeconomic conditions or respond to competitive pressure. As demand for older products declines, or as competition from competitors with lower product costs or lower profitability expectations increases, or during times of oversupply, ASPs may decline quickly.

32


To compete profitably we must continually improve our technology and processes, reduce unit costs in line with lower selling prices, and introduce new, higher margin products. If we are unable to offset ASP reductions with increased sales volumes or reduced product costs, or if we are unable to introduce new products that command higher prices and better gross margins, then our overall revenue and gross margins will suffer.

Though less common, we have also increased prices from time to time, especially during times of increasing wafer costs. For example, we raised prices in 2021, 2022 and 2023 to accommodate higher costs. We may be required to raise prices again if macroeconomic conditions, including inflation, create upward pressure on our product costs. Increased prices could dampen adoption and market growth.

Pricing commitments and other restrictive provisions in our customer agreements could adversely affect our operating results.

In the ordinary course of our business, we enter into agreements containing pricing terms that could, in some instances, adversely affect our operating results and gross margins. For example, some contracts specify future IC, reader or gateway pricing or contain most-favored-customer pricing for certain products. Other agreements contain exclusivity terms that prevent us from pursuing certain business with other customers during the exclusivity period. Reducing prices or offering favorable terms to one customer could adversely affect our ability to negotiate favorable terms with other customers.

Changes in our product mix could adversely affect our overall gross margin.

Endpoint IC sales, which constitute and likely will continue to constitute the majority of our product revenue, have, for the most part, lower gross margins than our systems product sales. Our overall product gross margins are affected by product mix, which can fluctuate based on supply and demand, competitive pressures and end-user needs and demand. A shift in sales mix away from our higher margin products to lower margin products, either within our endpoint IC product portfolio or from our systems business to our endpoint ICs, could negatively affect our gross margins.

Poor product quality could result in significant costs to us and impair our ability to sell our products.

Our products must meet increasingly demanding specifications for quality, reliability and performance. Our products are both highly technical and deployed in large, complex systems in which errors, defects or incompatibilities can be problematic for our partners and end users.

If we are unable to identify or correct errors, defects, incompatibilities or other problems in our products, we could experience:

loss of customer orders or customers;
lost or delayed market acceptance (either of our products and solutions or RAIN generally);
lost or delayed sales;
loss of market share;
damage to our brand and reputation;
impaired ability to attract new customers;
diversion of development resources;
increased service and warranty costs;
replacement costs;
legal actions by our partners or end users; and
increased insurance costs.

Moreover, if we encounter product quality issues, then we may be required to incur significant time and costs to diagnose, test and fix the issues. There can be no assurance that such remediation efforts would be successful. Even if successful, these efforts could further constrain our ability to supply our partners and end users with new products until we have resolved the issues.

End users and partners must design our products into their products and business processes.

Persuading end users or partners to design our products into their business processes or products requires educating them about RAIN’s and our products’ value. They may use other technologies or products and may not be receptive to introducing RAIN into their business processes or products. Even when convinced, they often undertake long pilot programs and qualifications prior to placing orders. These pilot programs and qualifications can be time-consuming and expensive, and there is no assurance they will

33


result in an order for our products. If we fail to develop new products that adequately or competitively address end users’ or our partners’ needs, then we may not receive product orders, which could adversely affect our business, prospects and operating results.

Our visibility into the length of the sales and deployment cycles for our products is limited.

We have limited visibility into end user sales and deployment cycles, and these cycles are often longer than we anticipate. Many factors contribute to our limited visibility, including the time our partners and end users spend evaluating our products, the time educating them on RAIN’s benefits and the time integrating our products with end users’ systems. The length and uncertain timing of the sales and deployment cycles can lead to delayed product orders. In anticipation of those orders, we may incur substantial costs before the sales cycle is complete and before we receive any customer orders or payments, if we receive them at all.

An inability or limited ability of end user systems to exploit RAIN information may adversely affect the market for our products.

A successful end-user deployment requires not only tags and readers or gateways, but RAIN integration with information systems and applications that create business value from the RAIN data. Unless third parties continue developing and advancing business analytics tools, and end users enhance their information systems to use these tools, RAIN deployments could stall. Our efforts to foster third-party development and deployment of these tools could fail. In addition, our guidance to business-analytics providers for integrating our products with their tools could prove ineffective.

Solution providers and SIs are essential to the RAIN market. They provide deployment know-how to enable end users to successfully deploy RAIN solutions. Integrating our products with end-user information systems could prove more difficult or time-consuming than we or they anticipate, which could delay deployments.

Alternative technologies may enable products and services that compete with ours.

Technology developments may affect our business negatively. Breakthroughs in legacy RFID technologies or markets, including those using low frequency or high frequency RFID technology, or in other radio technologies, could adversely affect RAIN market growth and demand for our products. Likewise, new technologies may enable lower-cost ICs than our products. If we are unable to innovate using new or enhanced technologies or are slow to react to changes in existing technologies or in the market, or if we have difficulty competing with advances in new or legacy technologies, then our development of new or enhanced products could be impacted and result in product obsolescence, decreased revenue and reduced market share.

Significant changes in RAIN standards bodies, standards or qualification processes could impede our ability to sell our products and services.

We have historically taken a leadership position in developing RAIN industry standards, including with GS1 and ISO, and have designed our products to comply with those standards. We could lose that leadership position; our influence in standards development could diminish; or we could choose not to participate in certain standards activities.

New or changed industry standards could affect us negatively. If industry standards diverge from our or the RAIN market’s needs, then our products may fail to keep pace with the market or cause end users to delay their deployments. Moreover, the adoption or expected adoption of new or changed standards could slow sales of our existing products before we can introduce new products that meet the new or changed standards. New standards or changes to existing standards could also limit our ability to implement new features in our products. The lost opportunities as well as time and expense to develop new products or change our existing products to comply with new or changed standards could be substantial, and we may not ultimately succeed in developing products that comply with the new or changed standards.

Certain organizations develop requirements for RAIN tags and test tags against those requirements. For example, the ARC Program at Auburn University develops tag performance and quality requirements for end users that engage them. Some participants in the RAIN market are ARC sponsors, but we are not among them. Some other organizations perform this function as well. ARC or a similar organization could develop specifications that some or all of our endpoint ICs fail to meet or could delay approval of tags incorporating our endpoint ICs, which could negatively impact market acceptance of our products.

Changes in government spectrum regulations or in their enforcement could adversely affect our ability to sell our products.

Our readers and gateways are collectively certified for use in more than 40 countries worldwide, including the United States, Canada, Mexico, China, Japan, South Korea and every country in the European Union, or the EU.

If spectrum regulations or the application or enforceability or such regulations should change, or if our products were found to be noncompliant despite being certified, we could need to redesign our products, potentially resulting in significant costs, including costs associated with obsolete inventory. Regulatory changes may also cause us to forego opportunities, adversely affecting our business.

Sales of some of our products could cannibalize revenue from other products.

34


Some of our partners develop products that compete with our products. For example, some of our OEM partners use our reader ICs to build and sell readers and gateways that compete with our readers and gateways. Similarly, some of our partners use our readers to build and sell gateways that compete with our gateways. If we fail to manage such conflicts successfully, then our business and operating results could be negatively affected.

Our licensing program is nascent.

While we believe we have valuable RAIN intellectual property and aspire to monetize that intellectual property by licensing it to third parties, including third parties who compete with us to some extent, our experience in doing so is nascent, and our ability to grow licensing revenue remains subject to numerous risks and uncertainties. To materially grow our licensing program and revenues, we will need to maintain and grow our intellectual property portfolio and continue to research and develop RAIN innovations that will generate and maintain demand for licenses to our technology and features. We will also need to develop and maintain an ability to monitor infringement of our intellectual property rights by others and possibly seek enforcement action against those who attempt to infringe our intellectual property rights. These enforcement actions could require significant investments in management time and attention as well as cash as we incur legal and other expenses. They could also compete with our objectives in other areas of our business such as wanting to maintain close, strategic relationships with important partners or end users of our products. These are just some of the risks and uncertainties we face with respect to our nascent licensing program.

We currently derive a substantial share of our licensing revenues from NXP, our primary endpoint IC competitor, based on our Settlement Agreement with them. For more information regarding the terms of our Settlement Agreement with NXP, please refer to Note 6 of our condensed consolidated financial statements included elsewhere in this report. If NXP were to breach its license payment obligations, or if NXP were to design around our intellectual property rights and exercise its right to terminate our license before the end of the agreement's 10-year term, our licensing revenues would decline and our overall results of operations and cash flows would suffer.

Risks Relating to Our Personnel and Business Operations

We obtain the products we sell through a limited number of third parties with whom we do not have long-term supply contracts.

Our ability to secure cost-effective, quality products in a timely manner could be adversely affected by many factors, including:

Third-party manufacturing capacity may not be available when we need it, particularly from our foundry partners from whom we procure silicon wafers.
Efforts to diversify our supplier base may be unsuccessful or may not result in us obtaining the anticipated benefits of such diversification.
Some products have long lead times, and we place orders for them many months before our anticipated delivery dates to our customers. If we inaccurately forecast customer demand, then we may be unable to meet our customers’ delivery requirements or we may accumulate excess inventory, increasing our costs.
Supply disruptions may affect our ability to meet partner or end-user demand, whether in a cost-effective manner or at all, potentially causing those partners or end users to cancel orders, qualify alternative suppliers or purchase from our competitors. Supply disruptions can also distort demand, making it even harder to meet true demand.

If our suppliers fail to manufacture our products at reasonable prices or with satisfactory quality levels, then our ability to bring those products to market and our reputation could both suffer. If supplier capacity diminishes, whether from equipment failures, closures, bankruptcy, capacity allocation, in response to public health events (such as Covid-19), catastrophic loss of facilities or otherwise, then we could have difficulty fulfilling orders, our revenue could decline and our growth prospects could be impaired. Transitioning our product manufacturing to new providers would take many months and, in the case of ICs, could take years. Any transition would require a requalification by our customers or end users, which could also adversely affect our ability to sell our products as well as our operating results.

Shortages of silicon wafers or components used in our readers and gateways may adversely affect our ability to meet demand for our products and adversely affect our revenue and/or gross margins.

Wafer shortfalls limit sales and may cause market-share losses. We expect wafer capacity in at least some of the semiconductor nodes we use to be tight for the foreseeable future. We procure wafers on a purchase-order basis, so our wafer supply is not guaranteed, and we may not receive adequate supply from our foundry partners when shortages occur.

Wafer shortages may also artificially increase bookings as customers over-order our products, and then cause sales declines as those customers consume their accumulated inventory. Additionally, if our suppliers charge us more but we are unable to raise our prices to cover those higher costs, our gross margins and other financial results could suffer.

35


Shortages of our silicon products can also occur due to post-processing constraints. To convert the wafers we receive from our foundry partner into saleable ICs, we perform additional steps including testing, thinning, bumping and dicing. If our third-party suppliers are unable to efficiently perform these steps, and our production capacity is constrained as a result, we may be unable to satisfy demand for our products and our financial results could suffer.

We have also experienced shortages and price increases for components we use in our readers and gateways, as well as in packaging and test capacity for our reader ICs, and we may continue to experience such shortages and price increases in the future. Any such shortages or price increases will negatively impact our product availability and costs and our financial results will suffer.

We bear inventory risks because our products have relatively long lead times, demand for our products are hard to accurately forecast, and we rely on partners to sell and distribute our products.

We maintain inventory to meet customer demand. To guard against wafer shortages, and to allow for production risks given the relatively long lead times for our many of our products, we may invest in inventory to support anticipated business growth, like we did with endpoint IC inventory in 2017, 2020 and late 2022/early 2023. When we introduce new products, we may also initially carry higher inventory or have slower inventory turns depending on market acceptance.

We typically order products from our suppliers based on partner forecasts before we receive purchase orders. However, many of our partners have difficulty accurately forecasting their demand and the timing of that demand, and sometimes cancel orders or reschedule product shipments, in some cases with little or no advance notice to us. Partners will also sometimes give us soft commitments for large orders that do not materialize. We have additional uncertainty arising from competition and from unanticipated external events, such as macroeconomic trends or events and changes in regulatory standards, all of which can adversely affect demand and consequently our inventory levels, sales and operating results.

High inventory levels can increase expenses or reserves and expose us to a higher risk of product obsolescence, especially when we introduce new products and technologies. If we are unable to sell the inventory we purchased, or if we must sell it at lower prices, then our business will be negatively impacted.

Acquisitions could result in operating difficulties, dilution and other harmful consequences.

We regularly evaluate potential strategic transactions, and we may pursue them if complementary to our business. For example, in April 2023 we completed our acquisition of Voyantic Oy, a global provider of RFID (primarily RAIN and NFC) inlay and label design, manufacturing and test systems. Strategic transactions could be material to our financial condition and operating results. We have limited experience executing acquisitions. Integrating an acquired company, business or technology may create unforeseen operating difficulties and expenditures. Acquisition-related risks include:

difficulties integrating acquired products or lines of business into our strategy and product plans;
customers switching from us to new suppliers because of the acquisition;
inability to retain employees from the business we acquire;
challenges associated with integrating employees from the acquired company into our organization;
difficulties integrating accounting, management information, human resource, legal and other administrative systems to permit effective management of the business we acquire;
potential requirements for remediating controls, procedures and policies appropriate for a public company in the acquired business that, prior to the acquisition, lacked these controls, procedures and policies;
potential liability for past or present environmental, hazardous substance or contamination concerns associated with the acquired business or its predecessors;
possible write-offs or impairment charges resulting from the acquisition; and
unanticipated or unknown liabilities relating to the acquired business.

Foreign acquisitions involve additional risks beyond those above, including those related to integrating operations across different cultures and languages, currency risks and the economic, political and regulatory risks associated with other countries. Also, the anticipated benefit of any acquisition, domestic or foreign, may not materialize. Future acquisitions or dispositions could result in potentially dilutive issuances of our equity securities, debt incurrence, contingent liabilities or amortization expenses or goodwill write-offs, any of which could harm our financial condition. Future acquisitions may require us to obtain additional equity or debt financing, which may not be available on favorable terms or at all.

36


Changes in global trade policies could have a material adverse effect on us.

Changes in U.S. and foreign laws and policies governing foreign trade, manufacturing, development and investment in the jurisdictions where we currently develop and sell products, and any negative consequences resulting from such changes, could materially affect our business.

The U.S. government has imposed significant tariffs on a variety of items imported from other countries, particularly China. China responded by imposing significant tariffs on a variety of items imported from the United States. These tariffs could materially and adversely affect our ability to compete internationally. Although the United States and China signed a preliminary trade agreement in early 2020, the tariffs remain in place as negotiations between the countries continue. The future of these tariffs, as well as the possibility for new tariffs, remains uncertain. Changes in U.S. and Chinese industrial policy also contribute to uncertainty regarding the global trade environment.

Other causes of uncertainty include the effects of sanctions and other actions against Russia after Russia invaded Ukraine. While we do not today have business with Russian partners or end users, the effect of these sanctions on global trade and macroeconomic conditions generally—such as increasing energy costs and inflation—could nevertheless negatively affect our business.

We are subject to risks inherent in operating abroad and may not be able to successfully maintain or expand our international operations.

In 2023, we derived 72% of our total revenue from sales outside the United States. We anticipate growing our business, in part, by growing our international operations, which presents a variety of risks, including:

changes, some unexpected or unanticipated, in regulatory requirements, taxes, trade laws, tariffs, export quotas, custom duties or other trade restrictions;
lack of established, clear or fairly implemented standards or regulations with which our products must comply;
greater difficulty in enforcing contracts, judgments and arbitration awards in international courts, and in collecting accounts receivable as well as longer payment and collection periods;
limited or unfavorable intellectual property protection;
misappropriation of our intellectual property;
inflation and fluctuations in foreign currency exchange and interest rates;
restrictions, or changes thereof, on foreign trade or investment, including currency-exchange controls, including as a result of sanctions against Russia;
changes in a country’s or region’s political, regulatory, legal or economic conditions, including, for example, global and regional economic disruptions caused by any future public health outbreaks or pandemics, including a resurgence of Covid-19;
political, social and economic instability abroad; wars and other armed conflicts, such as those in Ukraine and the Gaza Strip; geopolitical tensions, such as those between the United States, China and Taiwan; and terrorist attacks and security concerns in general;
differing regulations with regard to maintaining operations, products and public information;
inequities or difficulties obtaining or maintaining export and import licenses;
differing labor regulations, including where labor laws may be more advantageous to employees than in the United States;
restrictions on earnings repatriation;
corrupt or unethical practices in foreign jurisdictions that may subject us to exposure under applicable anti-corruption and anti-bribery laws such as the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the United Kingdom Bribery Act of 2010; and
regulations, and changes thereof, relating to data privacy, cybersecurity and the unauthorized use of, or access to, commercial and personal information, particularly in Europe.

37


We are subject to governmental export and import controls that could subject us to liability or impair our ability to compete in international markets.

We must export and import our products in compliance with U.S. export controls, including the Commerce Department’s Export Administration Regulations and economic and trade sanctions established by the Treasury Department’s Office of Foreign Assets Controls, as well as similar controls established in the countries in which we do business. For example, the U.S. Commerce Department recently strengthened rules regarding semiconductor- and supercomputer-related products and restrictions against sending certain chips and chip-related technology and software to China without an export license. The modifications included an expansion of the products and destinations that require licensing. In addition, the United States and other countries continue to expand the economic sanctions and export control restrictions imposed against Russia and Belarus and certain Russian nationals and entities after Russia invaded Ukraine. We must undertake additional diligence efforts to comply with these rules, which may be time-consuming and result in delayed or lost opportunities. We may not always be successful in obtaining necessary export or import licenses, and our failure to obtain required export or import approval for our products or limitations on our ability to export or sell our products may harm our domestic and international sales and negatively affect our revenue.

Tariffs could also have a material impact on our product costs and decrease our ability to sell our products to existing or potential customers as well as harm our ability to compete internationally. For more information, see “Changes in global trade policies could have a material adverse effect on us.” Any changes in our product or in export or import regulations or legislation; shifts or changes in enforcement; or changes in the countries, persons or technologies targeted by these regulations could delay us introducing new products in international markets, decrease use of our products by, or decrease our ability to export or sell our products to, existing or potential customers with international operations, adversely affecting our business and results of operations.

Instability or deterioration in the political, social, business or economic conditions in key jurisdictions could harm our supply or development of products.

Deterioration in the political, social, business or economic conditions in any jurisdictions in which we have significant suppliers, distributors or end users—including as a result of natural disasters, labor strikes, public health crises, geopolitical events or other developments—could slow or halt product shipments or disrupt our ability to manufacture, test or post-process our products., as well as our ability to effectively and timely execute on end user deployments. We outsource our manufacturing and production to suppliers in a small number of Asian jurisdictions, including Thailand, Malaysia, Taiwan and China. Some of these jurisdictions experienced significant restrictions during the Covid-19 pandemic. These jurisdictions have also experienced significant changes in political, social, business or economic conditions in the past and may experience them in the future.

We could be forced to transfer our manufacturing, testing and post-processing activities to more stable, and potentially more costly, regions or find alternative suppliers.

We source a significant portion of our wafers from suppliers in Taiwan, and our supply of wafers and other critical components may be materially and adversely affected by diplomatic, geopolitical and other developments between China and Taiwan. Notably, China has refused to renounce the use of military force against Taiwan, and there can be no assurance that relations between China and Taiwan will not deteriorate further, particularly in light of ongoing tensions between the United States and China. Any such developments could materially and adversely affect our business, financial condition and results of operations.

Our business operations could be adversely affected by public health outbreaks and pandemics, or by natural disasters.

Starting in 2020, Covid-19 created significant worldwide economic volatility, uncertainty and disruption, and presented our business with several risks and challenges. Although the Covid-19 global health emergency officially ended in 2023, experts caution that Covid-19 remains a public health risk, and the extent to which any public health outbreak or pandemic could impact future market demand and our business results is uncertain.

In addition, other disasters, whether natural or manmade, could decrease demand for our products, disable our facilities, disrupt operations or cause catastrophic losses. We have facilities in areas with known seismic activity, such as our headquarters in Seattle, Washington. We have facilities in areas with known flooding, such as our office in Shanghai, China. We have a wafer post-processing subcontractor in Thailand, a region with a known, and recent, history of flooding. A loss at any of these or other of our or our suppliers’ facilities could disrupt operations, delay production and shipments, reduce revenue and engender potentially large expenses. We do not carry insurance covering potential losses caused by pandemics, earthquakes, floods or other disasters.

Risks Relating to Our Relationships with Partners and End Users

We rely on a small number of customers for a large share of our revenue.

We sell our endpoint ICs directly to inlay and tag OEMs and ODMs. We sell our reader ICs to OEMs and ODMs and our readers and gateways to solution providers, VARs and SIs, all primarily through distribution. If we fail to retain our endpoint IC, reader IC, reader or gateway partners or distributors or fail to establish relationships with new partners, then our business, financial condition or operating results could be harmed.

38


In 2023, sales to tag OEMs Avery Dennison and Arizon accounted for 33% and 11% of our total revenue, respectively. Sales concentration to a small number of OEMs decreases our bargaining power and increases the risk that our pricing or sales could decline based on actions taken by our competitors or our own failure to compete effectively.

Our competitors’ relationships with, or acquisitions of, these partners or distributors could interfere with our relationships with them. Any such interference could impair or delay our product sales or increase our cost of sales.

We engage directly with some end users. Their projects, often involving large purchases of our readers and gateways, are often discrete deployments that can result in significant sales for periods of time. They also increase the volatility of our revenue and operating results. If we are unable to replace project-based revenue with new revenue streams, or if end users with large projects change or delay those projects without providing us with adequate notice, then our sales could decline from period to period and harm our stock price.

Our ability to affect or determine end-user demand is limited in part because we sell and fulfill primarily through partners and rarely directly to end users.

End users drive demand for our products but because we sell our products primarily through partners, we are one step removed from those end users and are often unable to directly assess and affect their demand. Our partners may choose to prioritize selling our competitors’ products over ours, or they may offer products that compete with our products or limit sales of our products. If our partners do not sell enough of our products or if they choose to decrease their inventories of our products, then our sales to those partners and our revenue will decline.

Our partners may not properly forecast end users’ demand for our products.

Our partners may purchase more of our products than they need to satisfy end-user demand, increasing their inventory and reducing our future sales to them. Distributors may, subject to time and quality limitations, return products in exchange for other products. Our reserve estimates for products stocked by our distributors are based primarily on reports provided to us by those distributors, typically monthly. If the inventory and resale information our partners and distributors provide is inaccurate, or if we do not receive it in a timely manner, then we may not have a reliable view of products being sold to end users which could negatively impact our operating results.

Our growth strategy depends in part on the success of strategic relationships with third parties and their continued performance and alignment.

We invest in relationships with solution providers, SIs, VARs and software providers whose product and/or solution offerings complement ours and through which we often fulfill our product sales. Our business will be harmed if we fail to develop and grow these partner relationships. For example, our operating results may suffer if our efforts developing partner relationships increase our costs but do not increase revenue. Partner relationships may also include exclusivity provisions, multiple levels of distribution, discounted pricing or investments in other companies. The cost of developing and maintaining these partner relationships may go unrecovered and our efforts may not generate a corresponding revenue increase.

Occasionally we also engage directly with end-users, often at their request, to help them develop solutions for challenging use cases. Such direct engagements could cause, or could be perceived to cause, conflicts with partners that could harm our partner relationships and our business, results of operations or financial condition.

If we fail to maintain or enhance our brand recognition or reputation on which our business depends, then our business could be harmed.

We believe that building our brand and reputation is key to our relationships with partners and end users and our ability to attract new partners and end users. We also believe that our brand and reputation will be increasingly important as market competition increases. Our success depends on a range of factors, including:

continuing to deliver high-quality, innovative and defect-free products;
maintaining high partner and end-user satisfaction;
successfully differentiating our products from those of our competitors; and
managing both positive and negative publicity.

Product supply shortages have challenged our ability to meet market needs and we have increased prices in response to our suppliers increasing their prices to us. Our inability to supply partners and end users with products they need, and/or our need to increase our prices could result in long-lasting, negative consequences to our relationships with those partners and end users, to RAIN adoption and to our business overall.

39


Increasing attention to environmental, social and governance matters may cause us to incur additional costs or expose us to additional risks.

Investors, governmental and nongovernmental organizations, partners and end users are increasingly focusing on environmental, social and governance, or ESG, practices. Our ESG practices may not meet their standards, and they as well as advocacy groups may campaign for us to change our business or practices to address their ESG-related concerns. Our failure, or perceived failure, to adequately respond to any such campaigns could harm our business and reputation and negatively impact the market price of our securities. Moreover, with the continued evolution of ESG practices and reporting and disclosure requirements, our costs related to those ESG practices and reporting and disclosure requirements could increase, which could negatively affect our operating results. For example, the SEC has adopted final rules regarding climate-related disclosures in public companies’ periodic reporting, and compliance with these rules—including the implementation of necessary internal controls and reporting procedures—may lead to increased expenses and additional demands on our management and board of directors.

Risks Relating to Our Intellectual Property

If we are unable to protect our intellectual property, then our business could be adversely affected.

Our success depends in part upon our ability to obtain, maintain and enforce our patents, copyrights, trade secrets, trademarks and other intellectual property rights and prevent third parties from infringing, misappropriating or circumventing those rights. We have historically focused on filing U.S. patent applications, for many reasons, including the fact that a significant portion of RAIN products are used in or imported into the United States. We have only a small number of foreign patents and applications. We also only have registered trademarks and domain names in select countries where we believe filing for such protection is appropriate. By focusing our intellectual property protection on the United States and a small number of foreign countries, we have a limited ability to assert intellectual property rights outside the United States, including in some significant foreign markets such as China. Moreover, the global manufacturing and distribution systems for tags or labels incorporating our endpoint IC products could complicate our efforts to enforce our U.S. patents.

As we increasingly work with third parties, possibly including parties that compete with us to an extent, to advance our technical innovations and features, we cannot guarantee that our efforts to protect our intellectual property will be completely effective.

We cannot guarantee that:

any of the patents, trademarks, copyrights, trade secrets or other intellectual property rights we presently employ in our business will not lapse or be invalidated, circumvented, challenged or abandoned;
our intellectual property rights will provide competitive advantages to us;
our ability to assert our intellectual property rights against potential competitors or to settle current or future disputes will not be limited by our agreements with third parties;
any of our pending or future patent applications will issue or have the coverage we originally sought;
our intellectual property rights can or will be enforced, particularly in jurisdictions where competition may be intense or where legal protections may be weak;
we will not lose the ability to assert our intellectual property rights against, or to license our technology to, others and collect royalties or other payments; or
we will retain the right to ask for a royalty-bearing license to an industry standard if we fail to file an intellectual property declaration pursuant to the standards process.

Monitoring and addressing unauthorized use of our intellectual property is difficult and costly, and litigation to enforce our intellectual property rights is time consuming, distracting, expensive and uncertain. Our failure to identify unauthorized use of, or otherwise adequately protect our intellectual property could adversely affect our business.

We have been and may in the future be party to intellectual property disputes which could be time consuming and costly to prosecute, defend or settle, result in the loss of significant rights, and adversely affect RAIN adoption or adoption of our products or platform.

Patent litigation is complex and uncertain. We may or may not prevail in patent-related proceedings and such proceedings may result in increased legal expenses, additional demands on our management’s time and attention, and negative effects on our relationships with partners or end users. If any pending or future proceedings result in an adverse outcome, our intellectual property rights could be weakened and we could be required to:

cease manufacturing, using or selling the infringing products, processes or technology;

40


pay substantial damages for infringement;
expend significant resources to develop noninfringing products, processes or technology;
license technology from the party claiming infringement, which license may not be available on commercially reasonable terms or at all;
cross-license our technology to a competitor to resolve an infringement claim, which could weaken our ability to compete with that competitor; or
pay substantial damages to our partners or end users for them to discontinue using, or replace, infringing products with noninfringing products.

Even if we do prevail in patent-related proceedings, verdicts and judgments can be modified or even reversed by trial or appellate courts. License agreements entered in settlement of patent litigation, particularly any entered into with our competition, may not be as effective over the long term in providing us with all the benefits we bargained for when we entered into them.

Many companies in our industry, as well as nonpracticing entities, hold patents and other intellectual property rights and may pursue, protect and enforce those intellectual property rights. We receive invitations to license patent and other intellectual property rights to technologies that could be important to our business. We also receive assertions against us, our partners and end users claiming we or they infringe patent or other intellectual property rights. If we decline to accept an invitation to license or to refute an asserted claim, then the offering or claiming party may pursue litigation against us.

Intellectual property disputes have adversely affected RAIN adoption in the past and could disrupt growth prospects in the future. In 2011, Round Rock Research filed lawsuits against 11 end users, including Walmart and Macy’s, for RAIN-related patent infringement. Despite the subsequent availability of an industry-wide license, we believe those lawsuits adversely affected demand for our products from 2011 to 2019. Subsequent litigation, including our patent litigation against NXP between 2019 and early 2024, may not have had as pronounced effects on demand as the Round Rock litigation, but could have dampened RAIN growth particularly in categories beyond those where RAIN is already established such as retail apparel. We, our partners, suppliers or end users could continue to be involved in intellectual property disputes in the future which could adversely affect our operating results and growth prospects.

Many of our agreements require us to indemnify and defend partners and end users from third-party infringement claims and pay damages in the case of adverse rulings. These damages could be sizable and disproportionate to the business we derive from those partners or end users. Moreover, we may not know whether we are infringing a third party’s intellectual property rights due to the large number of RAIN-related patents or other systemic factors. For example, patent applications in the United States are maintained in confidence for up to 18 months after filing or, in some instances, for the entire time prior to patent issuance. Consequently, we may not be able to account for such rights until after a patent issues.

Intellectual property policies of industry standards organizations in whose working groups we participate could require us to provide royalty-free licenses of some to our intellectual property.

When participating in GS1, ISO, RAIN and other industry-standards organizations, it is a general policy that those who participate in developing a protocol or standard must license, either royalty-free or under reasonable and nondiscriminatory, or RAND, terms, intellectual property that is necessary to implement all or part of the protocol or standard. The standards body may require that the license be granted to members, as in the case of GS1, or to all parties, as in the case of ISO, that implement the protocol or standard.

As a participant in developing GS1 EPCglobal UHF Gen2, UHF Gen2 V2, UHF Gen2 V3, tag data standards, low-level reader protocol and other GS1 EPCglobal protocols, we agreed to license to other GS1 EPCglobal members, on a royalty-free basis, those of our patents necessary to practice those protocols, subject to us receiving reciprocal royalty-free rights from the other GS1 EPCglobal member practicing the protocol. As a participant in developing ISO standards, we agreed to license on a RAND basis those of our patents necessary to practice those standards, subject to us receiving a reciprocal RAND license from the other entity practicing the standard.

Although the policies themselves seek to advance protocol or standards development, disputes can arise because it may not be clear whether certain intellectual property is necessary to practice a protocol or standard. Such uncertainty could complicate us asserting our not-necessary patents against others, or to use those patents in our own defense, thereby devaluing our intellectual property. Further, some GS1 EPCglobal members declined to license their intellectual property on royalty-free terms, instead retaining the right to license their technology on RAND terms. These members may choose to assert their intellectual property, in which case we will need to defend ourselves within the confines of the GS1 and ISO intellectual property policies.

41


We rely on third-party license agreements which, if impaired or terminated, could cause production or shipment delays that could harm our business.

We have license agreements with third parties for patents, software and technology we use in our operations and in our products. For example, we license tools from design-automation software vendors to design our silicon ICs. Third-party licenses for patents, software and other technology important to our business may not continue to be available on commercially reasonable terms or may not be available at all. Loss of any such licenses could cause manufacturing interruptions or delays or reductions in product shipments until we can develop, license, integrate and deploy alternative technologies, if even possible, which could harm our business and operating results.

Our use of open-source software may expose us to additional risks and weaken our intellectual property rights.

Our products, processes and technology sometimes use or incorporate software that is subject to an open-source license. Certain open-source licenses require a user who intends to distribute the open-source software as a component of the user’s software to disclose publicly part or all of the user’s source code. In addition, certain open-source software licenses require the user of such software to make derivative works of the open-source software available to others at low or no cost. Open-source licensors generally do not provide warranties or other contractual protections regarding infringement claims or the quality of their code, opening us to business risks that could materially harm our operating results.

We cannot guarantee that we have incorporated open-source software in a manner that is consistent with our policies and procedures relative to such open-source software, or in a manner that will not subject us to liability.

Risks Relating to Privacy and Cybersecurity

Privacy and security concerns relating to RAIN could damage our reputation and deter current or potential customers from using our products.

Privacy advocates and others have raised and may continue raising concerns about RAIN compromising consumer privacy or facilitating theft. These concerns include unauthorized parties potentially collecting personal information or personal data, tracking consumers, stealing identities or causing other issues relating to privacy or data protection. Any such incident could cause our or our partners’ or end users’ operations to be disrupted and subject us or them to regulatory investigations or proceedings and claims, demands or litigation; consequently, we could face potential liability and significant costs and expenses to remediate or otherwise respond to the incident. Any failure or perceived failure to comply with any privacy- or security-related laws, regulations or contractual or other obligations to which we are or may be subject may result in regulatory actions, claims or litigation; legal and other costs; substantial time and resources; and fines, penalties or other liabilities. Any actions or concerns about security and privacy may be expensive to defend, cause us to expend substantial time and resources and damage our reputation and operating results or negatively impact overall RAIN industry development, even if unfounded.

We cannot be sure that any limitation-of-liability provisions in our agreements with customers, contracts with third-party vendors and service providers or other contracts are enforceable or adequate or will protect us from any liabilities or damages against claims relating to a security breach or other privacy- or security-related issue.

Government regulations and guidelines and other standards relating to consumer privacy and cybersecurity may adversely impact adoption of our products, require us to make design changes or constrain our ability to implement new and desired product features, and actual or alleged violations of laws relating to privacy or cyber security may result in claims, proceedings and liability.

Our partners and end users are subject to laws and regulations related to collecting, storing, transmitting and using personal information and personal data, as well as to additional laws and regulations that address privacy and cybersecurity related to RFID in general. Because RAIN is a type of RFID, we believe these laws and regulations apply to RAIN.

The European Commission, or the EC, has issued guidance to address privacy concerns about RFID. In May 2009, the EC issued a recommendation that retailers in the EU inform their customers when RFID tags are either on or embedded within products. In April 2011, the EC signed a voluntary agreement with private and public entities to develop privacy guidelines for companies using RFID in the EU. Whereas compliance is voluntary, our partners and end users that do business in the EU prefer products that comply with the guidelines. If our products do not comply or enable compliance with the guidelines, then our business may suffer.

More generally, the data security and privacy legislative and regulatory landscape in the United States, EU and other jurisdictions continues evolving. Aspects of key privacy laws and regulations—including the California Consumer Privacy Act of 2018, the California Privacy Rights Act, similar privacy laws enacted in other states and the EU General Data Protection Regulation—remain unclear as of the date of this report and continue evolving, potentially with far-reaching implications. Laws and regulations relating to privacy, data protection and security; related industry standards and guidelines; and continued evolution of these laws, regulations, standards, guidelines and other actual and asserted obligations, as well as their interpretation and enforcement, may require us to modify our products, practices and policies, which we may not be able to do on commercially reasonable terms or at all,

42


and otherwise could cause us to incur substantial costs and expenses. Any failure or perceived failure by us or any third parties with which we do business to comply with these laws and regulations or other actual or asserted obligations may result in claims or litigation; actions against us by governmental entities; legal and other costs; substantial time and resources and fines, penalties or other liabilities. Any such actions may be expensive to defend, may incur substantial legal and other costs and substantial time and resources and likely would damage our reputation and adversely affect our business, financial condition and results of operations.

Additionally, if we fail to develop products that meet end-user privacy requirements, then end users may choose not to use our products.

Although the Gen2 V3 protocol includes features for addressing consumer privacy and authenticating a tag, and although we have incorporated custom features in our products to further protect consumer privacy, a third party may still breach these features, including as implemented in our products, in which case our reputation could be damaged and our business and prospects could suffer.

A breach of security or other security incident impacting our systems or others used in our business could have an adverse effect on our business.

We face risks of security breaches and incidents from a variety of sources including viruses, ransomware, hacking, malicious code, supply-chain attacks as well as social engineering or other employee or contractor negligence, malfeasance or unintentional acts. Accidental or willful security breaches or incidents, or unauthorized access to our facilities or information systems, or to others used in our business, could compromise the security of those facilities or information systems and the confidentiality, integrity and availability of confidential, personal or proprietary information. These risks may be heightened in connection with geopolitical tensions and events.

The consequences of loss, unavailability, misuse, corruption or other unauthorized processing of confidential, personal or proprietary information could include, among other things, unfavorable publicity, reputational damage, difficulty marketing or selling our products, customer allegations of breach of contract, loss or theft of intellectual property, claims and litigation, governmental and regulatory investigations and other proceedings and fines, penalties and other damages and liabilities. Any of these consequences could have a material adverse effect on our business, financial condition, reputation and business relationships.

We rely on third-party services to store and process data on our behalf, and on third-party security systems in a variety of applications. Our platform operates in conjunction with, and depends on, third-party products, services and components for security. The cybersecurity threat environment continues evolving, especially with heightened activity by state-sponsored actors. If we, our platform, or any of the third parties on which we rely suffers or is believed to have suffered a security breach or incident, vulnerability, error, ransomware or malicious event, then we could face increased costs, claims, liability, reduced revenue and harm to our reputation.

We devote resources to detect and prevent security breaches and other security-related incidents. In the event of an actual or perceived security breach or incident we may need to expend significant resources to mitigate, notify third parties of, and otherwise address the breach or incident, its root cause and take steps to prevent further breaches or incidents. Our insurance may not adequately cover claims relating to an actual or perceived security breach or incident and any breach or incident may increase our insurance costs as well as reduce or eliminate the future availability of such insurance, harming our business and reputation.

Risks Relating to Our Financial Position and Capital Needs

We have a history of losses and have only achieved profitability intermittently. We cannot be certain that we will attain or sustain profitability in the future.

We have incurred losses since our inception in 2000, with a net loss of $43.4 million for the year ended December 31, 2023, and an accumulated deficit of $430.2 million as of December 31, 2023. Although we reported GAAP net income for the first and second quarters of 2024, there can be no assurance that we will be able to sustain profitability in the future. Our ability to attain or sustain profitability depends on numerous factors, many of which are out of our control, including continued RAIN industry adoption and us maintaining or growing our market share. Our costs to support operations, product development and business and personnel expansion in sales, engineering and marketing are significant and are likely to increase as we invest to grow the market and our share of it, reduce our costs and improve our operations. If we fail to increase our revenue or manage our expenses, or if our investments in growing the market or our share of it fail, then we may not attain or sustain profitability.

We have a history of significant fluctuations in our quarterly and annual operating results.

Our history shows significant sales volatility and a limited ability to forecast sales. We anticipate that, for the foreseeable future, our visibility to future sales, including volumes and prices, will continue to be limited. That limited visibility may cause fluctuations in our operating results and differences between actual and expected quarterly or annual operating results.

Many factors, some outside our control, may cause or contribute to fluctuations in our quarterly and annual operating results. These fluctuations make financial planning and forecasting difficult. These fluctuations may also cause unanticipated decreases in our

43


available cash, which could negatively affect our business and prospects. Material factors that contribute to fluctuations in our operating results include:

macroeconomic conditions, including inflation, recession or economic slowdown, and their impact on our business and that of our suppliers, partners and end users;
fluctuations or delays in RAIN adoption and deployment by end users;
changes in the pace or direction of major deployments, whether due to macroeconomic conditions or enterprise-specific events or circumstances, and our, or our partners', ability to win business from these deployments;
fluctuations in demand for our products or platform, including by tag OEMs and other significant partners and end users on whom we rely for a substantial portion of our revenue;
fluctuations in the pricing and availability or supply of our products or key elements or components of those products, especially semiconductor wafers;
degradations in product quality, whether due to us or our suppliers, including quality claims or product returns;
delays in new-product introductions and in the maturity of our new-product technologies;
decreases in selling prices for our products;
delays in our product-shipment timing, customer or end-user sales or deployment cycles, or work performed under development contracts;
intellectual property disputes involving us, our partners, end users or other participants in our industry;
adverse outcomes of litigation or governmental proceedings;
timing variability in product introductions, enhancements, services and technologies by us and our competitors as well as market acceptance of new or enhanced products, services and technologies;
unanticipated excess or obsolete inventory as a result of significant demand fluctuations, supply-chain mismanagement, new-product introduction, quality issues or otherwise;
changes in the amount and timing of our operating costs, including those related to expanding our business, operations and infrastructure;
changes in business cycles or seasonal fluctuations that affect the markets in which we sell;
changes in industry standards or specifications, or changes in government regulations, relating to our products or our platform;
late, delayed or cancelled payments from our partners or end users; and
unanticipated impairment of long-lived assets and goodwill.

A substantial portion of our operating expenses are fixed in the short term, and as a result, fluctuations in revenue or unanticipated expenses can have a material and immediate impact on our profitability and negatively affect our operating results, which could cause the price of our common stock to decline.

We may need to raise additional capital, which may not be available on favorable terms or at all.

In the future, we may need to raise additional capital, including pursuant to shelf registration statements we may file from time to time with the SEC, potentially diluting our stockholders, restricting our operations or otherwise adversely affecting our business.

Debt financing, if available, may include covenants limiting or restricting our ability to take specific actions such as incurring additional debt, expending capital or declaring dividends, or may impose financial covenants that limit our ability to achieve our business objectives.

Our management has broad discretion in how to invest and spend our cash and cash equivalents and the proceeds from financings, including on capital expenditures, product development, working capital and other general corporate purposes. We may spend our cash and cash equivalents in ways that our stockholders may not agree with or that do not yield favorable returns.

If we need additional capital but cannot raise it on acceptable terms, if at all, then we may not be able to meet our business objectives, financial obligations or both. If we raise additional capital but do not deploy it effectively then our business, financial condition, results of operations and prospects could be harmed and the market price of our common stock could suffer.

44


Risks Relating to U.S. Federal Income Tax

Our ability to use net operating losses and research and development credits to offset future taxable income and income taxes may be limited.

As of December 31, 2023, we had federal U.S. net operating loss carryforwards, or NOLs, of $230.5 million and U.S. federal research and development credit carryforwards of $30.5 million, which we may use to reduce future taxable income or income taxes. We have established a valuation allowance against the carrying value of these deferred tax assets. The U.S. federal NOLs and U.S. federal research and development credit carryforwards began expiring in 2020.

Under Sections 382 and 383 of the U.S. Internal Revenue Code, or the Code, a corporation that experiences a more-than 50% ownership change by one or more stockholders or groups of stockholders who own at least 5% of a company's stock over a three-year testing period is limited in its ability to use its pre-change NOLs and other tax assets to offset future taxable income or income taxes. If we undergo a future ownership change then our ability to use our NOLs and credit carryforwards could be limited by Sections 382 and 383 of the Code. Our NOLs may also be limited under state law. As a result of these limitations, we may not be able to utilize a material portion of, or possibly any of, our NOLs and/or credit carryforwards to reduce future taxable income or income taxes.

We could be subject to additional income tax liabilities.

We are subject to income taxes in the United States and certain foreign jurisdictions. During the ordinary course of business, we use significant judgment in evaluating our worldwide income tax obligations and we conduct many transactions for which the ultimate tax determination is uncertain. Although we believe our tax determinations are proper, the final determination of any tax audits and any possible litigation could be materially different from our historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on our operating results or cash flows in the period or periods for which that determination is made.

Changes in tax laws could have a material adverse effect on our business, cash flow, results of operations or financial conditions.

We are subject to tax laws, regulations and policies of several taxing jurisdictions. Changes in tax laws, as well as other factors, could cause us to experience fluctuations in our tax obligations and effective tax rates and otherwise adversely affect our tax positions and results of our operations. For example, in August 2022, as part of the Inflation Reduction Act of 2022, the United States enacted a 1% excise tax on stock buybacks and a 15% alternative minimum tax on adjusted financial statement income. Additionally, beginning in 2022, the Code eliminated the right to deduct research and development expenditures and instead requires taxpayers to capitalize and amortize U.S. and foreign research and development expenditures over five and 15 tax years, respectively. We have accounted for these changes in accordance with our understanding of the guidance available as of the date of this filing and as described in more detail in our financial statements.

The CHIPS and Science Act, enacted August 9, 2022, provides tax credits for semiconductor manufacturing activities within the United States, but because we outsource our semiconductor manufacturing we do not expect to be entitled to these tax credits.

Many countries, as well as organizations such as the Organization for Economic Cooperation and Development, have proposed changes to existing tax laws, including a proposed 15% global minimum tax. Any of these developments or changes in U.S. federal, state or international tax laws or tax rulings could adversely affect our effective tax rate and our operating results. There can be no assurance that our effective tax rates, tax payments or tax credits and incentives will not be adversely affected by these or other developments or changes in law.

Taxing authorities may successfully assert that we should have collected or in the future should collect sales and use, value-added or similar taxes.

We do not collect sales and use, value-added or similar taxes in all jurisdictions in which we have sales, based on our belief that such taxes are either not applicable or an exemption from such taxes applies. Certain jurisdictions may assert that such taxes are applicable, which could result in tax assessments, penalties and interest, and we may be required to collect such taxes in the future, including as a result of a change in law. Such tax assessments, penalties and interest or future requirements may negatively affect our operating results.

Risks Relating to Our Financial Reporting and Disclosure

Any failure to maintain an effective system of disclosure and internal controls over financial reporting, or our ability to produce timely and accurate financial statements, could adversely affect investor confidence in us.

As a public company, we must maintain effective disclosure controls and procedures and internal control over financial reporting. Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud.

45


Any failure to implement and maintain effective disclosure controls and procedures and internal control over financial reporting, including identifying material weaknesses, could cause investors to lose confidence in the accuracy and completeness of our financial statements and reports, which could adversely affect the market price of our common stock. We could also be subject to sanctions or investigations by The Nasdaq Stock Market, the SEC and other regulatory authorities.

Risks Relating to Owning or Trading Our Securities

The market price of our common stock has been and will likely continue to be volatile, and the value of your investment could decline significantly.

The trading price of our common stock has fluctuated and is likely to continue to fluctuate substantially. The following factors, in addition to general risks and other risks described in this report, may have a material effect on the trading price of our common stock:

price and volume fluctuations in the overall stock market;
changes in operating performance, stock market valuations and volatility in the market prices of other technology companies generally, and of those in our industry in particular;
actual or anticipated quarterly variations in our results of operations or those of our competitors;
actual or anticipated changes in our growth rate relative to our competitors;
delays in end-user deployments of RAIN solutions;
announcements by us or our competitors of acquisitions, new products, significant contracts, commercial relationships or capital commitments;
supply interruptions, including semiconductor wafer or other product or component shortfalls;
developments relating to intellectual property rights or in disputes relating to those rights;
our ability to develop and market new and enhanced products on a timely basis;
commencement of, or our involvement in, litigation;
changes in our board of directors or management;
changes in governmental regulations or in the status of our regulatory approvals;
unstable political and economic conditions, including instability resulting from wars and other armed conflicts, such as those in Ukraine and the Gaza Strip, or geopolitical tensions, such as those between the U.S., China and Taiwan;
the trading volume of our stock;
actual or perceived security breaches or incidents;
limited public float;
any future sales of our common stock or other securities;
financial analysts dropping or reducing their coverage of us; changes in financial estimates by analysts who do cover us; or our failure to meet analyst estimates or investor expectations;
fluctuations in the values of companies that investors perceive to be comparable to us;
the financial projections we may provide to the public, as well as any changes in those projections or our failure to meet those projections; and
general economic conditions and slow or negative growth in the markets in which we operate.

Technology stocks like ours have experienced extreme price and volume fluctuations, often unrelated or disproportionate to the company’s underlying operating performance. Stock price volatility can cause stockholders to institute securities class-action litigation or stockholder derivative litigation, as occurred to us between 2018 and 2020. If any of our stockholders were to sue us, the defense and disposition of the lawsuit could be costly and divert the time and attention of our management, harm our operating results and negatively impact the trading price of our common stock.

46


Transactions relating to the 2021 Notes may affect our stock’s value.

If the 2021 Notes are converted by holders, then we are entitled to deliver cash, stock or any combination of cash or stock, at our election. If we elect to deliver stock, the ownership interests of our existing stockholders will be diluted, and public market sales of stock issued upon a conversion could decrease our stock price. Anticipated future conversions of the 2021 Notes into stock could also decrease our stock price, as could short selling by holders of the 2021 Notes to hedge their positions.

In December 2019, we issued the 2019 Notes. When we did so, we entered into privately negotiated capped-call transactions with financial counterparties to mitigate the dilutive impact on the Company above a given stock price. We left those capped-call transactions intact after we acquired the remainder of the outstanding 2019 Notes in June 2022. From time to time, the financial counterparties to the capped calls may modify their hedge positions by entering into or unwinding various derivative transactions involving our stock or by purchasing or selling our stock or other securities of ours in secondary market transactions prior to the maturity of the capped calls. This activity could cause a decrease in our stock price.

For more information on the 2019 Notes, the 2021 Notes and the capped-call transactions, see Note 8 of our consolidated financial statements included elsewhere in this report.

Our principal stockholders and management own a significant percentage of our stock and are able to exercise significant influence over matters subject to stockholder approval.

As of June 30, 2024, our executive officers, directors and principal stockholders, together with their respective affiliates, beneficially owned approximately 46.6% of our stock. As a result, our executive officers, directors and principal stockholders may be able to significantly influence, in their capacity as stockholders, matters requiring approval by our stockholders, including electing directors and approving mergers, acquisitions or other transactions. They may have interests that differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. This ownership concentration could have the effect of delaying or preventing a change in our control or otherwise discouraging a potential acquirer from attempting to obtain control of us, which in turn could have a material adverse effect on our stock price. This ownership concentration could also prevent attempts by our stockholders to replace or remove our board of directors or management.

We may not have sufficient cash flow or access to cash necessary to satisfy our obligations under the 2021 Notes, and our current and future indebtedness may restrict our business.

Our ability to make scheduled payments of the principal of, to pay interest on or to refinance any current or future indebtedness, including the 2021 Notes, or to make cash payments in connection with any conversion of the 2021 Notes or upon any fundamental change if holders require us to repurchase their 2021 Notes for cash, depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not generate sufficient future cash from operations to service our indebtedness and make necessary capital expenditures. If we are unable to generate sufficient cash flow, then we may be required to pursue other alternatives, such as selling assets, restructuring indebtedness or obtaining additional equity capital on terms that may be onerous or highly dilutive. Our ability to refinance any of our indebtedness, including the 2021 Notes, will depend on the capital markets and our financial condition at that time. We may not be able to pursue these alternatives on favorable terms or at all, which could result in us defaulting on our debt obligations.

Our existing and future indebtedness could have important consequences to our stockholders and significant effects on our business. For example, it could:

make it more difficult for us to satisfy our debt obligations, including the 2021 Notes;
increase our vulnerability to general adverse economic and industry conditions;
require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the cash available to run our business;
limit our flexibility in planning for, or reacting to, changes in our business or in our industry;
restrict us from exploiting business opportunities;
place us at a competitive disadvantage compared to our competitors that have less indebtedness; and
limit our ability to borrow additional funds for working capital, capital expenditures, acquisitions, debt service requirements, executing our business strategy or for other purposes.

Anti-takeover provisions in our charter documents and under Delaware or Washington law could prevent, delay or impede an acquisition of us and constrain our stock price.

Provisions of our certificate of incorporation and our bylaws may delay or discourage transactions involving an actual or potential change in our control or in our management, including transactions in which stockholders might otherwise receive a

47


premium for their shares, or transactions that our stockholders might otherwise deem to be in their best interests. These provisions could, therefore, adversely affect our stock price. Among other things, our certificate of incorporation and bylaws:

permit our board of directors to issue up to 5,000,000 shares of preferred stock, with any rights, preferences and privileges as they may designate;
provide that the authorized number of directors may be changed only by resolution of the board of directors;
provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;
restrict the forum for certain litigation against us to Delaware;
require that any action taken by our stockholders be effected at a duly called annual or special meeting of stockholders and not by written consent;
provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide notice in writing in a timely manner, and also specify requirements as to the form and content of a stockholder’s notice;
do not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to vote in any uncontested election of directors to elect all of the directors standing for election, if they should so choose); and
provide that special meetings of our stockholders may be called only by the chair of the board, our chief executive officer or the board of directors.

In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which generally prohibits a Delaware corporation from engaging in any of a broad range of business combinations with any “interested” stockholder for a period of three years following the date on which the stockholder became an “interested” stockholder. Likewise, because our principal executive offices are located in Washington, the anti-takeover provisions of the Washington Business Corporation Act may apply to us under certain circumstances now or in the future. These provisions prohibit a “target corporation” from engaging in any of a broad range of business combinations with any stockholder constituting an “acquiring person” for a period of five years following the date on which the stockholder became an “acquiring person.”

Our bylaws include provisions that could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.

Our bylaws provide that, unless we otherwise consent in writing, the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our certificate of incorporation or our bylaws; or any action asserting a claim against us that is governed by the internal affairs doctrine. The choice of forum provision may limit stockholders’ ability to bring a claim in a judicial forum favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and other employees. Alternatively, if a court were to find the choice of forum provision contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could adversely affect our business and financial condition.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

 

None.

Item 4. Mine Safety Disclosures

 

Not applicable.

48


Item 5. Other Information

Securities Trading Plans of Directors and Executive Officers

During our last fiscal quarter, no director or officer, as defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408 of Regulation S-K, except as follows:

Name and Title

 

Character of Trading Arrangement (1)

 

Date Adopted

 

Date Terminated

 

Duration (2)

 

Aggregate Number of Shares of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement

Jeff Dossett, Chief Revenue Officer

 

Rule 10b5-1 Trading Arrangement

 

May 1, 2024

 

-

 

January 31, 2025

 

Up to 30,000

(1) Except as indicated by footnote, each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended (the “Rule”).

(2) Except as indicated by footnote, each trading arrangement permits transactions through and including the earlier of (a) the execution or expiration of all trades specified under the trading arrangement or (b) the date listed in the table. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule.

 

49


Item 6. Exhibits

 

 

 

 

 

Incorporation by Reference

 

 

Exhibit

Number

 

Exhibit Description

 

Form

 

Date

 

Number

 

Filed Herewith

3.1(a)

 

Amended and Restated Certificate of Incorporation of Impinj, Inc., as filed with the Secretary of State of the State of Delaware on June 10, 2020

 

8-K

 

6/12/2020

 

3.1

 

 

 

 

 

 

 

 

 

 

 

 

 

3.1(b)

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Impinj, Inc., as filed with the Secretary of State of the State of Delaware on June 6, 2024

 

8-K

 

6/7/2024

 

3.1

 

 

 

 

 

 

 

 

 

 

 

 

 

3.2

 

Amended and Restated Bylaws of Impinj, Inc. adopted as of February 23, 2023

 

8-K

 

2/23/2023

 

3.1

 

 

 

 

 

 

 

 

 

 

 

 

 

31.1

Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended

X

 

 

 

 

 

 

 

 

 

 

 

31.2

Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended

X

 

 

 

 

 

 

 

 

 

 

 

32.1*

Certification of Principal Executive Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350

X

 

 

 

 

 

 

 

 

 

 

 

32.2*

Certification of Principal Financial Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350

X

 

 

 

 

 

 

 

 

 

 

 

101

Inline XBRL Document Set for the condensed consolidated financial statements and accompanying notes in Part I, Item 1, “Financial Statements” of this Quarterly Report on Form 10-Q.

X

104

Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.

X

 

* The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Impinj, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.

 

 

50


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Impinj, Inc.

 

 

 

 

 

Date: July 24, 2024

 

By:

 

/s/ Cary Baker

 

 

 

 

Cary Baker

Chief Financial Officer (principal financial officer and duly authorized signatory)

 

51


Exhibit 31.1

CERTIFICATIONS

I, Chris Diorio, Ph.D., certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Impinj, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 24, 2024

 

/s/ Chris Diorio

Chris Diorio, Ph.D.

Chief Executive Officer

(Principal Executive Officer)

 

 


Exhibit 31.2

CERTIFICATIONS

I, Cary Baker, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Impinj, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 24, 2024

 

/s/ Cary Baker

Cary Baker

Chief Financial Officer

(Principal Financial Officer)

 


Exhibit 32.1

IMPINJ, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Impinj, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Chris Diorio, Ph.D., Chief Executive Officer (Principal Executive Officer) of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Chris Diorio

Chris Diorio, Ph.D.

Chief Executive Officer

(Principal Executive Officer)

Date: July 24, 2024

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Impinj, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.

 


Exhibit 32.2

IMPINJ, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Impinj, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Cary Baker, Chief Financial Officer (Principal Financial Officer) of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Cary Baker

Cary Baker

Chief Financial Officer

(Principal Financial Officer)

Date: July 24, 2024

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Impinj, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.

 


v3.24.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2024
Jul. 12, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Entity Registrant Name IMPINJ, INC.  
Entity Central Index Key 0001114995  
Entity Current Reporting Status Yes  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Incorporation, State or Country Code DE  
Entity Common Stock Shares Outstanding   28,116,027
Entity Shell Company false  
Entity Small Business false  
Entity Emerging Growth Company false  
Document Transition Report false  
Document Quarterly Report true  
Trading Symbol PI  
Entity Address, State or Province WA  
Entity File Number 001-37824  
Entity Tax Identification Number 91-2041398  
Entity Address, Address Line One 400 Fairview Avenue North  
Entity Address, Address Line Two Suite 1200  
Entity Address, City or Town Seattle  
Entity Address, Postal Zip Code 98109  
City Area Code 206  
Local Phone Number 517-5300  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
v3.24.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 214,653 $ 94,793
Short-term investments 5,563 18,440
Accounts receivable, net 54,181 54,919
Inventory 80,773 97,172
Prepaid expenses and other current assets 3,148 4,372
Total current assets 358,318 269,696
Property and equipment, net 47,209 44,891
Intangible assets, net 11,645 13,913
Operating lease right-of-use assets 8,424 9,735
Other non-current assets 1,235 1,478
Goodwill 19,256 19,696
Total assets 446,087 359,409
Current liabilities:    
Accounts payable 15,305 8,661
Accrued compensation and employee related benefits 12,549 8,519
Accrued and other current liabilities 2,848 8,614
Current portion of operating lease liabilities 3,462 3,373
Current portion of long-term debt 282,671  
Current portion of deferred revenue 2,087 1,713
Total current liabilities 318,922 30,880
Long-term debt 0 281,855
Operating lease liabilities, net of current portion 7,546 9,360
Deferred tax liabilities, net 2,466 2,911
Deferred revenue, net of current portion 181 272
Total liabilities 329,115 325,278
Commitments and contingencies (Note 6)
Stockholders' equity:    
Preferred stock, $0.001 par value - 5,000 shares authorized, no shares issued and outstanding at June 30, 2024 and December 31, 2023
Common stock, $0.001 par value - 495,000 shares authorized, 28,073 and 27,166 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 28 27
Additional paid-in capital 504,206 463,900
Accumulated other comprehensive income (loss) (418) 355
Accumulated deficit (386,844) (430,151)
Total stockholders' equity 116,972 34,131
Total liabilities and stockholders' equity $ 446,087 $ 359,409
v3.24.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Jun. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 495,000,000 495,000,000
Common stock, shares issued 28,073,000 27,166,000
Common stock, shares outstanding 28,073,000 27,166,000
v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenue $ 102,495 $ 85,986 $ 179,320 $ 171,883
Cost of revenue 44,979 42,172 84,256 84,539
Gross profit 57,516 43,814 95,064 87,344
Operating expenses:        
Research and development 24,924 23,403 47,443 45,838
Sales and marketing 9,827 10,632 20,003 20,605
General and administrative 13,223 16,002 26,588 31,566
Amortization of intangibles 496 2,146 1,905 2,146
Restructuring costs     1,812  
Total operating expenses 48,470 52,183 97,751 100,155
Income (loss) from operations 9,046 (8,369) (2,687) (12,811)
Other income, net 2,122 1,165 3,414 2,530
Income from settlement of litigation     45,000  
Interest expense (1,217) (1,211) (2,433) (2,420)
Income (loss) before income taxes 9,951 (8,415) 43,294 (12,701)
Income tax benefit 12 349 13 277
Net income (loss) $ 9,963 $ (8,066) $ 43,307 $ (12,424)
Net income (loss) per share - basic $ 0.36 $ (0.30) $ 1.57 $ (0.47)
Net income (loss) per share - diluted $ 0.34 $ (0.30) $ 1.44 $ (0.47)
Weighted-average shares outstanding basic 27,889 26,713 27,623 26,499
Weighted-average shares outstanding diluted 29,422 26,713 31,718 26,499
v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ 9,963 $ (8,066) $ 43,307 $ (12,424)
Other comprehensive income (loss), net of tax:        
Unrealized loss on investments 13 193 47 837
Foreign currency translation adjustment (161) 87 (820) 87
Total other comprehensive income (loss) (148) 280 (773) 924
Comprehensive income (loss) $ 9,815 $ (7,786) $ 42,534 $ (11,500)
v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities:    
Net Income (Loss) $ 43,307 $ (12,424)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 6,908 6,066
Stock-based compensation 26,495 23,372
Restructuring equity modification expense 366  
Accretion of discount or amortization of premium on investments (109) (1,285)
Amortization of debt issuance costs 815 802
Deferred tax expense (372) (399)
Revaluation of acquisition-related contingent consideration liability 986  
Changes in operating assets and liabilities, net of amounts acquired:    
Accounts receivable 699 (7,755)
Inventory 16,378 (64,733)
Prepaid expenses and other assets 1,461 2,277
Accounts payable 6,996 6,113
Accrued compensation and employee related benefits 4,056 (1,879)
Accrued and other liabilities 290 2,043
Acquisition-related contingent consideration liability (2,556)  
Operating lease right-of-use assets 1,293 1,331
Operating lease liabilities (1,706) (1,661)
Deferred revenue 312 (972)
Net cash provided by (used in) operating activities 105,619 (49,104)
Investing activities:    
Proceeds from sales of investments   13,372
Proceeds from maturities of investments 13,033 92,424
Purchases of intangible assets   (250)
Purchases of property and equipment (7,568) (13,198)
Business acquisitions, net of cash acquired   (23,357)
Net cash provided by investing activities 5,465 68,991
Financing activities:    
Proceeds from exercise of stock options and employee stock purchase plan 13,446 5,753
Payment of acquisition-related contingent consideration (4,602)  
Net cash provided by financing activities 8,844 5,753
Effect of exchange rate changes on cash and cash equivalents (68) 7
Net increase in cash and cash equivalents 119,860 25,647
Cash and cash equivalents    
Beginning of period 94,793 19,597
End of period 214,653 45,244
Supplemental disclosure of cashflow information:    
Cash paid for interest 1,617 1,617
Purchases of property and equipment not yet paid $ 1,198 1,973
Operating lease liabilities arising from obtaining ROU assets   979
Lease liabilities arising from remeasurement of ROU assets   159
26,396 shares of common stock issued for Voyantic Oy acquisition   3,579
Acquisition-related contingent consideration liability   $ 4,602
v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Parenthetical)
Jun. 30, 2024
shares
Common stock, shares issued 28,073,000
Voyantic Oy [Member]  
Common stock, shares issued 26,396
v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In-Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (loss)
Beginning balance at Dec. 31, 2022 $ 15,591 $ 26 $ 403,599 $ (386,785) $ (1,249)
Beginning balance, shares at Dec. 31, 2022   26,098      
Issuance of common stock 4,520 $ 1 4,519    
Issuance of common stock, shares   483      
Stock-based compensation 10,224   10,224    
Net income (loss) (4,358)     (4,358)  
Other comprehensive income (loss) 644       644
Ending balance at Mar. 31, 2023 26,621 $ 27 418,342 (391,143) (605)
Ending balance, shares at Mar. 31, 2023   26,581      
Beginning balance at Dec. 31, 2022 15,591 $ 26 403,599 (386,785) (1,249)
Beginning balance, shares at Dec. 31, 2022   26,098      
Net income (loss) (12,424)        
Other comprehensive income (loss) 924        
Ending balance at Jun. 30, 2023 36,795 $ 27 436,302 (399,209) (325)
Ending balance, shares at Jun. 30, 2023   26,819      
Beginning balance at Mar. 31, 2023 26,621 $ 27 418,342 (391,143) (605)
Beginning balance, shares at Mar. 31, 2023   26,581      
Issuance of common stock 1,233   1,233    
Issuance of common stock, shares   211      
Stock-based compensation 13,148   13,148    
Net income (loss) (8,066)     (8,066)  
Common stock issued for Voyantic acquisition 3,579   3,579    
Common stock issued for Voyantic acquisition, shares   27      
Other comprehensive income (loss) 280       280
Ending balance at Jun. 30, 2023 36,795 $ 27 436,302 (399,209) (325)
Ending balance, shares at Jun. 30, 2023   26,819      
Beginning balance at Dec. 31, 2023 34,131 $ 27 463,900 (430,151) 355
Beginning balance, shares at Dec. 31, 2023   27,166      
Issuance of common stock 6,917 $ 1 6,916    
Issuance of common stock, shares   494      
Stock-based compensation 11,790   11,790    
Restructuring equity modification expense 366   366    
Net income (loss) 33,344     33,344  
Other comprehensive income (loss) (625)       (625)
Ending balance at Mar. 31, 2024 85,923 $ 28 482,972 (396,807) (270)
Ending balance, shares at Mar. 31, 2024   27,660      
Beginning balance at Dec. 31, 2023 34,131 $ 27 463,900 (430,151) 355
Beginning balance, shares at Dec. 31, 2023   27,166      
Net income (loss) 43,307        
Other comprehensive income (loss) (773)        
Ending balance at Jun. 30, 2024 116,972 $ 28 504,206 (386,844) (418)
Ending balance, shares at Jun. 30, 2024   28,073      
Beginning balance at Mar. 31, 2024 85,923 $ 28 482,972 (396,807) (270)
Beginning balance, shares at Mar. 31, 2024   27,660      
Issuance of common stock 6,529   6,529    
Issuance of common stock, shares   413      
Stock-based compensation 14,705   14,705    
Net income (loss) 9,963     9,963  
Other comprehensive income (loss) (148)       (148)
Ending balance at Jun. 30, 2024 $ 116,972 $ 28 $ 504,206 $ (386,844) $ (418)
Ending balance, shares at Jun. 30, 2024   28,073      
v3.24.2
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Pay vs Performance Disclosure            
Net Income (Loss) $ 9,963 $ 33,344 $ (8,066) $ (4,358) $ 43,307 $ (12,424)
v3.24.2
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement During our last fiscal quarter, no director or officer, as defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408 of Regulation S-K, except as follows:

Name and Title

 

Character of Trading Arrangement (1)

 

Date Adopted

 

Date Terminated

 

Duration (2)

 

Aggregate Number of Shares of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement

Jeff Dossett, Chief Revenue Officer

 

Rule 10b5-1 Trading Arrangement

 

May 1, 2024

 

-

 

January 31, 2025

 

Up to 30,000

(1) Except as indicated by footnote, each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended (the “Rule”).

(2) Except as indicated by footnote, each trading arrangement permits transactions through and including the earlier of (a) the execution or expiration of all trades specified under the trading arrangement or (b) the date listed in the table. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule.

Name Jeff Dossett
Title Chief Revenue Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 1, 2024
Expiration Date January 31, 2025
Aggregate Available 30,000
v3.24.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 1. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements include Impinj, Inc. and its wholly owned subsidiaries. We have eliminated intercompany balances and transactions in consolidation. We have prepared these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ("GAAP"), and applicable rules and regulations of the Securities and Exchange Commission ("SEC"), regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2023 included in Impinj, Inc.’s Annual Report on Form 10-K, which was filed with the SEC on February 12, 2024.

The unaudited condensed consolidated interim financial statements, in the opinion of management, reflect all adjustments, comprising normal recurring adjustments, necessary to state fairly our financial position, results of operations and our cash flows for the periods presented. Interim results are not necessarily indicative of the results for a full year or for any other future period.

Use of Estimates

Preparing financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and related disclosures as of the date of the financial statements, as well as the reported revenue and expenses during the periods presented. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, sales incentives, percentage completion of development contracts, inventory excess and obsolescence, income taxes and fair value of stock awards. To the extent there are material differences between our estimates, judgments, or assumptions and actual results, our financial statements will be affected.

Licensing of Intellectual Property

On March 13, 2024, we and NXP Semiconductors N.V. ("NXP") entered into a Settlement and Patent Cross-License Agreement (the “Settlement Agreement”). Under the Settlement Agreement, NXP made a one-time payment of $45 million and agreed to make annual license fee payments on April 1 of each year, starting on April 1, 2024, until the termination of the Settlement Agreement. The annual license fee payment for 2024 was $15 million and will increase each subsequent year by a fixed percentage. We allocated the consideration from the Settlement Agreement to the related components of the agreement. During the first quarter of 2024, we recorded the $45 million payment in income from settlement of litigation in the condensed consolidated statements of operations upon receipt. We will recognize the license fee, which relates to annual usage of the license from April 1 to March 31 of each applicable year, as revenue in the second quarter of each until the Settlement Agreement terminates. The license fee for the first annual usage period was recognized in the second quarter of 2024.

We recognize revenue from licensing the right to use functional intellectual property, such as the Settlement Agreement discussed above, at the point in time the control of the license transfers to the customer, which is generally upon delivery, or as usage occurs. See Note 6 Commitments and Contingencies for additional details of the Settlement Agreement with NXP.

Recently Issued Accounting Standards Not Yet Adopted

In November 2023, the FASB released ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which amends reportable segment requirements, primarily through enhanced disclosures about significant segment expenses, including for public entities that have a single reportable segment. The standard is effective for fiscal years beginning after December 31, 2023 and interim periods within fiscal years beginning after December 31, 2024. We are currently evaluating the impact of this standard, if any, on our financial statement disclosures.

In December 2023, the FASB released ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which amends income tax disclosure requirements to enhance the transparency and decision usefulness for users of the financial statements. The standard is effective for fiscal years beginning after December 31, 2024. We are currently evaluating impact of this standard, if any, on our financial statement disclosures.

v3.24.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 2. Fair Value Measurements

Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. The standards also establish a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:

Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Assets and liabilities valued based on observable market data for similar instruments, such as quoted prices for similar assets or liabilities.
Level 3 — Unobservable inputs that are supported by little or no market activity; instruments valued based on the best available data, some of which is internally developed, and considers risk premiums that a market participant would require.

We do not have any financial assets or liabilities in Level 3 as of June 30, 2024, and only had the liability for the earnout consideration related to the Voyantic Oy acquisition in Level 3 as of December 31, 2023. We classified this liability as Level 3 because we determined the fair value using significant unobservable inputs.

We applied the following methods and assumptions in estimating our fair value measurements:

Cash Equivalents — Cash equivalents comprise highly liquid investments, including money market funds with original maturities of less than three months at the acquisition date. We record the fair value measurement of these assets based on quoted market prices in active markets.

Investments — Our investments comprise fixed income securities, which include U.S. government agency securities, corporate notes and bonds, commercial paper, treasury bills and asset-backed securities. The fair value measurement of these assets is based on observable market-based inputs or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Long-term Debt — See Note 7 for the carrying amount and estimated fair value of the Notes.

Contingent Consideration — The contingent consideration liability is related to our acquisition of Voyantic Oy (see Note 4: Goodwill and Intangible Assets). We paid the contingent consideration amount of $7.2 million in second-quarter 2024.

The following table presents the balances of assets and liabilities measured at fair value on a recurring basis, by level within the fair value hierarchy, as of the dates presented (in thousands):

 

 

June 30, 2024

 

 

December 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

181,391

 

 

$

 

 

$

 

 

$

181,391

 

 

$

78,661

 

 

$

 

 

$

 

 

$

78,661

 

Total cash equivalents

 

 

181,391

 

 

 

 

 

 

 

 

 

181,391

 

 

 

78,661

 

 

 

 

 

 

 

 

 

78,661

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government agency securities

 

 

 

 

 

3,493

 

 

 

 

 

 

3,493

 

 

 

 

 

 

11,893

 

 

 

 

 

 

11,893

 

Yankee bonds

 

 

 

 

 

1,998

 

 

 

 

 

 

1,998

 

 

 

 

 

 

1,951

 

 

 

 

 

 

1,951

 

Agency bonds

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,994

 

 

 

 

 

 

2,994

 

Asset-backed securities

 

 

 

 

 

72

 

 

 

 

 

 

72

 

 

 

 

 

 

1,602

 

 

 

 

 

 

1,602

 

Total short-term investments

 

 

 

 

 

5,563

 

 

 

 

 

 

5,563

 

 

 

 

 

 

18,440

 

 

 

 

 

 

18,440

 

Total

 

$

181,391

 

 

$

5,563

 

 

$

 

 

$

186,954

 

 

$

78,661

 

 

$

18,440

 

 

$

 

 

$

97,101

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition related contingent consideration liability

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,180

 

 

 

6,180

 

Total liabilities at fair value

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

6,180

 

 

$

6,180

 

 

The following table presents additional information about liabilities measured at fair value for which the Company uses Level 3 inputs to determine fair value as of June 30, 2024 (in thousands):

 

 

 

Six Months Ended June 30,

 

 

 

2024

 

Balance as of January 1

 

$

6,180

 

Change in fair value of contingent consideration liability due to remeasurement

 

 

986

 

Contingent consideration payment made

 

 

(7,166

)

Balance as of June 30

 

$

 

 

 

At the acquisition date, we recorded the contingent consideration related to the Voyantic Oy acquisition at its fair value using unobservable inputs and used the Monte Carlo simulation option pricing framework, incorporating contractual terms and assumptions regarding financial forecasts, discount rates and volatility of forecasted revenue and gross margins. Developing and determining the unobservable inputs for Level 3 fair-value measurements and fair-value calculations is management's responsibility with assistance from a third-party valuation specialist. During the quarter ended June 30, 2024, we made the payment for contingent consideration and as of June 30, 2024, the contingent consideration liability is $0.

 

As of December 31, 2023, the contingent consideration liability was $6.2 million.

 

We expect short-term investments to mature within 1 year of the reporting date. See Note 7 for the carrying amount and estimated fair value of our convertible senior notes due 2027.

Investments

The following tables present the cost or amortized cost, gross unrealized gains, gross unrealized losses and total estimated fair value of our financial assets as of the dates presented (in thousands):

 

June 30, 2024

 

 

Cost or

 

 

Gross

 

 

Gross

 

 

Total Estimated

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

Description:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

181,391

 

 

$

 

 

$

 

 

$

181,391

 

U.S. government agency securities

 

3,496

 

 

 

 

 

 

(3

)

 

 

3,493

 

Yankee bonds

 

1,998

 

 

 

 

 

 

 

 

 

1,998

 

Asset-backed securities

 

72

 

 

 

 

 

 

 

 

 

72

 

Total

$

186,957

 

 

$

 

 

$

(3

)

 

$

186,954

 

 

 

December 31, 2023

 

 

Cost or

 

 

Gross

 

 

Gross

 

 

Total Estimated

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

Description:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

78,661

 

 

$

 

 

$

 

 

$

78,661

 

U.S. government agency securities

 

11,932

 

 

 

 

 

 

(39

)

 

 

11,893

 

Yankee bonds

 

1,956

 

 

 

 

 

 

(5

)

 

 

1,951

 

Agency bond

 

2,998

 

 

 

 

 

 

(4

)

 

 

2,994

 

Asset-backed securities

 

1,604

 

 

 

 

 

 

(2

)

 

 

1,602

 

Total

$

97,151

 

 

$

 

 

$

(50

)

 

$

97,101

 

Marketable securities in a continuous loss position for less than 12 months had an estimated fair value of $2.0 million and immaterial unrealized losses as of June 30, 2024, and an estimated fair value of $10.2 million and $25,000 in unrealized losses as of December 31, 2023. Marketable securities in a continuous loss position for greater than 12 months had an estimated fair value of $3.6 million and immaterial unrealized losses as of June 30, 2024, and an estimated fair value of $8.2 million $26,000 in unrealized losses as of December 31, 2023.

v3.24.2
Inventory
6 Months Ended
Jun. 30, 2024
Inventory Disclosure [Abstract]  
Inventory

Note 3. Inventory

The following table presents the detail of inventories as of the dates presented (in thousands):

 

 

 

 

 

 

 

 

 

June 30, 2024

 

 

December 31, 2023

 

Raw materials

 

$

18,972

 

 

$

21,773

 

Work-in-process

 

 

37,633

 

 

 

42,217

 

Finished goods

 

 

24,168

 

 

 

33,182

 

Total inventory

 

$

80,773

 

 

$

97,172

 

v3.24.2
Goodwill and Intangible Assets
6 Months Ended
Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets

Note 4. Goodwill and Intangible Assets

On April 3, 2023, we acquired all outstanding equity of Voyantic Oy for an aggregate purchase price of $32.7 million. Our acquisition of Voyantic Oy adds label design, manufacturing and testing to our systems offerings, to advance the quality, reliability and readability of partner inlays. The consideration comprised (i) $3.6 million in shares of our common stock valued using the market price on the date of the acquisition, (ii) $4.6 million in deferred payments contingent upon revenue and gross margin performance over a one-year period from the acquisition date and (iii) the remainder in cash paid at closing.

We recorded the assets acquired and liabilities assumed at their estimated fair values as of the acquisition date. We recorded the excess of the purchase price over the assets acquired and liabilities assumed as goodwill. The fair value of net assets acquired, goodwill, intangible assets and deferred tax liability were $2.4 million, $15.6 million, $18.4 million and $3.7 million, respectively. The goodwill amount represents synergies we expect to realize from the business combination and assembled workforce. We allocated the goodwill to our one reporting unit and reportable segment. The acquired goodwill and intangible assets were not deductible for tax purposes.

The transaction-related costs for the acquisition were $0.1 million and $1.0 million for the three and six months ended June 30, 2024. These costs are related to the revaluation of the contingent consideration subsequent to the acquisition date and are included in general and administrative expenses in the condensed consolidated statements of operations. See Note 2. Fair Value Measures for additional information on the contingent consideration.

This acquisition did not have a material impact on our reported revenue or net loss amounts for any period presented; therefore, we have not presented historical and pro forma disclosures.

Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in business combinations accounted for under the purchase method of accounting. The following table presents goodwill as of June 30, 2024 (in thousands):

 

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

Balance at beginning of period

 

$

19,696

 

 

$

3,881

 

Additions from acquisition

 

 

 

 

 

15,590

 

Foreign currency translation adjustment

 

 

(440

)

 

 

45

 

   Total

 

$

19,256

 

 

$

19,516

 

As of June 30, 2024, intangible assets comprised the following (in thousands):

 

 

 

Estimated Useful Life in Years

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net

 

Definite-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

   Backlog

 

0.25

 

$

751

 

 

$

(751

)

 

$

 

   Customer Relationships

 

1

 

 

3,595

 

 

 

(3,595

)

 

 

 

   Developed Technology

 

7.25

 

 

12,662

 

 

 

(2,183

)

 

 

10,479

 

   Patent

 

3

 

 

250

 

 

 

(80

)

 

 

170

 

   Tradename

 

8

 

 

1,180

 

 

 

(184

)

 

 

996

 

   Total definite-lived intangible assets (1)

 

 

 

 

18,438

 

 

 

(6,793

)

 

 

11,645

 

(1) Foreign intangible asset carrying amounts are affected by foreign currency translation

 

We amortize identifiable intangible assets with finite lives over their useful lives on a straight-line basis. The weighted average life of our intangible assets is approximately six years. Amortization of intangible assets was $0.5 million and $1.9 million for the three and six months ended June 30, 2024, respectively and $2.1 million for the three and six months ended June 30, 2023.

As of June 30, 2024, the estimated intangible asset amortization expense for the next five years and thereafter is as follows:

 

 

Estimated Amortization

 

 

 

(in thousands)

 

2024

 

 

989

 

2025

 

 

1,977

 

2026

 

 

1,939

 

2027

 

 

1,894

 

2028

 

 

1,894

 

Thereafter

 

 

2,952

 

Total

 

$

11,645

 

v3.24.2
Stock-Based Awards
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Awards

Note 5. Stock-Based Awards

Restricted Stock Units

We grant restricted stock units ("RSUs") with a service condition, and RSUs with market and service conditions ("MSUs").

The following table summarizes activity for RSUs and MSUs for the six months ended June 30, 2024 (in thousands):

 

 

Number of Underlying Shares

 

 

 

RSUs

 

 

MSUs

 

Outstanding at December 31, 2023

 

 

 

1,078

 

 

 

174

 

Granted

 

 

 

397

 

 

 

161

 

Vested

 

 

 

(313

)

 

 

(98

)

Forfeited

 

 

 

(97

)

 

 

(2

)

Outstanding at June 30, 2024

 

 

 

1,065

 

 

 

235

 

Stock-Based Compensation Expense

The following table presents the detail of stock-based compensation expense amounts included in our condensed consolidated statements of operations for the periods presented (in thousands):

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of revenue

$

534

 

 

$

472

 

 

$

987

 

 

$

889

 

Research and development expense

 

6,543

 

 

 

5,879

 

 

 

11,805

 

 

 

10,448

 

Sales and marketing expense

 

2,802

 

 

 

2,790

 

 

 

5,211

 

 

 

4,929

 

General and administrative expense

 

4,826

 

 

 

4,007

 

 

 

8,492

 

 

 

7,106

 

Total stock-based compensation expense

$

14,705

 

 

$

13,148

 

 

$

26,495

 

 

$

23,372

 

v3.24.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 6. Commitments and Contingencies

For information on our commitments and contingencies, see Part II, Item 8 (Financial Statements and Supplementary Data, Note 12, Commitments and Contingencies) of our Annual Report on Form 10-K for the year ended December 31, 2023. There have been no material changes to our commitments and contingencies as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023, except for “Obligations with Third Parties” and “Litigation” as discussed below.

Obligations with Third Parties

We manufacture products with third-party manufacturers. We are committed to purchase $27.8 million of inventory as of June 30, 2024.

Litigation

From time to time, we are subject to various legal proceedings or claims that arise in the ordinary course of business. We accrue a liability when management believes that it is both probable that we have incurred a liability and we can reasonably estimate the amount of loss. As of June 30, 2024 and December 31, 2023, we did not have accrued contingency liabilities. The following is a description of our significant legal proceedings.

Patent Infringement Claims and Counterclaims

Impinj Patent Infringement Claims Against NXP

From 2019 to 2023, we engaged in active patent litigation against our primary endpoint IC competitor, NXP Semiconductors N.V., or NXP. During this time, we filed three patent infringement lawsuits against subsidiaries of NXP in federal courts in California and Texas. Our complaints alleged that certain NXP endpoint ICs infringed a number of our U.S. patents. In response, NXP filed a suit against us in federal court in Delaware, later transferred to Washington, countersued us in Texas, and filed three lawsuits against our subsidiary in China. NXP’s complaints alleged that certain of our endpoint ICs infringed a number of their own U.S. or Chinese patents or U.S. patents that they exclusively licensed from a third-party to assert against us.

Through 2023, we prevailed in these lawsuits. In three U.S. trials held in 2023, juries in California and Texas returned verdicts that NXP endpoint ICs infringed five of our patents that made it to trial, and juries in Washington and Texas ruled that we did not infringe any of the three patents NXP accused us in court of infringing. Also in 2023, NXP withdrew all three cases it filed against us in China.

On March 13, 2024, while additional trials were pending in China and Texas, and post-trial motions and appeals were pending in China and the U.S., we and NXP entered into the Settlement Agreement. Under the agreement we and NXP agreed to terminate and withdraw all pending proceedings and release one another for all patent infringement claims preceding March 31, 2024 and grant to each other non-exclusive, worldwide patent licenses to make, have made, import, use, offer for sale, and sell their respective products and services, subject to the terms of the agreement. The Settlement Agreement will remain in force until all the valid claims of a specified set of Impinj patents (the “Indicator Patents”) expire in about ten years. Either party can terminate the Settlement Agreement if the other party materially breaches the terms of the Agreement and NXP can terminate the Settlement Agreement if it successfully designs out all valid claims of the Indicator Patents.

Under the Settlement Agreement, NXP paid us a one-time amount of $45 million and agreed to make annual license fee payments, if the specified set of Indicator Patents are still in use, on April 1 of each year, effective April 1, 2024. The annual license fee will increase by a fixed percentage each year after 2024 for the remaining term of the Settlement Agreement. We have no obligation to pay NXP under the Settlement Agreement.

We allocated the consideration from the Settlement Agreement to the components of the Settlement Agreement. We recorded the $45 million payment in income from settlement of litigation in the condensed consolidated statements of operations in the first quarter of 2024, upon receipt. Licensing of our intellectual property is part of our ongoing operations and therefore, we will recognize the license fee, which relates to annual usage of the license from April 1 to March 31 of each applicable year, as revenue in the second quarter of each year until the Settlement Agreement terminates. We recognized the first annual license fee of $15 million in revenue in the second quarter of 2024.

v3.24.2
Long-term Debt
6 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
Long-term Debt

Note 7. Long-term debt

Convertible Senior Notes

In November 2021, we issued $287.5 million aggregate principal amount of convertible promissory notes due May 15, 2027 (the “2021 Notes”).

The following table presents the outstanding principal amount and carrying value of the 2021 Notes as of the dates indicated (in thousands):

 

 

June 30, 2024

 

 

December 31, 2023

 

 

 

Principal Amount

 

 

Unamortized debt issuance costs

 

 

Net Carrying Amount

 

 

Principal Amount

 

 

Unamortized debt issuance costs

 

 

Net Carrying Amount

 

2021 Notes

 

 

287,500

 

 

 

(4,830

)

 

 

282,670

 

 

 

287,500

 

 

 

(5,645

)

 

 

281,855

 

Further details of the 2021 Notes are as follows:

Issuance

 

Maturity Date

 

Interest Rate

 

First Interest Payment Date

 

Effective Interest Rate

 

Semi-Annual Interest Payment Dates

 

Initial Conversion Rate per $1,000 Principal

 

Initial Conversion Price

 

 

Number of Shares (in millions)

2021 Notes

 

May 15, 2027

 

1.125%

 

May 15, 2022

 

1.72%

 

May 15; November 15

 

9.0061

 

$

111.04

 

 

2.6

 

The 2021 Notes are senior unsecured obligations, do not contain any financial covenants and are governed by indentures (the Indentures). The total net proceeds from the 2021 Notes, after deducting initial debt issuance costs, fees and expenses, was $278.4 million. We used approximately $183.6 million of the 2021 Notes net proceeds, excluding accrued interest, to repurchase approximately $76.4 million aggregate principal amount of convertible notes due 2026 (the “2019 Notes” and, together with the 2021 Notes, the “Notes”) through individual privately negotiated transactions concurrent with us offering the 2021 Notes. We used approximately $17.6 million, excluding accrued interest, to repurchase the remaining $9.9 million aggregate principal amount of the 2019 Notes in June 2022. We will use the remainder of the net proceeds from the 2021 Notes for general corporate purposes.

Terms of the 2021 Notes

The holders of the 2021 Notes may convert their respective 2021 Notes at their option at any time prior to the close of business on the business day immediately preceding the respective conversion dates under the following circumstances:

during any fiscal quarter commencing after the fiscal quarter ending on March 31, 2022 (and only during such fiscal quarter), if the last reported sale price of our common stock, for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2021 Notes for each trading day was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day;
prior to the close of business on the second scheduled trading day immediately preceding the redemption date if we call the 2021 Notes for redemption; or
upon the occurrence of specified corporate events, as described in the indenture.

Regardless of the foregoing circumstances, holders may convert all or any portion of the 2021 Notes, in increments of $1,000 principal amount, on or after February 15, 2027, until the close of business on the second scheduled trading day immediately preceding the maturity date.

We may redeem all or a portion of the 2021 Notes for cash, at our option, on or after November 20, 2024, if the last reported sale price of our common stock has been at least 130% of the conversion price at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period at a redemption price equal to 100% of the principal amount of the 2021 Notes being redeemed, plus any accrued and unpaid interest to, but excluding, the redemption date.

Holders who convert their 2021 Notes in connection with certain corporate events that constitute a make-whole fundamental change (as defined in the indenture) are, under certain circumstances, entitled to an increase in the conversion rate. Additionally in the event of a corporate event constituting a fundamental change (as defined in the indenture), holders of the 2021 Notes may require us to repurchase all or a portion of their 2021 Notes at a repurchase price equal to 100% of the principal amount of the 2021 Notes being repurchased, plus any accrued and unpaid interest to, but excluding, the repurchase date.

Our common stock exceeded 130% of the conversion price of the 2021 Notes for more than 20 trading days during the 30 consecutive trading days ended June 30, 2024. Accordingly, the 2021 Notes are convertible at the option of the holders as of June 30, 2024 and have been reclassified to current portion of long-term debt on the condensed consolidated balance sheet as of June 30, 2024. The “if-converted value” exceeded the principal amounts by $118.4 million based on the closing price of our common stock of $156.77 as of June 30, 2024.

Interest expense related to the Notes was as follows (in thousands):

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

2021 Notes

 

 

2021 Notes

 

 

2021 Notes

 

 

2021 Notes

 

Amortization of debt issuance costs

 

 

409

 

 

 

402

 

 

 

816

 

 

 

802

 

Cash interest expense

 

 

808

 

 

 

809

 

 

 

1,617

 

 

 

1,618

 

Total interest expense

 

$

1,217

 

 

$

1,211

 

 

$

2,433

 

 

$

2,420

 

Accrued interest related to the 2021 Notes as of June 30, 2024 and December 31, 2023 was $0.4 million, for both periods. We record accrued interest in accrued liabilities in our consolidated balance sheet.

We estimate the fair value of the 2021 Notes to be $446.2 million and $314.0 million as of June 30, 2024 and December 31, 2023, respectively, which we determined through consideration of quoted market prices. The fair value for the 2021 Notes is classified as Level 2, as defined in Note 2.

Capped Calls

In connection with the issuance of the 2019 Notes, we entered into privately negotiated capped-call transactions with certain financial counterparties. The capped call transactions are generally designed to reduce the potential dilution to our common stock upon any conversion or settlement of the 2019 Notes, or to offset any cash payments we are required to make in excess of the principal amount upon conversion of the 2019 Notes, as the case may be, with the reduction or offset subject to a cap based on the cap price. If, however, the market price per share of our common stock exceeds the cap price of the capped-call transactions, then our stock would experience some dilution and/or the capped call would not fully offset the potential cash payments, in each case, to the extent then-market price per share of our common stock exceeds the cap price. The capped call remains outstanding even though we have repurchased the 2019 Notes. The initial cap price of the capped call transactions is $54.20 per share, subject to certain adjustments under the terms of the capped call transactions. The capped call transactions expire over 40 consecutive scheduled trading days ending on December 11, 2026. The capped call transactions meet the criteria for classification in equity, are not accounted for as derivatives and are not remeasured each reporting period.

v3.24.2
Net Earnings (Loss) Per Share
6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Net Earnings (Loss) Per Share

Note 8. Net Earnings (Loss) Per Share

For the periods presented, the following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net earnings (loss) per share (in thousands, except per share amounts):

 

 

Three months ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

9,963

 

 

$

(8,066

)

 

$

43,307

 

 

$

(12,424

)

Interest add back

 

 

 

 

 

 

 

 

2,433

 

 

 

 

Net income (loss) attributable to common stock holders

 

$

9,963

 

 

$

(8,066

)

 

$

45,740

 

 

$

(12,424

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding, basic

 

 

27,889

 

 

 

26,713

 

 

 

27,623

 

 

 

26,499

 

Dilutive effect of:

 

 

 

 

 

 

 

 

 

 

 

 

Stock plans

 

 

1,533

 

 

 

 

 

 

1,506

 

 

 

 

2021 Notes

 

 

 

 

 

 

 

 

2,589

 

 

 

 

Weighted average common shares outstanding, diluted

 

 

29,422

 

 

 

26,713

 

 

 

31,718

 

 

 

26,499

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings (loss) per share — basic

 

$

0.36

 

 

$

(0.30

)

 

$

1.57

 

 

$

(0.47

)

Net earnings (loss) per share — diluted

 

$

0.34

 

 

$

(0.30

)

 

$

1.44

 

 

$

(0.47

)

 

Basic net earnings (loss) per share is calculated using our net income (loss) and our weighted average outstanding common shares.

Diluted net earnings (loss) per share is calculated using our net income (loss) attributable to common stockholders with interest charges applicable to our convertible debt added back under the if converted method, if dilutive, and our weighted average outstanding common shares including the dilutive effect of stock awards and employee stock purchase plan shares as determined under the treasury stock method and of our convertible notes using the if converted method, if dilutive. In periods when we recognize a net loss, we exclude the impact of outstanding stock awards and the potential share settlement impact related to our convertible notes from the diluted loss per share calculation as their inclusion would have an antidilutive effect.

The following table presents the outstanding shares of our common stock equivalents excluded from the computation of diluted net earnings (loss) per share as of the dates presented because their effect would have been antidilutive (in thousands):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Stock options

 

 

 

 

 

1,543

 

 

 

 

 

 

1,543

 

RSUs, MSUs and PSUs

 

 

114

 

 

 

1,475

 

 

 

737

 

 

 

1,475

 

Employee stock purchase plan shares

 

 

 

 

 

23

 

 

 

 

 

 

23

 

2021 Notes

 

 

2,589

 

 

 

2,589

 

 

 

 

 

 

2,589

 

v3.24.2
Segment Information
6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Segment Information

Note 9. Segment Information

We have one reportable and operating segment: developing and selling of our RAIN products and services. We identified our operating segment based on how our chief operating decision-maker manages our business, makes operating decisions and evaluates our operating performance. Our chief executive officer acts as the chief operating decision-maker and reviews financial and operational information on an entity-wide basis. Accordingly, we have determined we have a single reportable and operating segment.

Our chief executive officer reviews information about our revenue categories, endpoint ICs, including licensing revenue, and systems, defined as reader ICs, readers, gateways, test and measurement solutions and software and cloud services. The following table presents our revenue categories for the indicated periods (in thousands):

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Endpoint ICs

$

89,392

 

 

$

64,905

 

 

$

150,898

 

 

$

131,954

 

Systems

 

13,103

 

 

 

21,081

 

 

 

28,422

 

 

 

39,929

 

Total revenue

$

102,495

 

 

$

85,986

 

 

$

179,320

 

 

$

171,883

 

v3.24.2
Deferred Revenue
6 Months Ended
Jun. 30, 2024
Deferred Revenue Disclosure [Abstract]  
Deferred Revenue

Note 10. Deferred Revenue

Deferred revenue, comprising individually immaterial amounts for extended warranty, enhanced product maintenance and advance payments on nonrecurring engineering ("NRE") services contracts, represents contracted revenue that has not yet been recognized. We recognized $1.1 million of revenue related to amounts included in deferred revenue as of December 31, 2023 for the six months ended June 30, 2024. We recognized $2.0 million of revenue related to amounts included in deferred revenue as of December 31, 2022 for the six months ended June 30, 2023.

The following table presents the changes in deferred revenue for the indicated periods (in thousands):

 

Six Months Ended June 30,

 

 

2024

 

 

2023

 

Balance at beginning of period

$

1,985

 

 

$

2,599

 

Opening balance from Voyantic acquisition

 

 

 

 

1,233

 

Deferral of revenue

 

1,630

 

 

 

1,672

 

Recognition of deferred revenue

 

(1,347

)

 

 

(2,640

)

Balance at end of period

$

2,268

 

 

$

2,864

 

v3.24.2
Related-Party Transactions
6 Months Ended
Jun. 30, 2024
Related Party Transactions [Abstract]  
Related-Party Transactions

Note 11. Related-Party Transactions

On June 23, 2023, we acquired a patent from a related party in which a member of our board of directors holds an executive leadership position. The patent pertains to our endpoint IC products and the acquisition price was $250,000. The patent is included in the Indicator Patents, expires on July 17, 2026 and does not have renewal rights. This patent is included in our intangible assets on our condensed consolidated balance sheet as of June 30, 2024.

v3.24.2
Restructuring
6 Months Ended
Jun. 30, 2024
Restructuring and Related Activities [Abstract]  
Restructuring

Note 12. Restructuring

On February 7, 2024, we initiated a strategic restructuring to align financial, business and research and development objectives for long-term growth, including a reduction-in-force affecting approximately 10% of our employees. We incurred restructuring charges of $1.8 million for employee terminations benefits, including equity modification expense for the three and six months ended June 30, 2024. Restructuring payments were complete as of June 30, 2024.

A summary of accrued restructuring costs as of June 30, 2024 is shown in the table below (in thousands):

 

 

 

Six months ended June 30, 2024

 

Restructuring costs

 

 

1,812

 

Non cash payments

 

 

(366

)

Cash payments

 

 

(1,446

)

Accrued restructuring costs as of June 30, 2024

 

$

 

v3.24.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

The accompanying condensed consolidated financial statements include Impinj, Inc. and its wholly owned subsidiaries. We have eliminated intercompany balances and transactions in consolidation. We have prepared these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ("GAAP"), and applicable rules and regulations of the Securities and Exchange Commission ("SEC"), regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2023 included in Impinj, Inc.’s Annual Report on Form 10-K, which was filed with the SEC on February 12, 2024.

The unaudited condensed consolidated interim financial statements, in the opinion of management, reflect all adjustments, comprising normal recurring adjustments, necessary to state fairly our financial position, results of operations and our cash flows for the periods presented. Interim results are not necessarily indicative of the results for a full year or for any other future period.

Use of Estimates

Use of Estimates

Preparing financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and related disclosures as of the date of the financial statements, as well as the reported revenue and expenses during the periods presented. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, sales incentives, percentage completion of development contracts, inventory excess and obsolescence, income taxes and fair value of stock awards. To the extent there are material differences between our estimates, judgments, or assumptions and actual results, our financial statements will be affected.
Licensing of Intellectual Property

Licensing of Intellectual Property

On March 13, 2024, we and NXP Semiconductors N.V. ("NXP") entered into a Settlement and Patent Cross-License Agreement (the “Settlement Agreement”). Under the Settlement Agreement, NXP made a one-time payment of $45 million and agreed to make annual license fee payments on April 1 of each year, starting on April 1, 2024, until the termination of the Settlement Agreement. The annual license fee payment for 2024 was $15 million and will increase each subsequent year by a fixed percentage. We allocated the consideration from the Settlement Agreement to the related components of the agreement. During the first quarter of 2024, we recorded the $45 million payment in income from settlement of litigation in the condensed consolidated statements of operations upon receipt. We will recognize the license fee, which relates to annual usage of the license from April 1 to March 31 of each applicable year, as revenue in the second quarter of each until the Settlement Agreement terminates. The license fee for the first annual usage period was recognized in the second quarter of 2024.

We recognize revenue from licensing the right to use functional intellectual property, such as the Settlement Agreement discussed above, at the point in time the control of the license transfers to the customer, which is generally upon delivery, or as usage occurs. See Note 6 Commitments and Contingencies for additional details of the Settlement Agreement with NXP.

Recently Issued Accounting Standards Not Yet Adopted

Recently Issued Accounting Standards Not Yet Adopted

In November 2023, the FASB released ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which amends reportable segment requirements, primarily through enhanced disclosures about significant segment expenses, including for public entities that have a single reportable segment. The standard is effective for fiscal years beginning after December 31, 2023 and interim periods within fiscal years beginning after December 31, 2024. We are currently evaluating the impact of this standard, if any, on our financial statement disclosures.

In December 2023, the FASB released ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which amends income tax disclosure requirements to enhance the transparency and decision usefulness for users of the financial statements. The standard is effective for fiscal years beginning after December 31, 2024. We are currently evaluating impact of this standard, if any, on our financial statement disclosures.

v3.24.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table presents the balances of assets and liabilities measured at fair value on a recurring basis, by level within the fair value hierarchy, as of the dates presented (in thousands):

 

 

June 30, 2024

 

 

December 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

181,391

 

 

$

 

 

$

 

 

$

181,391

 

 

$

78,661

 

 

$

 

 

$

 

 

$

78,661

 

Total cash equivalents

 

 

181,391

 

 

 

 

 

 

 

 

 

181,391

 

 

 

78,661

 

 

 

 

 

 

 

 

 

78,661

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government agency securities

 

 

 

 

 

3,493

 

 

 

 

 

 

3,493

 

 

 

 

 

 

11,893

 

 

 

 

 

 

11,893

 

Yankee bonds

 

 

 

 

 

1,998

 

 

 

 

 

 

1,998

 

 

 

 

 

 

1,951

 

 

 

 

 

 

1,951

 

Agency bonds

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,994

 

 

 

 

 

 

2,994

 

Asset-backed securities

 

 

 

 

 

72

 

 

 

 

 

 

72

 

 

 

 

 

 

1,602

 

 

 

 

 

 

1,602

 

Total short-term investments

 

 

 

 

 

5,563

 

 

 

 

 

 

5,563

 

 

 

 

 

 

18,440

 

 

 

 

 

 

18,440

 

Total

 

$

181,391

 

 

$

5,563

 

 

$

 

 

$

186,954

 

 

$

78,661

 

 

$

18,440

 

 

$

 

 

$

97,101

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition related contingent consideration liability

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,180

 

 

 

6,180

 

Total liabilities at fair value

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

6,180

 

 

$

6,180

 

Schedule of Additional Information of Liabilities Measured at Fair Value for Company Utilized Level 3 Inputs to Determine Fair Value

The following table presents additional information about liabilities measured at fair value for which the Company uses Level 3 inputs to determine fair value as of June 30, 2024 (in thousands):

 

 

 

Six Months Ended June 30,

 

 

 

2024

 

Balance as of January 1

 

$

6,180

 

Change in fair value of contingent consideration liability due to remeasurement

 

 

986

 

Contingent consideration payment made

 

 

(7,166

)

Balance as of June 30

 

$

 

 

Schedule of Cost Or Amortized Cost, Gross Unrealized Gains, Gross Unrealized Losses, And Total Estimated Fair Value Of Financial Assets

The following tables present the cost or amortized cost, gross unrealized gains, gross unrealized losses and total estimated fair value of our financial assets as of the dates presented (in thousands):

 

June 30, 2024

 

 

Cost or

 

 

Gross

 

 

Gross

 

 

Total Estimated

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

Description:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

181,391

 

 

$

 

 

$

 

 

$

181,391

 

U.S. government agency securities

 

3,496

 

 

 

 

 

 

(3

)

 

 

3,493

 

Yankee bonds

 

1,998

 

 

 

 

 

 

 

 

 

1,998

 

Asset-backed securities

 

72

 

 

 

 

 

 

 

 

 

72

 

Total

$

186,957

 

 

$

 

 

$

(3

)

 

$

186,954

 

 

 

December 31, 2023

 

 

Cost or

 

 

Gross

 

 

Gross

 

 

Total Estimated

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

Description:

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

78,661

 

 

$

 

 

$

 

 

$

78,661

 

U.S. government agency securities

 

11,932

 

 

 

 

 

 

(39

)

 

 

11,893

 

Yankee bonds

 

1,956

 

 

 

 

 

 

(5

)

 

 

1,951

 

Agency bond

 

2,998

 

 

 

 

 

 

(4

)

 

 

2,994

 

Asset-backed securities

 

1,604

 

 

 

 

 

 

(2

)

 

 

1,602

 

Total

$

97,151

 

 

$

 

 

$

(50

)

 

$

97,101

 

v3.24.2
Inventory (Tables)
6 Months Ended
Jun. 30, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventories

The following table presents the detail of inventories as of the dates presented (in thousands):

 

 

 

 

 

 

 

 

 

June 30, 2024

 

 

December 31, 2023

 

Raw materials

 

$

18,972

 

 

$

21,773

 

Work-in-process

 

 

37,633

 

 

 

42,217

 

Finished goods

 

 

24,168

 

 

 

33,182

 

Total inventory

 

$

80,773

 

 

$

97,172

 

v3.24.2
Goodwill and Intangible Assets (Tables)
6 Months Ended
Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill The following table presents goodwill as of June 30, 2024 (in thousands):

 

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

Balance at beginning of period

 

$

19,696

 

 

$

3,881

 

Additions from acquisition

 

 

 

 

 

15,590

 

Foreign currency translation adjustment

 

 

(440

)

 

 

45

 

   Total

 

$

19,256

 

 

$

19,516

 

Schedule of Intangible Assets

As of June 30, 2024, intangible assets comprised the following (in thousands):

 

 

 

Estimated Useful Life in Years

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net

 

Definite-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

   Backlog

 

0.25

 

$

751

 

 

$

(751

)

 

$

 

   Customer Relationships

 

1

 

 

3,595

 

 

 

(3,595

)

 

 

 

   Developed Technology

 

7.25

 

 

12,662

 

 

 

(2,183

)

 

 

10,479

 

   Patent

 

3

 

 

250

 

 

 

(80

)

 

 

170

 

   Tradename

 

8

 

 

1,180

 

 

 

(184

)

 

 

996

 

   Total definite-lived intangible assets (1)

 

 

 

 

18,438

 

 

 

(6,793

)

 

 

11,645

 

(1) Foreign intangible asset carrying amounts are affected by foreign currency translation

 

Schedule of Estimated Intangible Asset Amortization Expense

As of June 30, 2024, the estimated intangible asset amortization expense for the next five years and thereafter is as follows:

 

 

Estimated Amortization

 

 

 

(in thousands)

 

2024

 

 

989

 

2025

 

 

1,977

 

2026

 

 

1,939

 

2027

 

 

1,894

 

2028

 

 

1,894

 

Thereafter

 

 

2,952

 

Total

 

$

11,645

 

v3.24.2
Stock-Based Awards (Tables)
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Restricted Stock Units

The following table summarizes activity for RSUs and MSUs for the six months ended June 30, 2024 (in thousands):

 

 

Number of Underlying Shares

 

 

 

RSUs

 

 

MSUs

 

Outstanding at December 31, 2023

 

 

 

1,078

 

 

 

174

 

Granted

 

 

 

397

 

 

 

161

 

Vested

 

 

 

(313

)

 

 

(98

)

Forfeited

 

 

 

(97

)

 

 

(2

)

Outstanding at June 30, 2024

 

 

 

1,065

 

 

 

235

 

Summary of Stock-Based Compensation Expense

The following table presents the detail of stock-based compensation expense amounts included in our condensed consolidated statements of operations for the periods presented (in thousands):

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of revenue

$

534

 

 

$

472

 

 

$

987

 

 

$

889

 

Research and development expense

 

6,543

 

 

 

5,879

 

 

 

11,805

 

 

 

10,448

 

Sales and marketing expense

 

2,802

 

 

 

2,790

 

 

 

5,211

 

 

 

4,929

 

General and administrative expense

 

4,826

 

 

 

4,007

 

 

 

8,492

 

 

 

7,106

 

Total stock-based compensation expense

$

14,705

 

 

$

13,148

 

 

$

26,495

 

 

$

23,372

 

v3.24.2
Long-term Debt (Tables)
6 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
Summary of Outstanding Principal Amount and Carrying Value

The following table presents the outstanding principal amount and carrying value of the 2021 Notes as of the dates indicated (in thousands):

 

 

June 30, 2024

 

 

December 31, 2023

 

 

 

Principal Amount

 

 

Unamortized debt issuance costs

 

 

Net Carrying Amount

 

 

Principal Amount

 

 

Unamortized debt issuance costs

 

 

Net Carrying Amount

 

2021 Notes

 

 

287,500

 

 

 

(4,830

)

 

 

282,670

 

 

 

287,500

 

 

 

(5,645

)

 

 

281,855

 

Schedule of Notes

Further details of the 2021 Notes are as follows:

Issuance

 

Maturity Date

 

Interest Rate

 

First Interest Payment Date

 

Effective Interest Rate

 

Semi-Annual Interest Payment Dates

 

Initial Conversion Rate per $1,000 Principal

 

Initial Conversion Price

 

 

Number of Shares (in millions)

2021 Notes

 

May 15, 2027

 

1.125%

 

May 15, 2022

 

1.72%

 

May 15; November 15

 

9.0061

 

$

111.04

 

 

2.6

 

Schedule of Interest Expense

Interest expense related to the Notes was as follows (in thousands):

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

2021 Notes

 

 

2021 Notes

 

 

2021 Notes

 

 

2021 Notes

 

Amortization of debt issuance costs

 

 

409

 

 

 

402

 

 

 

816

 

 

 

802

 

Cash interest expense

 

 

808

 

 

 

809

 

 

 

1,617

 

 

 

1,618

 

Total interest expense

 

$

1,217

 

 

$

1,211

 

 

$

2,433

 

 

$

2,420

 

v3.24.2
Net Earnings (Loss) Per Share (Tables)
6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Reconciliation of the Numerator and Denominator used in Computing Basic and Diluted Net Earnings (Loss) Per Share

For the periods presented, the following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net earnings (loss) per share (in thousands, except per share amounts):

 

 

Three months ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

9,963

 

 

$

(8,066

)

 

$

43,307

 

 

$

(12,424

)

Interest add back

 

 

 

 

 

 

 

 

2,433

 

 

 

 

Net income (loss) attributable to common stock holders

 

$

9,963

 

 

$

(8,066

)

 

$

45,740

 

 

$

(12,424

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding, basic

 

 

27,889

 

 

 

26,713

 

 

 

27,623

 

 

 

26,499

 

Dilutive effect of:

 

 

 

 

 

 

 

 

 

 

 

 

Stock plans

 

 

1,533

 

 

 

 

 

 

1,506

 

 

 

 

2021 Notes

 

 

 

 

 

 

 

 

2,589

 

 

 

 

Weighted average common shares outstanding, diluted

 

 

29,422

 

 

 

26,713

 

 

 

31,718

 

 

 

26,499

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings (loss) per share — basic

 

$

0.36

 

 

$

(0.30

)

 

$

1.57

 

 

$

(0.47

)

Net earnings (loss) per share — diluted

 

$

0.34

 

 

$

(0.30

)

 

$

1.44

 

 

$

(0.47

)

Computation of Diluted Net Earnings (Loss) Per Share Effect in Antidilutive

The following table presents the outstanding shares of our common stock equivalents excluded from the computation of diluted net earnings (loss) per share as of the dates presented because their effect would have been antidilutive (in thousands):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Stock options

 

 

 

 

 

1,543

 

 

 

 

 

 

1,543

 

RSUs, MSUs and PSUs

 

 

114

 

 

 

1,475

 

 

 

737

 

 

 

1,475

 

Employee stock purchase plan shares

 

 

 

 

 

23

 

 

 

 

 

 

23

 

2021 Notes

 

 

2,589

 

 

 

2,589

 

 

 

 

 

 

2,589

 

v3.24.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Summary of Revenue Categories The following table presents our revenue categories for the indicated periods (in thousands):

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Endpoint ICs

$

89,392

 

 

$

64,905

 

 

$

150,898

 

 

$

131,954

 

Systems

 

13,103

 

 

 

21,081

 

 

 

28,422

 

 

 

39,929

 

Total revenue

$

102,495

 

 

$

85,986

 

 

$

179,320

 

 

$

171,883

 

v3.24.2
Deferred Revenue (Tables)
6 Months Ended
Jun. 30, 2024
Deferred Revenue Disclosure [Abstract]  
Summary of Changes in Deferred Revenue

The following table presents the changes in deferred revenue for the indicated periods (in thousands):

 

Six Months Ended June 30,

 

 

2024

 

 

2023

 

Balance at beginning of period

$

1,985

 

 

$

2,599

 

Opening balance from Voyantic acquisition

 

 

 

 

1,233

 

Deferral of revenue

 

1,630

 

 

 

1,672

 

Recognition of deferred revenue

 

(1,347

)

 

 

(2,640

)

Balance at end of period

$

2,268

 

 

$

2,864

 

v3.24.2
Restructuring (Tables)
6 Months Ended
Jun. 30, 2024
Restructuring and Related Activities [Abstract]  
Summary of Accrued Restructuring Costs

A summary of accrued restructuring costs as of June 30, 2024 is shown in the table below (in thousands):

 

 

 

Six months ended June 30, 2024

 

Restructuring costs

 

 

1,812

 

Non cash payments

 

 

(366

)

Cash payments

 

 

(1,446

)

Accrued restructuring costs as of June 30, 2024

 

$

 

v3.24.2
Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 13, 2024
Jun. 30, 2024
Mar. 31, 2024
Accounting Policies [Abstract]      
Annual license fee payment $ 45    
Additional annual license fee payment $ 15 $ 15  
Litigation settlement expense     $ 45
v3.24.2
Fair Value Measurements - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Contingent consideration liability $ 0 $ 0 $ 6,200,000
Contingent consideration amount paid   4,602,000  
Marketable securities continuous loss position for less than 12 months, estimated fair value 2,000,000 2,000,000 10,200,000
Marketable securities continuous loss position for less than 12 months, unrealized losses 2,000,000 2,000,000 25,000
Marketable securities continuous loss position for greater than 12 months, estimated fair value 3,600,000 3,600,000 8,200,000
Marketable securities continuous loss position for greater than 12 months, unrealized losses 3,600,000 $ 3,600,000 26,000
Voyantic Oy      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Contingent consideration amount paid 7,200,000    
2021 Convertible Senior Notes due 2027      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Debt instrument, maturity year   2027  
Fair Value Measurements Recurring      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Contingent consideration liability     6,180,000
Assets measured at fair value $ 186,954,000 $ 186,954,000 97,101,000
Fair Value Measurements Recurring | Level 3      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Contingent consideration liability     6,180,000
Liabilities measured at fair value     $ 6,180,000
v3.24.2
Fair Value Measurements - Summary of Assets Measured at Fair Value on Recurring Basis (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Acquisition-related contingent consideration liability $ 0 $ 6,200
Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 186,954 97,101
Acquisition-related contingent consideration liability   6,180
Cash Equivalents | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 181,391 78,661
Cash Equivalents | Money Market Funds | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 181,391 78,661
Short-term Investments | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 5,563 18,440
Short-term Investments | U.S. Government Agency Securities | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 3,493 11,893
Short-term Investments | Yankee Bonds | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 1,998 1,951
Short-term Investments | Agency Bonds | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value   2,994
Short-term Investments | Asset-backed Securities | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 72 1,602
Level 1 | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 5,563 18,440
Level 1 | Cash Equivalents | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 181,391 78,661
Level 1 | Cash Equivalents | Money Market Funds | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 181,391 78,661
Level 2 | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 181,391 78,661
Level 2 | Short-term Investments | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 5,563 18,440
Level 2 | Short-term Investments | U.S. Government Agency Securities | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 3,493 11,893
Level 2 | Short-term Investments | Yankee Bonds | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value 1,998 1,951
Level 2 | Short-term Investments | Agency Bonds | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value   2,994
Level 2 | Short-term Investments | Asset-backed Securities | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Assets measured at fair value $ 72 1,602
Level 3 | Fair Value Measurements Recurring    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Acquisition-related contingent consideration liability   6,180
Total liabilities at fair value   $ 6,180
v3.24.2
Fair Value Measurements - Schedule of Additional Information of Liabilities Measured at Fair Value for Company Utilized Level 3 Inputs to Determine Fair Value (Details) - Contingent Consideration Liability
$ in Thousands
6 Months Ended
Jun. 30, 2024
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Balance at beginning of period $ 6,180
Change in fair value of contingent consideration liability due to remeasurement 986
Contingent consideration payment made (7,166)
Balance at end of period $ 0
v3.24.2
Fair Value Measurements - Schedule of Cost Or Amortized Cost, Gross Unrealized Gains, Gross Unrealized Losses, And Total Estimated Fair Value Of Financial Assets (Details) - Fair Value Measurements Recurring - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cost or Amortized Cost $ 186,957 $ 97,151
Gross Unrealized Losses (3) (50)
Total Estimated Fair Value 186,954 97,101
Money Market Funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cost or Amortized Cost 181,391 78,661
Total Estimated Fair Value 181,391 78,661
U.S. Government Agency Securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cost or Amortized Cost 3,496 11,932
Gross Unrealized Losses (3) (39)
Total Estimated Fair Value 3,493 11,893
Yankee Bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cost or Amortized Cost 1,998 1,956
Gross Unrealized Losses   (5)
Total Estimated Fair Value 1,998 1,951
Agency Bond    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cost or Amortized Cost   2,998
Gross Unrealized Losses   (4)
Total Estimated Fair Value   2,994
Asset-Backed Securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cost or Amortized Cost 72 1,604
Gross Unrealized Losses   (2)
Total Estimated Fair Value $ 72 $ 1,602
v3.24.2
Inventory - Schedule of Inventories (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Raw materials $ 18,972 $ 21,773
Work-in-process 37,633 42,217
Finished goods 24,168 33,182
Total inventory $ 80,773 $ 97,172
v3.24.2
Goodwill and Intangible Assets - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 03, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Goodwill [Line Items]              
Goodwill   $ 19,256 $ 19,516 $ 19,256 $ 19,516 $ 19,696 $ 3,881
Weighted average life of intangible assets   6 years   6 years      
Amortization of intangible assets   $ 496 $ 2,146 $ 1,905 $ 2,146    
Voyantic Oy              
Goodwill [Line Items]              
Purchase price $ 32,700            
Consideration value of common stock 3,600            
Deferred payments 4,600            
Fair value of net assets acquired 2,400            
Goodwill 15,600            
Intangible assets 18,400            
Deferred tax liability $ 3,700            
Voyantic Oy | General and Administrative Expense              
Goodwill [Line Items]              
Transaction-related costs for acquisition   $ 100   $ 1,000      
v3.24.2
Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]    
Balance at beginning of period $ 19,696 $ 3,881
Additions from acquisition   15,590
Foreign currency translation adjustment (440) 45
Total $ 19,256 $ 19,516
v3.24.2
Goodwill and Intangible Assets - Schedule of Intangible Assets (Details)
$ in Thousands
Jun. 30, 2024
USD ($)
Finite-Lived Intangible Assets [Line Items]  
Estimated Useful Life in Years 6 years
Gross Carrying Amount $ 18,438
Accumulated Amortization (6,793)
Net Total $ 11,645
Backlog  
Finite-Lived Intangible Assets [Line Items]  
Estimated Useful Life in Years 3 months
Gross Carrying Amount $ 751
Accumulated Amortization $ (751)
Customer Relationships  
Finite-Lived Intangible Assets [Line Items]  
Estimated Useful Life in Years 1 year
Gross Carrying Amount $ 3,595
Accumulated Amortization $ (3,595)
Developed Technology  
Finite-Lived Intangible Assets [Line Items]  
Estimated Useful Life in Years 7 years 3 months
Gross Carrying Amount $ 12,662
Accumulated Amortization (2,183)
Net Total $ 10,479
Patent  
Finite-Lived Intangible Assets [Line Items]  
Estimated Useful Life in Years 3 years
Gross Carrying Amount $ 250
Accumulated Amortization (80)
Net Total $ 170
Tradename  
Finite-Lived Intangible Assets [Line Items]  
Estimated Useful Life in Years 8 years
Gross Carrying Amount $ 1,180
Accumulated Amortization (184)
Net Total $ 996
v3.24.2
Goodwill and Intangible Assets - Schedule of Estimated Intangible Asset Amortization Expense (Details)
$ in Thousands
Jun. 30, 2024
USD ($)
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]  
2024 $ 989
2025 1,977
2026 1,939
2027 1,894
2028 1,894
Thereafter 2,952
Net Total $ 11,645
v3.24.2
Stock-Based Awards - Summary of Restricted Stock Units (Details)
shares in Thousands
6 Months Ended
Jun. 30, 2024
shares
Restricted Stock Units  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Number of Underlying Shares Outstanding, Balance 1,078
Number of Underlying Shares, Granted 397
Number of Underlying Shares, Vested (313)
Number of Underlying Shares, Forfeited (97)
Number of Underlying Shares Outstanding, Balance 1,065
Market and Service Conditions Units  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Number of Underlying Shares Outstanding, Balance 174
Number of Underlying Shares, Granted 161
Number of Underlying Shares, Vested (98)
Number of Underlying Shares, Forfeited (2)
Number of Underlying Shares Outstanding, Balance 235
v3.24.2
Stock-Based Awards - Summary of Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total stock-based compensation expense $ 14,705 $ 13,148 $ 26,495 $ 23,372
Cost of Revenue        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 534 472 987 889
Research and Development Expense        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 6,543 5,879 11,805 10,448
Sales and Marketing Expense        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 2,802 2,790 5,211 4,929
General and Administrative Expense        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total stock-based compensation expense $ 4,826 $ 4,007 $ 8,492 $ 7,106
v3.24.2
Commitments and Contingencies - Additional Information (Details) - USD ($)
3 Months Ended
Mar. 13, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Commitments And Contingencies [Line Items]        
Inventory purchase commitment, amount   $ 27,800,000    
Annual license fee payment $ 45,000,000      
Additional annual license fee payment $ 15,000,000 15,000,000    
Litigation settlement expense     $ 45,000,000  
Accrued Liabilities        
Commitments And Contingencies [Line Items]        
Contingent liabilities   $ 0   $ 0
v3.24.2
Long-term Debt - Summary of Outstanding Principal Amount and Carrying Value (Details) - 2021 Convertible Senior Notes due 2027 - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Principal Amount $ 287,500 $ 287,500
Unamortized debt issuance costs (4,830) (5,645)
Net Carrying Amount $ 282,670 $ 281,855
v3.24.2
Long-term Debt - Convertible Senior Notes - Additional Information (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended
Dec. 11, 2019
Jun. 30, 2022
USD ($)
Nov. 30, 2021
USD ($)
Dec. 31, 2019
Days
$ / shares
Jun. 30, 2024
USD ($)
Days
$ / shares
Dec. 31, 2023
USD ($)
Debt Instrument [Line Items]            
Aggregate principal amount         $ 118,400  
Debt instrument, threshold trading days | Days         5  
Number of business day | Days         5  
Long-term debt         $ 0 $ 281,855
Additional paid in capital         (504,206) (463,900)
Accumulated deficit         $ 386,844 430,151
Closing price of common stock | $ / shares         $ 156.77  
2019 Convertible Senior Notes due 2026            
Debt Instrument [Line Items]            
Cap price of the capped call transactions | $ / shares       $ 54.2    
Capped call transactions expiration consecutive days | Days       40    
Capped call transaction expiring date Dec. 11, 2026          
2019 Convertible Senior Notes due 2026 | 2019 Note Repurchase            
Debt Instrument [Line Items]            
Payment of 2019 Notes   $ 17,600 $ 183,600      
Repurchase of debt principal amount   $ 9,900 $ 76,400      
2021 Convertible Senior Notes due 2027            
Debt Instrument [Line Items]            
Debt instrument, maturity date     May 15, 2027      
Net proceeds from issuing notes     $ 278,400      
Accrued interest         $ 400 400
Unamortized debt issuance costs         4,830 5,645
2021 Convertible Promissory Notes due 2027            
Debt Instrument [Line Items]            
Aggregate principal amount     $ 287,500      
Debt instrument, maturity date     May 15, 2027      
2021 Convertible Promissory Notes due 2027 | Level 2            
Debt Instrument [Line Items]            
Estimated fair value         $ 446,200 $ 314,000
Convertible Senior Notes            
Debt Instrument [Line Items]            
Debt instrument, threshold consecutive trading days | Days         30  
Debt instrument, threshold percentage of stock price trigger         130.00%  
Debt instrument, terms of conversion feature         Regardless of the foregoing circumstances, holders may convert all or any portion of the 2021 Notes, in increments of $1,000 principal amount, on or after February 15, 2027, until the close of business on the second scheduled trading day immediately preceding the maturity date.  
Percentage of repurchase price of principal amount         100.00%  
Convertible Senior Notes | Minimum            
Debt Instrument [Line Items]            
Debt instrument, threshold trading days | Days         20  
Convertible Senior Notes | Maximum            
Debt Instrument [Line Items]            
Debt instrument, threshold percentage of stock price trigger         98.00%  
v3.24.2
Long-term Debt - Schedule of Notes (Details) - 2021 Notes
Unit in Millions
1 Months Ended
Nov. 30, 2021
Unit
$ / shares
shares
Debt Instrument [Line Items]  
Maturity Date May 15, 2027
Interest Rate 1.125%
First Interest Payment Date May 15, 2022
Effective Interest Rate 1.72%
Semi-Annual Interest Payment Dates May 15; November 15
Initial Conversion Rate per $1,000 Principal | shares 9.0061
Initial Conversion Price | $ / shares $ 111.04
Number of Shares (in millions) | Unit 2.6
v3.24.2
Long-term Debt - Schedule of Interest Expense (Details) - 2021 Convertible Senior Notes due 2027 - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Debt Instrument [Line Items]        
Amortization of debt issuance costs $ 409 $ 402 $ 816 $ 802
Cash interest expense 808 809 1,617 1,618
Total interest expense $ 1,217 $ 1,211 $ 2,433 $ 2,420
v3.24.2
Net Earnings (Loss) Per Share - Reconciliation of the Numerator and Denominator used in Computing Basic and Diluted Net Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Numerator:        
Net income (loss) $ 9,963 $ (8,066) $ 43,307 $ (12,424)
Interest add back 0 0 2,433 0
Net income (loss) attributable to common stock holders $ 9,963 $ (8,066) $ 45,740 $ (12,424)
Denominator:        
Weighted-average shares outstanding - basic 27,889 26,713 27,623 26,499
Weighted-average shares outstanding - diluted 29,422 26,713 31,718 26,499
Net loss per share - basic $ 0.36 $ (0.30) $ 1.57 $ (0.47)
Net loss per share - diluted $ 0.34 $ (0.30) $ 1.44 $ (0.47)
Stock Plans        
Denominator:        
Weighted-average shares outstanding - diluted 1,533   1,506  
2021 Notes        
Denominator:        
Weighted-average shares outstanding - diluted 0   2,589  
v3.24.2
Net Earnings (Loss) Per Share - Computation of Diluted Net Earnings (Loss) Per Share Effect in Antidilutive (Details) - shares
shares in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Employee Stock Option        
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share 0 1,543 0 1,543
RSUs, MSUs, and PSUs        
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share 114 1,475 737 1,475
Employee Stock Purchase Plan Shares        
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share 0 23 0 23
2021 Notes        
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share 2,589 2,589 0 2,589
v3.24.2
Segment Information - Additional Information (Details)
6 Months Ended
Jun. 30, 2024
Segment
Segment Reporting [Abstract]  
Number of reportable segments 1
Number of operating segments 1
v3.24.2
Segment Information - Summary of Revenue Categories (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Segment Reporting Information [Line Items]        
Total revenue $ 102,495 $ 85,986 $ 179,320 $ 171,883
Endpoint ICs        
Segment Reporting Information [Line Items]        
Total revenue 89,392 64,905 150,898 131,954
Systems        
Segment Reporting Information [Line Items]        
Total revenue $ 13,103 $ 21,081 $ 28,422 $ 39,929
v3.24.2
Deferred Revenue - Additional Information (Details) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Deferred Revenue Disclosure [Abstract]    
Recognition of deferred revenue $ 1.1 $ 2.0
v3.24.2
Deferred Revenue - Summary of Changes in Deferred Revenue (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Deferred Revenue Disclosure [Abstract]    
Balance at beginning of period $ 1,985 $ 2,599
Opening balance from Voyantic acquisition   1,233
Deferral of revenue 1,630 1,672
Recognition of deferred revenue (1,347) (2,640)
Balance at end of period $ 2,268 $ 2,864
v3.24.2
Related-Party Transactions - Additional Information (Details)
Jun. 23, 2023
USD ($)
Related Party | Endpoint ICs | Patent  
Related Party Transaction [Line Items]  
Patent acquired $ 250,000
v3.24.2
Restructuring - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Feb. 07, 2024
Jun. 30, 2024
Jun. 30, 2024
Restructuring Cost and Reserve [Line Items]      
Number of positions eliminated, percent 10.00%    
Restructuring charges   $ 1,800 $ 1,812
v3.24.2
Restructuring - Summary of Accrued Restructuring Costs (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Restructuring and Related Activities [Abstract]    
Restructuring costs $ 1,800 $ 1,812
Non cash payments   (366)
Cash payments   $ (1,446)

Impinj (NASDAQ:PI)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Impinj Charts.
Impinj (NASDAQ:PI)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Impinj Charts.